<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003738.pub3" GROUP_ID="EYES" ID="411901111615220119" MERGED_FROM="" MODIFIED="2010-02-16 14:47:46 +0100" MODIFIED_BY="Anupa Shah" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.0.23" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2010-02-16 14:47:46 +0100" MODIFIED_BY="Anupa Shah">
<TITLE>Interventions for preventing posterior capsule opacification</TITLE>
<CONTACT MODIFIED="2010-02-16 14:47:46 +0100" MODIFIED_BY="Anupa Shah"><PERSON ID="18230" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Oliver</FIRST_NAME><LAST_NAME>Findl</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>oliver@findl.at</EMAIL_1><URL>www.findl.at</URL><MOBILE_PHONE>+43 6509694020</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Ophthalmology</DEPARTMENT><ORGANISATION>Hanusch Hospital</ORGANISATION><ADDRESS_1>Heinrich-Collin-Strasse 30</ADDRESS_1><CITY>Vienna</CITY><ZIP>A-1140</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 910 21 84610</PHONE_1><FAX_1>+43 1 910 21 84619</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-02-16 14:47:46 +0100" MODIFIED_BY="Anupa Shah"><PERSON ID="18230" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Oliver</FIRST_NAME><LAST_NAME>Findl</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>oliver@findl.at</EMAIL_1><URL>www.findl.at</URL><MOBILE_PHONE>+43 6509694020</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Ophthalmology</DEPARTMENT><ORGANISATION>Hanusch Hospital</ORGANISATION><ADDRESS_1>Heinrich-Collin-Strasse 30</ADDRESS_1><CITY>Vienna</CITY><ZIP>A-1140</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 910 21 84610</PHONE_1><FAX_1>+43 1 910 21 84619</FAX_1></ADDRESS></PERSON><PERSON ID="3487F58982E26AA200B56EFE8576F267" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Wolf</FIRST_NAME><LAST_NAME>Buehl</LAST_NAME><POSITION>Specialist in Ophthalmology</POSITION><EMAIL_1>wolf.buehl@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Ophthalmology</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 40400 7962</PHONE_1><FAX_1>+43 1 40400 7932</FAX_1></ADDRESS></PERSON><PERSON ID="18227" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><LAST_NAME>Bauer</LAST_NAME><POSITION>Head of Medical Institute of Statistics</POSITION><EMAIL_1>peter.bauer@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Medical Statistics</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Spitalgasse23</ADDRESS_1><CITY>Vienna</CITY><ZIP>A-1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 40400 7485</PHONE_1><FAX_1>+43 1 40400 7477</FAX_1></ADDRESS></PERSON><PERSON ID="8888" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Thomas</FIRST_NAME><LAST_NAME>Sycha</LAST_NAME><POSITION>Consultant</POSITION><EMAIL_1>thomas.sycha@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Neurology</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20</ADDRESS_1><CITY>Vienna</CITY><ZIP>A-1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 40400 3120</PHONE_1><FAX_1>+43 1 40400 6215</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-02-16 13:37:16 +0000" MODIFIED_BY="Anupa Shah">
<UP_TO_DATE>
<DATE DAY="27" MONTH="3" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="27" MONTH="3" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2010-02-16 13:46:04 +0000" MODIFIED_BY="Anupa Shah">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-02-16 13:43:03 +0000" MODIFIED_BY="Anupa Shah">
<DATE DAY="16" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Declarations of interest section amended.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-02-16 13:46:04 +0000" MODIFIED_BY="Anupa Shah">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2010-02-16 13:46:04 +0000" MODIFIED_BY="Anupa Shah">
<DATE DAY="26" MONTH="7" YEAR="2009"/>
<DESCRIPTION>
<P>Issue 2, 2010: Updated searches yielded 13 new trials that were included in the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-26 20:32:12 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="26" MONTH="2" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-02-16 13:40:13 +0000" MODIFIED_BY="Anupa Shah">
<SUMMARY MODIFIED="2010-01-20 13:25:21 +0000" MODIFIED_BY="Anupa Shah">
<TITLE>Interventions for preventing posterior capsule opacification</TITLE>
<SUMMARY_BODY MODIFIED="2010-01-20 13:25:21 +0000" MODIFIED_BY="Anupa Shah">
<P>Posterior capsule opacification (PCO) is the most common long-term complication after cataract surgery with implantation of an intraocular lens (IOL). It can be treated by cutting a hole in the posterior lens capsule with an Nd:YAG laser (Neodymium:YAG laser capsulotomy), however this procedure may lead to other complications. It is also expensive and not available in large parts of the developing world. Therefore, many studies have been performed to investigate the pathogenesis of PCO and to find possible ways of preventing it. This review included 66 prospective, randomised, controlled trials assessing the effect of different interventions on PCO. These interventions included modifications in surgical technique explicitly to inhibit PCO, modifications in IOL design (material and geometry), implantation of additional devices and pharmacological therapy compared to each other, placebo or standard treatment. All trials had a follow-up time of at least 12 months. The effect of the intervention on PCO was assessed by measuring visual acuity, (subjective or objective) PCO score and the number of performed Nd:YAG laser capsulotomies. The results of the review were divided into three parts. In part one (effect of IOL material on PCO), the meta-analysis of the included trials found no significant differences in the PCO scores between different IOL materials. In part two (effect of IOL geometry), the meta-analysis showed significantly lower PCO rates in IOLs with sharp posterior optic edges than in IOLs with round optic edges. However, there was no difference between 1-piece and 3-piece IOLs. In part three (influence of surgical technique and drugs on PCO), one trial found a lower PCO rate in IOLs placed in the capsular bag compared to IOLs placed in the sulcus. Another study found a lower PCO rate in eyes with a small capsulorhexis compared to a large capsulorhexis. Where drugs were concerned, only treatment with an immunotoxin led to significantly less PCO in two studies. In summary, primarily the choice of the IOL geometry seems to have a significant influence on the development of PCO. Therefore, IOLs with sharp optic edges should be preferred.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-01-20 13:25:17 +0000" MODIFIED_BY="Anupa Shah">
<ABS_BACKGROUND MODIFIED="2010-01-19 09:46:56 +0000" MODIFIED_BY="[Empty name]">
<P>Posterior capsule opacification (PCO) remains the most common long-term complication after cataract surgery. It can be treated by Nd:YAG laser capsulotomy, however this may lead to other complications and laser treatment is not available in large parts of the developing world. Therefore, many studies try to find factors influencing the development of PCO.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To summarise the effects of different interventions to inhibit PCO. These include modifications of surgical technique and intraocular lens (IOL) design, implantation of additional devices and pharmacological interventions.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-07-26 20:26:37 +0100" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL, MEDLINE, EMBASE, LILACS in March 2009 and reference lists of identified trial reports.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-01-19 10:26:31 +0000" MODIFIED_BY="[Empty name]">
<P>We included only prospective, randomised and controlled trials with a follow-up time of at least 12 months. Interventions included modifications in surgical technique explicitly to inhibit PCO, modifications in IOL design (material and geometry), implantation of additional devices and pharmacological therapy compared to each other, placebo or standard treatment.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2010-01-20 13:17:28 +0000" MODIFIED_BY="Anupa Shah">
<P>We extracted data and entered it into RevMan. We compared visual acuity data, PCO scores and YAG capsulotomy rates and performed a meta-analysis when possible.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-01-20 13:25:17 +0000" MODIFIED_BY="Anupa Shah">
<P>Sixty six studies were included in the review. The review was divided into three parts.<BR/>1. Influence of IOL optic material on the development of PCO. There was no significant difference in PCO development between the different IOL materials (PMMA, hydrogel, hydrophobic acrylic, silicone) although hydrogel IOLs tend to have higher PCO scores and silicone IOLs lower PCO scores than the other materials.<BR/>2. Influence of IOL optic design on the development of PCO. There was a significantly lower PCO score (-8.65 (-10.72 to -6.59), scale 0 to 100) and YAG rate (0.19 (0.11 to 0.35)) in sharp edged than in round edged IOLs, however not between 1-piece and 3-piece IOLs.<BR/>3. Influence of surgical technique and drugs on the development of PCO. There was no significant difference between different types of intraoperative/postoperative anti-inflammatory treatment except for treatment with an immunotoxin (MDX-A) which led to a significantly lower PCO rate.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2010-01-20 13:22:43 +0000" MODIFIED_BY="Anupa Shah">
<P>Due to the highly significant difference between round and sharp edged IOL optics, IOLs with sharp (posterior) optic edges should be preferred. There is no clear difference between optic materials. The choice of postoperative anti-inflammatory treatment does not seem to influence PCO development.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-01-20 14:48:14 +0000" MODIFIED_BY="Anupa Shah">
<BACKGROUND MODIFIED="2010-01-20 13:26:11 +0000" MODIFIED_BY="Anupa Shah">
<P>Extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens (IOL) implantation is the preferred surgical technique for the treatment of cataract in developed countries, and most surgeons in developing countries are now being trained in this method (<LINK REF="REF-Riaz-2006" TYPE="REFERENCE">Riaz 2006</LINK>). In this technique, the lens contents are removed leaving the posterior lens capsule intact. This forms an anatomical barrier between the anterior and posterior segments of the eye. This is thought to reduce the risk of posterior segment complications following surgery (such as cystoid macular oedema and retinal detachment) compared to intracapsular cataract extraction (ICCE), in which the whole lens with intact capsule is removed from the eye. However, leaving the capsule intact may result in long-term complications, mainly that of posterior capsule opacification (PCO) (<LINK REF="REF-Schaumberg-1998" TYPE="REFERENCE">Schaumberg 1998</LINK>). People with PCO suffer from decreased visual acuity, impaired contrast sensitivity and glare disability.</P>
<SUBSECTION>
<HEADING LEVEL="5">Clinical presentation and diagnosis</HEADING>
<P>Clinically, PCO (or after-cataract) is subdivided into two types: regeneratory and fibrotic PCO. Regeneratory PCO is much more common and is the main cause of a decrease in visual function after cataract surgery. Regeneratory PCO is a result of migration of lens epithelial cells along the posterior capsule, behind the IOL. These cells proliferate to form layers of lens material and Elschnig pearls, leading to opacification. In fibrotic PCO, lens epithelial cells of the anterior capsule undergo transformation to myofibroblasts, causing fibrosis and contraction of the capsule bag. This can lead to decentration of the IOL and hinder visualisation of the peripheral retina. If present on the posterior capsule, this may cause vision to deteriorate. Diagnosis is made by slit-lamp examination.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Treatment options</HEADING>
<P>Posterior capsule opacification is usually treated by cutting an opening into the posterior capsule with a neodymium:YAG (Nd:YAG) laser, or rarely by surgical capsulotomy. However, laser treatment may damage the IOL optic, transiently increase intraocular pressure (IOP), induce cystoid macular oedema, increase the incidence of retinal detachment and often does not improve visualisation of the peripheral retina (<LINK REF="REF-Javitt-1992" TYPE="REFERENCE">Javitt 1992</LINK>). Additionally, Nd:YAG laser treatment is associated with high costs for the health care system. In the United States, Nd:YAG capsulotomy is the second most commonly performed ophthalmic surgical procedure after cataract surgery. The annual cost of Nd:YAG capsulotomy was estimated to be $250 million in the United States alone (<LINK REF="REF-Apple-1992" TYPE="REFERENCE">Apple 1992</LINK>). The lack of availability of laser treatment is one of the major reasons why ECCE with IOL implantation is not extensively used in the developing world.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Interventions to reduce posterior capsule opacification</HEADING>
<P>Interventions for preventing PCO fall into four main categories.<BR/>1. Intraocular lens design is determined by two major factors: geometric and material properties. The introduction of sharp optic edges appears to reduce the incidence of PCO. It is unclear whether differences in the style of IOL loops (or haptics) play a role in PCO inhibition. Intraocular lens optic materials range from the high water content hydrophilic acrylic material to low water content hydrophobic acrylic material to hydrophobic silicone material. These materials differ in their physical and chemical properties. To date, the effect of IOL material on PCO is unclear.</P>
<P>2. Surgical modifications include polishing the capsule to reduce the number of lens epithelial cells remaining in the capsule bag after surgery with the aim of delaying the formation of PCO and reducing the amount of PCO. Another surgical strategy is to control the size of the capsulorhexis (the opening in the anterior capsule); a smaller capsulorhexis usually results in a complete overlap of anterior capsule and IOL optic. This sealing is thought to enhance the PCO inhibiting effect of the IOL optic.</P>
<P>3. Additional implants such as capsular tension rings that are implanted into the capsule bag before IOL implantation may contribute to inhibiting PCO. </P>
<P>4. Pharmacological interventions during or after surgery with the goal of depleting or inhibiting regeneration of remaining lens epithelial cells have recently received some attention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Rationale for a systematic review</HEADING>
<P>There is an extensive body of published data on interventions to reduce the incidence of PCO. In order to draw conclusions regarding the different interventions for preventing PCO, a systematic review of randomised controlled trials (RCTs) was undertaken. A Cochrane review evaluating different surgical interventions for age-related cataract has already been published (<LINK REF="REF-Riaz-2006" TYPE="REFERENCE">Riaz 2006</LINK>).</P>
</SUBSECTION>
</BACKGROUND>
<OBJECTIVES MODIFIED="2010-01-19 11:21:07 +0000" MODIFIED_BY="[Empty name]">
<P>The aim of this review was to summarise the effects of different interventions to inhibit posterior capsule opacification after cataract surgery. The types of interventions include modifications of surgical technique, modifications in intraocular lens design, implantation of additional devices and pharmacological interventions.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-01-20 13:27:14 +0000" MODIFIED_BY="Anupa Shah">
<SELECTION_CRITERIA MODIFIED="2010-01-20 13:26:48 +0000" MODIFIED_BY="Anupa Shah">
<CRIT_STUDIES MODIFIED="2009-12-08 11:42:11 +0000" MODIFIED_BY="Anupa Shah">
<P>This review included only prospective, randomised and controlled trials with a follow-up time of at least 12 months.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-01-20 13:26:21 +0000" MODIFIED_BY="Anupa Shah">
<P>Participants in the trials were people with age-related cataract without prior sight threatening ocular disease (glaucoma, corneal disease, uveitis, traumatic or complicated cataract, retinal disease or history of diabetes mellitus with diabetic retinopathy) who underwent cataract surgery with implantation of an intraocular lens into the capsule bag.<BR/>
</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2010-01-20 13:26:38 +0000" MODIFIED_BY="Anupa Shah">
<P>Interventions included modifications in surgical technique explicitly to inhibit PCO, modifications in intraocular lens design (material and geometry), implantation of additional devices and pharmacological therapy compared to each other, placebo or standard treatment.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-01-20 13:26:48 +0000" MODIFIED_BY="Anupa Shah">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2010-01-20 13:26:42 +0000" MODIFIED_BY="Anupa Shah">
<P>The primary outcome measure for this review was best corrected visual acuity (BCVA). The minimum length of follow-up was 12 months. We chose visual acuity as our primary outcome parameter because, at the time the review was planned, we expected more studies reporting visual acuity data than PCO scores and because visual acuity would be easier to compare than different types of PCO scores.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-01-20 13:26:48 +0000" MODIFIED_BY="Anupa Shah">
<P>The secondary outcome measures were intensity of PCO, as assessed with scoring techniques or quantification by image analysis, and proportion of people needing capsulotomy (Nd:YAG laser capsulotomy rate). Assessment of PCO intensity/severity is complicated by the fact that there is no commonly accepted scoring method for PCO (<LINK REF="REF-Findl-2003" TYPE="REFERENCE">Findl 2003</LINK>). There are several well-known subjective scoring systems such as the EPCO (Evaluation of PCO) computer-aided scoring system as well as 'semi-objective' or objective systems such as the POCO (posterior capsule opacification) and AQUA (Automated Quantification of After-Cataract) systems, both based on automated analysis of retro-illumination PCO images. Besides, there is a frequently used objective PCO assessment method based on analysis of Scheimpflug images.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-12-09 16:30:28 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2009-12-09 16:30:28 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group Trials Register) (<I>The Cochrane Library, </I>Issue 1, 2009), MEDLINE (January 1950 to March 2009), EMBASE (January 1980 to March 2009) and Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to March 2009). There were no language or date restrictions in the search for trials. The electronic databases were last searched on 27 March 2009.</P>
<P>See: Appendices for details of search strategies for CENTRAL (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), MEDLINE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), EMBASE (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and LILACS (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-12-08 11:42:26 +0000" MODIFIED_BY="Anupa Shah">
<P>We manually searched reference lists of relevant trial reports. We did not manually search any conference abstracts for this review. There were no language restrictions in the searches for trials. If there was no English abstract available in foreign language publications or any doubts whether a trial should be included in the review, we asked a translator for advice.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-01-20 13:27:14 +0000" MODIFIED_BY="Anupa Shah">
<SUBSECTION>
<HEADING LEVEL="5">Selection of trials</HEADING>
<P>Two review authors reviewed the titles and abstracts resulting from the searches. The same authors obtained full text copies of possibly and definitely relevant trials and assessed them according to the definitions in the 'Criteria for considering studies for review'. We only assessed trials meeting these criteria for methodological quality. There were no restrictions concerning publication date.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Assessment on methodological quality</HEADING>
<P>We assessed trial quality according to the new methods set out in Chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We used four components to determine methodological quality: allocation concealment, performance bias, detection bias and attrition bias. We graded each component as Yes (low risk of bias), No (high risk of bias) and Unclear. Two review authors assessed the trial quality and resolved disagreements by discussion, the use of additional referees or both. The review authors were not masked to any trial detail during the assessment. If we were unable to make a decision about the classification of a study due to lack of information, we tried to contact the study authors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Data collection</HEADING>
<P>Two review authors independently extracted data onto forms developed by the Cochrane Eyes and Vision Group. The authors compared these and resolved discrepancies by discussion. One author entered data into RevMan (Cochrane software). If data were missing, we tried to contact the authors by email and asked them to provide the missing information within a period of two months. We contacted 10 authors concerning 22 studies and got replies from five authors for 12 studies. We did not exclude studies with missing standard deviation (SD) values but we could not incorporate them in the meta-analyses.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Data synthesis</HEADING>
<P>We performed data synthesis according to the Cochrane Eyes and Vision Group review development guidelines. We summarised data from studies collecting comparable outcome measures with similar follow-up times. We presented dichotomous outcomes as odds ratios or risk ratios, and continuous outcomes as the mean difference. We used a random-effects model, unless there were fewer than three trials in a comparison, when we used a fixed-effect model. We examined heterogeneity between trial results using a Chi<SUP>2</SUP> test. If we detected heterogeneity either by the test (I<SUP>2 </SUP>statistic) or clinically within the trials, we mentioned this in the results section of the review.</P>
<P>Since different types of PCO scores (EPCO, POCO, AQUA system, other scoring techniques) were used in the studies, we attempted to convert the values to a "common score" (0 to 100) to be able to compare these values in forest plots. It was presumed that the PCO scoring systems were linear systems. Otherwise, it would not have been possible to perform meta-analyses for the PCO score. Both analysis of PCO scores and of visual acuity data is additionally complicated by the fact that YAG capsulotomies may lead to a bias in many studies; when PCO scores or visual acuity data or both includes eyes after a YAG capsulotomy. The best way to handle this problem would be to estimate the missing PCO scores after a capsulotomy (<LINK REF="STD-Buehl-2005" TYPE="STUDY">Buehl 2005</LINK>; <LINK REF="STD-Findl-2005a" TYPE="STUDY">Findl 2005a</LINK>), however, in most studies there is no information on how the problem of YAG drop-outs was handled. When there were several follow-up examinations in a study, we used data of the last available follow-up examination for the meta-analysis in this review.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-01-20 14:48:14 +0000" MODIFIED_BY="Anupa Shah">
<STUDY_DESCRIPTION MODIFIED="2010-01-20 13:27:26 +0000" MODIFIED_BY="Anupa Shah">
<SEARCH_RESULTS MODIFIED="2010-01-20 13:27:26 +0000" MODIFIED_BY="Anupa Shah">
<P>
<I>See</I>: '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' and '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' tables</P>
<P>The electronic searches (the original search and March 2009 update) revealed 642 reports in total. In many cases it was obvious from the title or from the methods section of the abstract that the study did not meet our inclusion criteria (such as no original paper, not age-related cataracts, no PCO assessment, not prospective and randomised, follow-up time too short). After excluding these papers, review papers and papers with insufficient data or without a translation, we identified 106 controlled trials that seemed to meet the review inclusion criteria.</P>
<P>Of those 106 reports, we had to exclude:</P>
<UL>
<LI>26 papers because it turned out that these trials were not randomised (<LINK REF="STD-Aasuri-2002" TYPE="STUDY">Aasuri 2002</LINK>; <LINK REF="STD-Abhilakh-2003" TYPE="STUDY">Abhilakh 2003</LINK>; <LINK REF="STD-Auffarth-2003" TYPE="STUDY">Auffarth 2003</LINK>; <LINK REF="STD-Cumming-2001" TYPE="STUDY">Cumming 2001</LINK>; <LINK REF="STD-D_x0027_Eliseo-2003" TYPE="STUDY">D'Eliseo 2003</LINK>; <LINK REF="STD-Dada-1999" TYPE="STUDY">Dada 1999</LINK>; <LINK REF="STD-Davison-2002" TYPE="STUDY">Davison 2002</LINK>; <LINK REF="STD-Georgopoulos-2001" TYPE="STUDY">Georgopoulos 2001</LINK>; <LINK REF="STD-Georgopoulos-2003" TYPE="STUDY">Georgopoulos 2003</LINK>; <LINK REF="STD-Khalifa-1992" TYPE="STUDY">Khalifa 1992</LINK>; <LINK REF="STD-Kruger-2000" TYPE="STUDY">Kruger 2000</LINK>; <LINK REF="STD-Li-2008" TYPE="STUDY">Li 2008</LINK>; <LINK REF="STD-Meacock-2001b" TYPE="STUDY">Meacock 2001b</LINK>; <LINK REF="STD-Miyata-2007" TYPE="STUDY">Miyata 2007</LINK>; <LINK REF="STD-Mootha-2004" TYPE="STUDY">Mootha 2004</LINK>; <LINK REF="STD-Nekolov_x00e1_-2008" TYPE="STUDY">Nekolová 2008</LINK>; <LINK REF="STD-Nirmalan-2002" TYPE="STUDY">Nirmalan 2002</LINK>; <LINK REF="STD-Nishi-1998" TYPE="STUDY">Nishi 1998</LINK>; <LINK REF="STD-Nishi-2007" TYPE="STUDY">Nishi 2007</LINK>; <LINK REF="STD-Oharazawa-2007" TYPE="STUDY">Oharazawa 2007</LINK>; <LINK REF="STD-Ozdemir-2007" TYPE="STUDY">Ozdemir 2007</LINK>; <LINK REF="STD-Ram-2001" TYPE="STUDY">Ram 2001</LINK>; <LINK REF="STD-Strobel-2002" TYPE="STUDY">Strobel 2002</LINK>; <LINK REF="STD-Tassignon-2002" TYPE="STUDY">Tassignon 2002</LINK>; <LINK REF="STD-Wren-2005" TYPE="STUDY">Wren 2005</LINK>) or randomisation was not appropriate (participants were selected retrospectively from another study) (<LINK REF="STD-Thompson-2004" TYPE="STUDY">Thompson 2004</LINK>);</LI>
<LI>one paper because it contained data of other included studies (<LINK REF="STD-Sacu-2005b" TYPE="STUDY">Sacu 2005b</LINK>) and one paper because the main outcome measure was not PCO and a PCO score was not assessable (<LINK REF="STD-Abela_x002d_Formanek-2002" TYPE="STUDY">Abela-Formanek 2002</LINK>);</LI>
<LI>three papers because follow-up time was less than one year (<LINK REF="STD-Afsar-1999" TYPE="STUDY">Afsar 1999</LINK>; <LINK REF="STD-Aktan-1992" TYPE="STUDY">Aktan 1992</LINK>; <LINK REF="STD-Tobari-1999" TYPE="STUDY">Tobari 1999</LINK>);</LI>
<LI>one paper because it was not on age-related cataracts (<LINK REF="STD-Alio-2002" TYPE="STUDY">Alio 2002</LINK>); and</LI>
<LI>two papers because they did not fit into any category of this review (<LINK REF="STD-Hayashi-2008" TYPE="STUDY">Hayashi 2008</LINK>; <LINK REF="STD-Vock-2007" TYPE="STUDY">Vock 2007</LINK>).</LI>
</UL>
<P>Of the remaining 72 papers, we pooled some publications because they seemed to report on identical patient groups (<LINK REF="STD-Clark-1998" TYPE="STUDY">Clark 1998</LINK>; <LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-H_x00fc_tz-1989" TYPE="STUDY">Hütz 1989</LINK>). We therefore finally included 66 original RCTs that fulfilled the criteria. All studies used a standard cataract surgery technique (either ECCE or phacoemulsification).</P>
<P>There were no adverse events or any harms of treatment caused by the investigated devices/drugs described in the included studies.</P>
</SEARCH_RESULTS>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-01-20 13:28:17 +0000" MODIFIED_BY="Anupa Shah">
<P>
<I>See</I>: '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table</P>
<P>Inclusion criteria: all included studies were prospective, randomised and included only otherwise healthy people with age-related cataracts.</P>
<P>Exclusion criteria: exclusion criteria were quite similar in all included studies (i.e. other severe ocular diseases affecting visual acuity like glaucoma, severe age-related macular degeneration and other pathologies of the cornea, vitreous or retina as well as non-compliance or bad overall constitution).</P>
<P>Some of the studies did not adequately describe the randomisation process. It is therefore unclear in these cases if allocation concealment was performed properly (i.e. no description of randomisation method used, no information on blinding (double-masked etc.). In those cases, we graded the studies as Unclear. All other studies we graded as Yes (low risk of bias). We tried to contact some of the authors of studies graded Unclear, however, we did not get many replies. As mentioned above, all included studies were prospective and randomised.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-01-20 14:48:14 +0000" MODIFIED_BY="Anupa Shah">
<P>The following abbreviations have been used for this section:<BR/>BCDVA: best corrected distance visual acuity<BR/>ECCE: extracapsular cataract extraction<BR/>HSM-PMMA: heparin surface modified polymethyl methacrylate<BR/>ICCE: intracapsular cataract extraction<BR/>IOL: intraocular lens<BR/>PCO: posterior capsular opacification<BR/>PMMA: polymethyl methacrylate<BR/>SD: standard deviation</P>
<SUBSECTION>
<HEADING LEVEL="5">A. Influence of IOL optic material on the development of PCO</HEADING>
<P>The meta-analysis of the included studies showed no significant differences in PCO scores between the different IOL optic materials (PMMA, hydrophilic acrylic, hydrophobic acrylic, silicone). However, some of the studies compared round edge IOLs with sharp edge IOLs. In those cases, the optic edge design probably had more effect on the development of PCO than the IOL optic material (see also B below).</P>
<P>
<B>
<I>1. PMMA versus silicone IOLs (ECCE technique in one study)</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Only one included trial (53 eyes) reported adequate visual acuity data (<LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>), which favoured the silicone group (mean difference: -0.11; 95% CI: -0.16 to -0.06).<BR/>
<I>(b) PCO score:</I>
<BR/>A total of 652 eyes were randomised in nine studies, one of them using ECCE (<LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>) and the other eight using a phaco technique (<LINK REF="STD-Dick-1997" TYPE="STUDY">Dick 1997</LINK>; <LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; <LINK REF="STD-Olson-1998" TYPE="STUDY">Olson 1998</LINK>; <LINK REF="STD-Wang-2000" TYPE="STUDY">Wang 2000</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>; <LINK REF="STD-Yoshida-2002" TYPE="STUDY">Yoshida 2002</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>). Two of these studies compared sharp edge silicone IOLs with round edge PMMA IOLs (<LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>). Posterior capsule opacification scores were lower in the silicone group in seven of the studies and equal to the PMMA group in one study. In one study, the PCO score was higher in the silicone group than in the PMMA group (<LINK REF="STD-Wang-2000" TYPE="STUDY">Wang 2000</LINK>). However, SD values were missing in five studies (<LINK REF="STD-Dick-1997" TYPE="STUDY">Dick 1997</LINK>; <LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Olson-1998" TYPE="STUDY">Olson 1998</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). The mean difference of the remaining four studies was 5.69 (95% CI: -1.50 to 12.88). We did not present a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see </I>
<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 478 eyes were randomised in six studies, all of them using a phaco technique (<LINK REF="STD-Dick-1997" TYPE="STUDY">Dick 1997</LINK>; <LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; <LINK REF="STD-Olson-1998" TYPE="STUDY">Olson 1998</LINK>; <LINK REF="STD-Wang-2000" TYPE="STUDY">Wang 2000</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). Two of the six studies favoured the silicone group, one the PMMA group, and three showed no difference between groups. The overall effect favours silicone over PMMA (odds ratio: 1.69, 95% CI: 0.58 to 4.91). However, one of these studies compared round edge PMMA with sharp edge silicone IOLs (<LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). Again, we presented no summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see</I> <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).<BR/>
<I>
<BR/>
<B>2. PMMA versus hydrogel IOLs</B>
</I>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>No significant difference in best corrected visual acuity between the groups was found in one study (<LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; 53 eyes). The mean difference was 0.06 (95% CI: -0.02 to 0.14).<BR/>
<I>(b) PCO score:</I>
<BR/>A total of 105 eyes were randomised in two studies (<LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; <LINK REF="STD-Meacock-2001" TYPE="STUDY">Meacock 2001</LINK>). The pooled estimate of effect favours PMMA over hydrogel (mean difference: -17.0; 95% CI: -27.69 to -6.31).<BR/>
<I>(c) YAG rate:</I>
<BR/>Only one trial (<LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>) reported YAG rates. There was no significant difference in the number of Nd:YAG laser capsulotomies between the PMMA and the hydrogel group (odds ratio: 0.43; 95% CI: 0.11 to 1.69).</P>
<P>
<B>
<I>3. PMMA versus acrylic IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>We found no study reporting visual acuity data that met the inclusion criteria of this review.<BR/>
<I>(b) PCO score (BCDVA):</I>
<BR/>A total of 733 eyes were randomised in seven trials (<LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Khanzada-2008" TYPE="STUDY">Khanzada 2008</LINK>; <LINK REF="STD-Shah-2008" TYPE="STUDY">Shah 2008</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>; <LINK REF="STD-Yoshida-2002" TYPE="STUDY">Yoshida 2002</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>), four of them found significantly lower PCO scores in the acrylic group (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Shah-2008" TYPE="STUDY">Shah 2008</LINK>; <LINK REF="STD-Yoshida-2002" TYPE="STUDY">Yoshida 2002</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>). Three studies did not report SD values and the effect was not estimable, however all of them also found lower PCO scores in the acrylic group (<LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Khanzada-2008" TYPE="STUDY">Khanzada 2008</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). All of these studies compared sharp edge acrylic with round edge PMMA IOLs. The overall effect of the four studies reporting SD values was 11.28 (95% CI: 3.25 to 19.31). We presented no summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see</I> <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 403 eyes were randomised in three studies reporting YAG rates (<LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Shah-2008" TYPE="STUDY">Shah 2008</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). The overall effect favoured acrylic over PMMA (odds ratio: 7.19; 95% CI: 2.72 to 18.96). However, sharp edge acrylic IOLs were compared with round edge PMMA IOLs in these studies.</P>
<P>
<B>
<I>4. Acrylic versus silicone IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>There was no significant difference in visual acuity between groups in three studies (285 eyes; <LINK REF="STD-Allers-2000" TYPE="STUDY">Allers 2000</LINK>; <LINK REF="STD-Hayashi-2007" TYPE="STUDY">Hayashi 2007</LINK>; <LINK REF="STD-Rabsilber-2006" TYPE="STUDY">Rabsilber 2006</LINK>) (mean difference: -0.05; 95% CI: -0.13 to 0.03) but this result is inconclusive because of statistical heterogeneity.<BR/>
<I>(b) PCO score:</I>
<BR/>Twelve studies (1140 eyes) reported PCO scores, most of them comparing sharp edge acrylic and sharp edge silicone IOLs (<LINK REF="STD-Allers-2000" TYPE="STUDY">Allers 2000</LINK>; <LINK REF="STD-Findl-2005b" TYPE="STUDY">Findl 2005b</LINK>; <LINK REF="STD-Hayashi-2007" TYPE="STUDY">Hayashi 2007</LINK>; <LINK REF="STD-Kohnen-2008" TYPE="STUDY">Kohnen 2008</LINK>; <LINK REF="STD-Mester-2004" TYPE="STUDY">Mester 2004</LINK>; <LINK REF="STD-Prosdocimo-2003" TYPE="STUDY">Prosdocimo 2003</LINK>; <LINK REF="STD-Rabsilber-2006" TYPE="STUDY">Rabsilber 2006</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>; <LINK REF="STD-Wejde-2004" TYPE="STUDY">Wejde 2004</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>) except for two studies comparing sharp edge acrylic IOLs with round edge silicone IOLs (<LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>; <LINK REF="STD-Yoshida-2002" TYPE="STUDY">Yoshida 2002</LINK>). The pooled estimate of effect for seven studies reporting SD values did not show a difference between both groups (0.16; 95% CI: -0.19 to 0.51), this result is inconclusive because of statistical heterogeneity (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). However, five of the studies did not report SDs, three of them favouring acrylic (<LINK REF="STD-Allers-2000" TYPE="STUDY">Allers 2000</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>; <LINK REF="STD-Wejde-2004" TYPE="STUDY">Wejde 2004</LINK>) and two favouring silicone (<LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>; <LINK REF="STD-Prosdocimo-2003" TYPE="STUDY">Prosdocimo 2003</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 1051 eyes were randomised in ten studies, three of them favouring the acrylic group (<LINK REF="STD-Hayashi-1998" TYPE="STUDY">Hayashi 1998</LINK>; <LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>) and three the silicone group (<LINK REF="STD-Hayashi-2007" TYPE="STUDY">Hayashi 2007</LINK>; <LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>; <LINK REF="STD-Rabsilber-2006" TYPE="STUDY">Rabsilber 2006</LINK>). Four studies found no difference between groups (<LINK REF="STD-Allers-2000" TYPE="STUDY">Allers 2000</LINK>; <LINK REF="STD-Findl-2005b" TYPE="STUDY">Findl 2005b</LINK>; <LINK REF="STD-Kohnen-2008" TYPE="STUDY">Kohnen 2008</LINK>; <LINK REF="STD-Mester-2004" TYPE="STUDY">Mester 2004</LINK>). However, three studies compared round edge silicone with sharp edge acrylic IOLs (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>). Two of these three studies found a lower YAG rate in the (sharp edge) acrylic group, but one found a lower YAG rate in the (round edge) silicone group (<LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>). One study did not report SD values (<LINK REF="STD-Allers-2000" TYPE="STUDY">Allers 2000</LINK>). The pooled estimate of effect for the remaining nine studies does not show a significant difference between groups (odds ratio: 0.84; 95% CI: 0.43 to 1.64). When looking only at those seven studies (829 eyes) comparing sharp edge acrylic and sharp edge silicone IOLs, the overall effect was 0.97 (95% CI: 0.45 to 2.07) (<I>see</I> <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>).</P>
<P>
<B>
<I>5. Acrylic versus hydrogel IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Five studies (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>; <LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>) reported visual acuity results (follow-up of 424 eyes), all of them favouring the acrylic group. The overall mean difference was 0.09 (95% CI: 0.06 to 0.12) (<I>see </I>
<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).<BR/>
<I>(b) PCO score:</I>
<BR/>Six studies (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>; <LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>; <LINK REF="STD-Kugelberg-2006" TYPE="STUDY">Kugelberg 2006</LINK>) reported PCO scores (follow-up of 540 eyes), again favouring the acrylic group. Two trials did not report SD values (<LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-Kugelberg-2006" TYPE="STUDY">Kugelberg 2006</LINK>). The mean difference of the remaining four studies (two of them (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>) comparing sharp edge acrylic with round edge hydrogel IOLs) was -40.76 (95% CI: -86.58 to 5.06). We have not presented a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see </I>
<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>The same six studies (follow-up of 550 eyes) also found significantly lower YAG rates in the acrylic group. The overall odds ratio was 0.14 (95% CI: 0.03 to 0.68; result inconclusive) (<I>see</I> <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). Again, sharp edge acrylic IOLs were compared with round edge hydrogel IOLs in two studies (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>). Four studies compared a sharp edge acrylic with a sharp edge hydrogel IOL, one of them favouring the acrylic IOL (<LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>) and three the hydrogel IOL (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>; <LINK REF="STD-Kugelberg-2006" TYPE="STUDY">Kugelberg 2006</LINK>).</P>
<P>
<B>
<I>6. Silicone versus hydrogel IOLs</I>
</B>
<BR/>We found no study comparing silicone and hydrogel IOLs that met the inclusion criteria of this review.<BR/>
<I>
<BR/>
<B>7. Hydrogel versus all other materials<BR/>
</B>(a) Visual acuity (BCDVA):<BR/>
</I>A total of 477 eyes were randomised in six trials, two of them favouring the (sharp edge) hydrogel group (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>). One study found no difference (<LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>) and three found significantly worse visual acuity results in the hydrogel group (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>
<I>; </I>
<LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>). The overall mean difference was -0.01 (95% CI: -0.04 to 0.01; result inconclusive) (<I>see</I> <LINK REF="CMP-007.01" TYPE="ANALYSIS">Analysis 7.1</LINK>).<BR/>
<I>(b) PCO score:<BR/>
</I>A total of 529 eyes were randomised in seven trials, five of them found significantly higher PCO scores in the hydrogel group (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>; <LINK REF="STD-Meacock-2001" TYPE="STUDY">Meacock 2001</LINK>), two found lower PCO scores in the (sharp edge) hydrogel group (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>). The overall effect was 2.07 (95% CI: -0.35 to 4.48; result inconclusive) (<I>see</I> <LINK REF="CMP-007.02" TYPE="ANALYSIS">Analysis 7.2</LINK>).<BR/>
<I>(c) YAG rate:<BR/>Six</I> studies (487 eyes) reported YAG rates, two of them favouring the (sharp edge) hydrogel group (<LINK REF="STD-Cleary-2009" TYPE="STUDY">Cleary 2009</LINK>; <LINK REF="STD-Hancox-2007" TYPE="STUDY">Hancox 2007</LINK>) and four the other IOL material (<LINK REF="STD-Hayashi-2004" TYPE="STUDY">Hayashi 2004</LINK>; <LINK REF="STD-Heatley-2005" TYPE="STUDY">Heatley 2005</LINK>; <LINK REF="STD-Hollick-2000" TYPE="STUDY">Hollick 2000</LINK>; <LINK REF="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TYPE="STUDY">Kücüksümer 2000</LINK>) (odds ratio: 2.04; 95% CI: 1.22 to 3.44; result inconclusive) (<I>see</I> <LINK REF="CMP-007.03" TYPE="ANALYSIS">Analysis 7.3</LINK>).</P>
<P>
<B>
<I>8. HSM-PMMA IOLs versus PMMA IOLs</I>
</B>
<BR/>Two hundred and fifty eyes were randomised in one study comparing HSM-PMMA and PMMA IOLs (<LINK REF="STD-Winther-1998" TYPE="STUDY">Winther 1998</LINK>). The YAG capsulotomy rate was significantly lower in the HSM-PMMA group (odds ratio: 0.26; 95% CI: 0.15 to 0.45).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">B. Influence of IOL optic design on the development of PCO</HEADING>
<P>The meta-analysis of the included studies showed significantly less PCO in sharp edge than in round edge IOLs of the same optic material. Looking at the pooled results of all studies comparing sharp and round optic edges (irrespective of the optic material), there was also a clear difference between the two IOL edge designs, not only in PCO score and YAG rates, but also in BCDVA. There was no clear evidence for a significant effect of a laser ridge in PMMA IOLs on the development of PCO (pooled results).</P>
<P>
<B>
<I>9. Sharp versus round optic edges in PMMA IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Two studies (<LINK REF="STD-Findl-2005a" TYPE="STUDY">Findl 2005a</LINK>; <LINK REF="STD-Shah-2007" TYPE="STUDY">Shah 2007</LINK>) compared sharp and round optic edges in PMMA IOLs (278 eyes) and found no significant difference between the two groups. Only one study (<LINK REF="STD-Findl-2005a" TYPE="STUDY">Findl 2005a</LINK>) reported SD values (mean difference: -0.05; 95% CI: -0.18 to 0.08).<BR/>
<I>(b) PCO score:</I>
<BR/>The same two studies found a significantly higher PCO score in the round edge group (mean difference: -19.67; 95% CI: -28.87 to -10.47).<BR/>
<I>(c) YAG rate:</I>
<BR/>There was no significant overall difference in the YAG capsulotomy rate in the same two studies (odds ratio: 0.54; 95% CI: 0.26 to 1.13).</P>
<P>
<B>
<I>10. Sharp versus round optic edges in acrylic IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Two hundred eyes were randomised in two studies. Visual acuity was significantly better in the sharp edge group in one of these studies (<LINK REF="STD-Buehl-2005" TYPE="STUDY">Buehl 2005</LINK>). It was slightly but not significantly better in the second study (<LINK REF="STD-Hayashi-2005" TYPE="STUDY">Hayashi 2005</LINK>). The mean difference was 0.06 (95% CI: 0.01 to 0.12). This result is inconclusive.<BR/>
<I>(b) PCO score:</I>
<BR/>A total of 334 eyes were randomised in three studies reporting PCO scores (<LINK REF="STD-Buehl-2002" TYPE="STUDY">Buehl 2002</LINK>; <LINK REF="STD-Hayashi-2005" TYPE="STUDY">Hayashi 2005</LINK>; <LINK REF="STD-Sacu-2004d" TYPE="STUDY">Sacu 2004d</LINK>), all of them favouring the sharp edge group (mean overall effect: -10.47; 95% CI: -17.23 to -3.72). We have not presented a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see </I>
<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>Two studies (200 eyes) reported YAG rates (<LINK REF="STD-Buehl-2005" TYPE="STUDY">Buehl 2005</LINK>; <LINK REF="STD-Hayashi-2005" TYPE="STUDY">Hayashi 2005</LINK>), both of them favouring the sharp edge group (odds ratio: 0.07; 95% CI: 0.02 to 0.32).</P>
<P>
<B>
<I>11. Sharp versus round optic edges in silicone IOLs</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Visual acuity was found to be significantly better in the sharp edge group in one study (<LINK REF="STD-Sundelin-2005" TYPE="STUDY">Sundelin 2005</LINK>; 116 eyes) while there was no difference in visual acuity in another study (<LINK REF="STD-Buehl-2004" TYPE="STUDY">Buehl 2004</LINK>; 80 eyes). The mean difference was 0.06 (95% CI: 0.00 to 0.12). This result is inconclusive because of statistical heterogeneity.<BR/>
<I>(b) PCO score:</I>
<BR/>Six studies (576 eyes) reported PCO scores, all of them favouring the sharp edge group (<LINK REF="STD-Buehl-2004" TYPE="STUDY">Buehl 2004</LINK>; <LINK REF="STD-Kohnen-2008" TYPE="STUDY">Kohnen 2008</LINK>; <LINK REF="STD-Mester-2004" TYPE="STUDY">Mester 2004</LINK>; <LINK REF="STD-Sacu-2004d" TYPE="STUDY">Sacu 2004d</LINK>; <LINK REF="STD-Sacu-2005a" TYPE="STUDY">Sacu 2005a</LINK>; <LINK REF="STD-Sundelin-2005" TYPE="STUDY">Sundelin 2005</LINK>). The mean overall effect was -6.99 (95% CI: -11.46 to -2.51). Again, this result is inconclusive because of statistical heterogeneity (<I>see </I>
<LINK REF="CMP-011.02" TYPE="ANALYSIS">Analysis 11.2</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 554 eyes were randomised in five studies, all of them favouring the sharp edge group (<LINK REF="STD-Buehl-2007" TYPE="STUDY">Buehl 2007</LINK>; <LINK REF="STD-Kohnen-2008" TYPE="STUDY">Kohnen 2008</LINK>; <LINK REF="STD-Mester-2004" TYPE="STUDY">Mester 2004</LINK>; <LINK REF="STD-Sacu-2005a" TYPE="STUDY">Sacu 2005a</LINK>; <LINK REF="STD-Sundelin-2005" TYPE="STUDY">Sundelin 2005</LINK>). The mean overall effect was 0.23 (95% CI: 0.10 to 0.52) (<I>see</I> <LINK REF="CMP-011.03" TYPE="ANALYSIS">Analysis 11.3</LINK>).</P>
<P>
<B>
<I>12. Sharp versus round optic edges without consideration of the IOL material</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Eight studies (906 eyes) reported visual acuity results, five of them favouring the sharp edge group. There was no significant difference between the groups in three studies (<LINK REF="STD-Buehl-2002" TYPE="STUDY">Buehl 2002</LINK>; <LINK REF="STD-Findl-2005a" TYPE="STUDY">Findl 2005a</LINK>; <LINK REF="STD-Shah-2007" TYPE="STUDY">Shah 2007</LINK>). One study did not report SD values (<LINK REF="STD-Shah-2007" TYPE="STUDY">Shah 2007</LINK>). The overall mean difference of the remaining seven studies was 0.09 (95% CI: 0.02 to 0.15). We have not presented a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see </I>
<LINK REF="CMP-012.01" TYPE="ANALYSIS">Analysis 12.1</LINK>).<BR/>
<I>(b) PCO score:</I>
<BR/>Eighteen studies (1889 eyes) reported PCO scores, all except two (<LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>) favouring the sharp edge group. However, four of them did not report SD values (<LINK REF="STD-Hollick-1998" TYPE="STUDY">Hollick 1998</LINK>; <LINK REF="STD-Khanzada-2008" TYPE="STUDY">Khanzada 2008</LINK>; <LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>; <LINK REF="STD-Wejde-2003" TYPE="STUDY">Wejde 2003</LINK>). The mean overall effect for the 14 remaining studies was -8.07 (95% CI: -10.01 to -6.13). Again, we have not presented a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see</I> <LINK REF="CMP-012.02" TYPE="ANALYSIS">Analysis 12.2</LINK>).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 1456 eyes were randomised in 13 studies, 12 of them favouring the sharp edge group and one the round edge group (<LINK REF="STD-Pohjalainen-2002" TYPE="STUDY">Pohjalainen 2002</LINK>). The mean overall effect was 0.26 (95% CI: 0.15 to 0.45) (<I>see </I>
<LINK REF="CMP-012.03" TYPE="ANALYSIS">Analysis 12.3</LINK>).<BR/>
<I>
<BR/>
<B>13. 1-piece versus 3-piece acrylic IOLs</B>
</I>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>Five studies (320 eyes) reported visual acuity results. Four of them found no significant difference between the groups (<LINK REF="STD-Leydolt-2007" TYPE="STUDY">Leydolt 2007</LINK>; <LINK REF="STD-Nejima-2004" TYPE="STUDY">Nejima 2004</LINK>; <LINK REF="STD-Nejima-2006" TYPE="STUDY">Nejima 2006</LINK>; <LINK REF="STD-Sacu-2004a" TYPE="STUDY">Sacu 2004a</LINK>), one favoured the 1-piece group (<LINK REF="STD-Hancox-2008" TYPE="STUDY">Hancox 2008</LINK>). One study did not report SD values (<LINK REF="STD-Sacu-2004a" TYPE="STUDY">Sacu 2004a</LINK>). The mean overall difference was 0.01 (95% CI: -0.02 to 0.05).<BR/>
<I>(b) PCO score:</I>
<BR/>Nine studies (1123 eyes) reported PCO scores, two of them favouring the 3-piece IOL (<LINK REF="STD-Sacu-2004a" TYPE="STUDY">Sacu 2004a</LINK>; <LINK REF="STD-Zemaitiene-2004" TYPE="STUDY">Zemaitiene 2004</LINK>) and one the 1-piece IOL (<LINK REF="STD-Hancox-2008" TYPE="STUDY">Hancox 2008</LINK>). The other six studies found no significant difference between the groups (<LINK REF="STD-Bender-2004" TYPE="STUDY">Bender 2004</LINK>; <LINK REF="STD-Bilge-2004" TYPE="STUDY">Bilge 2004</LINK>; <LINK REF="STD-Leydolt-2007" TYPE="STUDY">Leydolt 2007</LINK>; <LINK REF="STD-Nejima-2004" TYPE="STUDY">Nejima 2004</LINK>; <LINK REF="STD-Nejima-2006" TYPE="STUDY">Nejima 2006</LINK>; <LINK REF="STD-Zemaitiene-2007" TYPE="STUDY">Zemaitiene 2007</LINK>). One study did not report SD values (<LINK REF="STD-Bilge-2004" TYPE="STUDY">Bilge 2004</LINK>). The mean difference of the remaining eight studies was 0.40 (95% CI: -1.06 to 1.86), the result inconclusive due to statistical heterogeneity).<BR/>
<I>(c) YAG rate:</I>
<BR/>There was no significant difference in the YAG rate in five studies (<LINK REF="STD-Bender-2004" TYPE="STUDY">Bender 2004</LINK>; <LINK REF="STD-Bilge-2004" TYPE="STUDY">Bilge 2004</LINK>; <LINK REF="STD-Leydolt-2007" TYPE="STUDY">Leydolt 2007</LINK>; <LINK REF="STD-Sacu-2004a" TYPE="STUDY">Sacu 2004a</LINK>; <LINK REF="STD-Zemaitiene-2007" TYPE="STUDY">Zemaitiene 2007</LINK>) (871 eyes; odds ratio: 1.06; 95% CI: 0.27 to 4.19).</P>
<P>
<B>
<I>14. 1-piece versus 3-piece PMMA IOLs</I>
</B>
<BR/>There was no significant difference in the YAG capsulotomy rate in one study (<LINK REF="STD-Martin-1992" TYPE="STUDY">Martin 1992</LINK>; 314 eyes) comparing 1-piece and 3-piece PMMA IOLs (odds ratio: 0.94; 95% CI: 0.59 to 1.51).<BR/>
<I>
<BR/>
<B>15. Convex-plano versus Plano-convex (reverse optic) IOLs (ECCE)</B>
</I>
<BR/>One study (<LINK REF="STD-Sellmann-1988" TYPE="STUDY">Sellmann 1988</LINK>; 237 eyes) found a significantly lower PCO incidence in the reverse optic group (odds ratio: 2.63; 95% CI: 1.16 to 5.96). However, there was no significant difference in the YAG rate at one year in the same study (odds ratio: 1.18; 95% CI: 0.51 to 2.72). An ECCE technique was used in this study.</P>
<P>
<B>
<I>16. PMMA IOLs with ridge versus PMMA IOLs without ridge</I>
</B>
<BR/>
<I>(a) Visual acuity (BCDVA):</I>
<BR/>We found no study reporting visual acuity data that met the inclusion criteria of this review.<BR/>
<I>(b) PCO incidence:</I>
<BR/>One study (<LINK REF="STD-Westling-1991" TYPE="STUDY">Westling 1991</LINK>; 257 eyes) found less presence of PCO in the group with laser ridge one year after surgery (odds ratio: 0.55; 95% CI: 0.33 to 0.9).<BR/>
<I>(c) YAG rate:</I>
<BR/>A total of 565 eyes were randomised in three studies, one of them favouring the no-ridge group (<LINK REF="STD-Winther-1998" TYPE="STUDY">Winther 1998</LINK>). However, the pooled estimate of effect did not show a significant difference between the groups (odds ratio: 1.37; 95% CI: 0.88 to 2.16) (<I>see </I>
<LINK REF="CMP-016.01" TYPE="ANALYSIS">Analysis 16.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">C. Influence of surgical technique and drugs on the development of PCO</HEADING>
<P>Only a few studies could be combined in a meta-analysis. We therefore provided a description of the individual study findings in most cases.<BR/>
<B>
<I>
<BR/>17. Bag versus sulcus placement of IOLs</I>
</B>
<BR/>One study (<LINK REF="STD-Martin-1992" TYPE="STUDY">Martin 1992</LINK>) found a significantly lower YAG rate in IOLs placed in the capsular bag (odds ratio: 0.20; 95% CI: 0.12 to 0.35).<BR/>
<I>
<BR/>
<B>18. Rhexis on versus rhexis off</B>
</I>
<BR/>Three studies (<LINK REF="STD-Aykan-2003" TYPE="STUDY">Aykan 2003</LINK>; <LINK REF="STD-Vasavada-2004" TYPE="STUDY">Vasavada 2004</LINK>; <LINK REF="STD-Wejde-2004" TYPE="STUDY">Wejde 2004</LINK>) randomised 718 eyes. Two studies found a significantly higher PCO score in eyes with no contact between IOL and anterior rhexis (<LINK REF="STD-Aykan-2003" TYPE="STUDY">Aykan 2003</LINK>; <LINK REF="STD-Wejde-2004" TYPE="STUDY">Wejde 2004</LINK>). However, another study found no difference in the PCO score and in the YAG rate between both groups (<LINK REF="STD-Vasavada-2004" TYPE="STUDY">Vasavada 2004</LINK>). We were not able to calculate the overall effect because of missing SD values in these studies.</P>
<P>
<B>
<I>19. Small versus large rhexis</I>
</B>
<BR/>One study comparing small and large rhexis diameters (<LINK REF="STD-Hollick-1999" TYPE="STUDY">Hollick 1999</LINK>) found a significantly lower PCO score in the small rhexis group (mean difference: -3.35; 95% CI: -4.89 to -1.81).</P>
<P>
<B>
<I>20. Anterior capsule polishing</I>
</B>
<BR/>Two studies reported fibrotic PCO scores; one of them found a significantly higher rate of (fibrotic) PCO in the unpolished eyes (<LINK REF="STD-Sacu-2004b" TYPE="STUDY">Sacu 2004b</LINK>), whereas the other one did not (<LINK REF="STD-Sacu-2004c" TYPE="STUDY">Sacu 2004c</LINK>). The mean difference in (fibrotic) PCO score was -5.55 (95% CI: -19.47 to 8.36). We have not presented a summary analysis in the forest plot due to statistical heterogeneity and the result is therefore inconclusive (<I>see</I> <LINK REF="CMP-020.01" TYPE="ANALYSIS">Analysis 20.1</LINK>). Another study (<LINK REF="STD-Bolz-2006" TYPE="STUDY">Bolz 2006</LINK>) reported regeneratory PCO scores and found no difference between groups (0.13; 95% CI: -0.63 to 0.89).</P>
<P>
<B>
<I>21. Capsular bending ring versus no ring</I>
</B>
</P>
<P>One study comparing additional implantation of a sharp edged capsular bending ring with standard IOL implantation found significantly better visual acuity (mean difference 0.13; 95% CI: 0.3 to 0.23) and significantly lower PCO score (-15.3; 95% CI: -19.34 to -11.26) and YAG capsulotomy rate (odds ratio 0.04; 95% CI: 0.01 to 0.34) in eyes implanted with an additional capsular bending ring.</P>
<P>
<B>
<I>22. Sealed capsule irrigation with distilled water versus none</I>
</B>
</P>
<P>There was no significant difference in PCO score (mean difference: -2.5; 95% CI: -14.35 to 9.35) and YAG capsulotomy rate (odds ratio: 1.61; 95% CI: 0.23 to 11.09) in one study (<LINK REF="STD-Rabsilber-2007" TYPE="STUDY">Rabsilber 2007</LINK>).</P>
<P>
<B>
<I>23. Dexamethasone versus placebo</I>
</B>
<BR/>There was no significant difference in PCO score in one study (<LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>; no SD values). Two studies (<LINK REF="STD-Laurell-2002" TYPE="STUDY">Laurell 2002</LINK>; <LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>; 200 eyes) found no difference in the YAG rate between both groups (odds ratio: 1.16; 95% CI: 0.54 to 2.48).</P>
<P>
<B>
<I>24. Diclofenac versus placebo</I>
</B>
<BR/>There was no significant difference in PCO score in one study (<LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>; no SD values). Two studies (<LINK REF="STD-Laurell-2002" TYPE="STUDY">Laurell 2002</LINK>; <LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>; 205 eyes) found no difference in the YAG rate between both groups (odds ratio: 1.25; 95% CI: 0.6 to 2.63).<BR/>
<I>
<BR/>
<B>25. Dexamethasone/Betamethasone versus Diclofenac</B>
</I>
<BR/>Four studies randomised 283 eyes. Three studies (<LINK REF="STD-Barequet-2002" TYPE="STUDY">Barequet 2002</LINK>; <LINK REF="STD-Tsuchiya-2003" TYPE="STUDY">Tsuchiya 2003</LINK>; <LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>) reported PCO scores and found no significant difference between groups (mean difference: 1.95; 95% CI: -0.28 to 4.18). One of these studies did not report SD values (<LINK REF="STD-Zaczek-2004" TYPE="STUDY">Zaczek 2004</LINK>). All studies found no significant difference in the YAG capsulotomy rate between both groups (odds ratio: 1.07; 95% CI: 0.56 to 2.06) (<I>see </I>
<LINK REF="CMP-025.02" TYPE="ANALYSIS">Analysis 25.2</LINK>).<BR/>
<I>
<BR/>
<B>26. Diclofenac versus Ketorolac</B>
</I>
<BR/>In one study (<LINK REF="STD-Flach-2000" TYPE="STUDY">Flach 2000</LINK>; 120 eyes) there was no significant difference between both groups in the PCO incidence (mean difference: 1.77; 95% CI: 0.82 to 3.82) nor in the YAG rate (odds ratio: 1.08; 95% CI: 0.37 to 3.19).</P>
<P>
<B>
<I>27. Immunotoxin MDX-A versus Placebo</I>
</B>
<BR/>Eighty-nine eyes were randomised in two studies (<LINK REF="STD-Clark-1998" TYPE="STUDY">Clark 1998</LINK>; <LINK REF="STD-Meacock-2000" TYPE="STUDY">Meacock 2000</LINK>). Both studies found a lower PCO score after treatment with the immunotoxin MDX-A. However, we were not able to calculate the overall effect because of missing SD values in both studies. One study (<LINK REF="STD-Clark-1998" TYPE="STUDY">Clark 1998</LINK>) also reported a lower YAG rate in the treatment group (odds ratio: 0.08; 95% CI: 0.02 to 0.30).</P>
<P>
<B>
<I>28. Heparin eye drops versus no treatment</I>
</B>
<BR/>One study (<LINK REF="STD-Mastropasqua-1997" TYPE="STUDY">Mastropasqua 1997</LINK>; 192 eyes) found a lower, although not significantly lower, YAG rate in eyes treated with heparin eye drops (odds ratio: 0.45; 95% CI: 0.17 to 1.17).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-01-20 13:36:18 +0000" MODIFIED_BY="Anupa Shah">
<P>This systematic review included 66 prospective RCTs dealing with factors that may have an effect on the development of posterior capsule opacification (PCO) after cataract surgery. We compared visual acuity data, PCO scores and YAG capsulotomy rates.</P>
<P>It should be mentioned that the PCO scoring systems varied largely among the studies. Some authors used subjective scoring techniques and some used objective methods or both. Objective methods should be preferred for evidence based studies because the results can be compared more easily and usually do not depend on the examiner. A comparison between four commonly used scoring techniques was published previously by our group (<LINK REF="REF-Findl-2003" TYPE="REFERENCE">Findl 2003</LINK>). Apart from the PCO scores and Nd:YAG laser capsulotomy rates, there was little evidence on patient oriented outcomes such as visual acuity, contrast sensitivity or general vision related quality of life. However, it has already been shown that many PCO scores correlate well with the PCO-induced loss of visual acuity, contrast sensitivity or both (<LINK REF="REF-Buehl-2005b" TYPE="REFERENCE">Buehl 2005b</LINK>; <LINK REF="REF-Buehl-2005c" TYPE="REFERENCE">Buehl 2005c</LINK>; <LINK REF="REF-Hayashi-2003" TYPE="REFERENCE">Hayashi 2003</LINK>; <LINK REF="REF-Meacock-2003" TYPE="REFERENCE">Meacock 2003</LINK>). Therefore, it can be assumed that a PCO score is a good substitute for PCO-related patient discomfort.</P>
<P>Despite the different scoring techniques we were able to convert the results to a "common PCO score" ranging from 0 (no PCO) to 100 (maximum PCO score) in most cases, in order to calculate the overall effect (mean difference). However, we were unable to include the results of several studies in the meta-analysis because of missing standard deviations. Apart from the different PCO scoring methods, different follow-up periods were used in the included studies. Nevertheless, we decided to combine the data of all studies, provided that there was a follow-up time of at least one year. Otherwise, there would have been too many subgroups and a meta-analysis of the data would not have been possible for most of the comparisons.</P>
<P>Due to the large number of included studies we divided the review into three parts.</P>
<SUBSECTION>
<HEADING LEVEL="5">1. Influence of IOL optic material on PCO</HEADING>
<P>The meta-analysis of the included studies showed no significant differences between different IOL optic materials (PMMA, hydrophilic acrylic, hydrophobic acrylic, silicone), although silicone IOLs seem to have lower PCO rates in several studies and hydrogel (hydrophilic acrylic) IOLs tend to have higher PCO scores than other materials. However, the meta-analysis of the data in this first part of the review was complicated by the fact that some of the studies compared round edge IOLs with sharp edge IOLs. In those cases, the difference in optic edge design probably had more effect on the development of PCO than the difference in optic material. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Influence of IOL design on PCO</HEADING>
<P>We could provide clear evidence that sharp edge IOLs develop significantly less PCO than round edge IOLs of the same optic material. Looking at the pooled results of all studies comparing sharp and round optic edges (irrespective of the optic material), there was a clear difference between the two IOL edge designs, not only in PCO score and YAG rates, but also in best corrected distance visual acuity. There was no clear evidence for a significant effect of a laser ridge in PMMA IOLs on the development of PCO (pooled results).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Influence of surgical techniques and drugs on PCO</HEADING>
<P>We could only combine a few studies in a meta-analysis. We therefore provided a description of the individual study findings in most cases. We found a significant influence of anterior capsule polishing and of the additional implantation of a capsular bending ring on the amount of PCO. There was no clear evidence for a significant effect of capsulorrhexis size and IOL/capsulorrhexis overlap on PCO. Looking at the effect of drugs on PCO development, most studies found no significant difference between various drugs, except for an Immunotoxin (MDX-A) which led to significantly lower PCO rates in two studies.</P>
<P>In summary, there are still many open questions. It has been shown in several studies that sharp IOL optic edges show significantly less PCO than round edged IOLs. However, there is too little data on additional factors influencing PCO, especially on surgical techniques and drugs.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-01-20 13:36:43 +0000" MODIFIED_BY="Anupa Shah">
<IMPLICATIONS_PRACTICE MODIFIED="2009-07-26 19:52:55 +0100" MODIFIED_BY="[Empty name]">
<P>Due to the highly significant difference between round and sharp edge intraocular lenses (IOL) optics, IOLs with sharp (posterior) optic edges should be preferred. However, most round edge IOL types have already disappeared from the market in the meantime. On the other hand, there is no clear difference between optic materials, although hydrogel IOLs showed more and silicone IOLs less posterior capsule opacification (PCO) than other materials in some studies. The choice of postoperative anti-inflammatory treatment does not seem to influence PCO development; however, there are too few evidence-based studies up to now.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-01-20 13:36:43 +0000" MODIFIED_BY="Anupa Shah">
<P>Further efforts should be directed to the question of whether there is a difference between the currently widely used IOL materials (hydrophobic acrylic and silicone). There are still no prospective RCTs focusing on the effect of posterior capsule polishing, capsular tension rings and primary posterior capsulorrhexis on PCO, nor on the effect of drugs on PCO. It has also become obvious that it is important to use a standardised method for quantification of PCO. A "common" PCO scoring method would make the comparison of different trials easier.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The electronic searches were developed and executed by the Cochrane Eyes and Vision Group editorial team. We are grateful to Bruce Allan for peer review comments on the protocol of this review. We thank David Allen, Marie Diener-West and Roberta Scherer for their comments on the review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2010-02-16 13:40:13 +0000" MODIFIED_BY="Anupa Shah">
<P>Oliver Findl and Wolf Buehl are authors on some of the studies that have been included in the review. However, neither author has any financial or proprietary interests in any of the studies included.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2010-01-20 14:47:01 +0000" MODIFIED_BY="Anupa Shah">
<P>Oliver Findl and Wolf Buehl were responsible for:<BR/>Screening search results<BR/>Data management<BR/>Extracting data from papers<BR/>Analysis of data<BR/>Interpretation of data<BR/>Writing the review<BR/>Updating the review</P>
<P>Oliver Findl was responsible for:<BR/>Conceiving the review<BR/>Designing the review<BR/>Coordinating the review</P>
<P>Wolf Buehl was responsible for:<BR/>Entering data into RevMan</P>
<P>Peter Bauer was responsible for:<BR/>Statistical analysis</P>
<P>Thomas Sycha was responsible for:<BR/>Screening retrieved papers against inclusion criteria<BR/>Appraising quality of papers<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2010-01-20 14:39:42 +0000" MODIFIED_BY="Anupa Shah">
<P>This is the last version of this review. Due to the length of the review and the increasing number of included trials and because of the requirements to update the review with new Cochrane methodology, the review will be split up in to 3 new reviews; one assessing the influence of IOL optic material on PCO, the second assessing the influence of IOL optic design on PCO and a third one assessing the influence of surgical and pharmacological interventions on PCO.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-01-20 14:15:30 +0000" MODIFIED_BY="Anupa Shah">
<STUDIES MODIFIED="2010-01-20 14:15:30 +0000" MODIFIED_BY="Anupa Shah">
<INCLUDED_STUDIES MODIFIED="2010-01-20 14:15:30 +0000" MODIFIED_BY="Anupa Shah">
<STUDY DATA_SOURCE="PUB" ID="STD-Allers-2000" NAME="Allers 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allers A, Baumeister M, Steinkamp GWK, Ohrloff C, Kohnen T</AU>
<TI>Intraindividual comparison of intraocular lenses made of highly refractive silicone (Allergan SI40NB) and hydrophobic acrylic (Alcon Acrysof MA60BM): 1-year follow-up</TI>
<TO>Intraindividueller Vergleich von Intraokularlinsen aus hochrefraktivem Silikon (Allergan SI40NB) und hydrophobem Acrylat (Alcon Acrysof MA60BM): 1-Jahresergebnisse</TO>
<SO>Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft</SO>
<YR>2000</YR>
<VL>97</VL>
<NO>10</NO>
<PG>669-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aykan-2003" NAME="Aykan 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aykan U, Bilge AH, Karadayi K, Akin T</AU>
<TI>The effect of capsulorhexis size on development of posterior capsule opacification: small (4.5 to 5.0 mm) versus large (6.0 to 7.0 mm)</TI>
<SO>European Journal of Ophthalmology</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>6</NO>
<PG>541-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barequet-2002" NAME="Barequet 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barequet IS, Wygnanski-Jaffe T, Sachs D</AU>
<TI>Effect on posterior capsule opacification of topical diclofenac sodium vs dexamethasone phosphate after cataract surgery</TI>
<SO>Annals of Ophthalmology</SO>
<YR>2002</YR>
<VL>34</VL>
<NO>2</NO>
<PG>142-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bender-2004" NAME="Bender 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bender LE, Nimsgern C, Jose R, Jayaram H, Spalton DJ, Tetz MR, et al</AU>
<TI>Effect of 1-piece and 3-piece AcrySof intraocular lenses on the development of posterior capsule opacification after cataract surgery</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>4</NO>
<PG>786-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bilge-2004" NAME="Bilge 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bilge AH, Aykan U, Akin T, Unsal U</AU>
<TI>The effects of three-piece or single-piece acrylic intraocular lens implantation on posterior capsule opacification</TI>
<SO>European Journal of Ophthalmology</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>5</NO>
<PG>375-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bolz-2006" NAME="Bolz 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bolz M, Menapace R, Findl O, Sacu S, Buehl W, Wirtitsch M, et al</AU>
<TI>Effect of anterior capsule polishing on the posterior capsule opacification-inhibiting properties of a sharp-edged, 3-piece, silicone intraocular lens. Three- and 5-year results of a randomized trial</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>9</NO>
<PG>1513-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buehl-2002" NAME="Buehl 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Findl O, Menapace R, Rainer G, Sacu S, Kiss B, et al</AU>
<TI>Effect of an acrylic intraocular lens with a sharp posterior optic edge on posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>7</NO>
<PG>1105-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buehl-2004" MODIFIED="2010-01-20 14:15:30 +0000" MODIFIED_BY="Anupa Shah" NAME="Buehl 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-01-20 14:15:30 +0000" MODIFIED_BY="Anupa Shah" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Menapace R, Sacu S, Kriechbaum K, Koeppl C, Wirtitsch M, et al</AU>
<TI>Effect of a silicone intraocular lens with a sharp posterior optic edge on posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>8</NO>
<PG>1661-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buehl-2005" NAME="Buehl 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Findl O, Menapace R, Sacu S, Kriechbaum K, Koeppl C, et al</AU>
<TI>Long-term effect of optic edge design in an acrylic intraocular lens on posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>5</NO>
<PG>954-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buehl-2007" MODIFIED="2009-06-29 20:31:47 +0100" MODIFIED_BY="[Empty name]" NAME="Buehl 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-06-29 20:31:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Menapace R, Findl O, Neumayer T, Bolz M, Prinz A</AU>
<TI>Long-term effect of optic edge design in a silicone intraocular lens on posterior capsule opacification</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2007</YR>
<VL>143</VL>
<NO>6</NO>
<PG>913-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-1998" NAME="Clark 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark DS, Emery JM, Munsell MF</AU>
<TI>Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24 month clinical results</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>12</NO>
<PG>1614-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark DS, Munsell MF, Emery JM</AU>
<TI>Mathematical model to predict the need for neodymium:YAG capsulotomy based on posterior capsule opacification rate</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>12</NO>
<PG>1621-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cleary-2009" MODIFIED="2009-07-11 18:03:49 +0100" MODIFIED_BY="[Empty name]" NAME="Cleary 2009" YEAR="2009">
<REFERENCE MODIFIED="2009-07-11 18:03:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cleary G, Spalton DJ, Hancox J, Boyce J, Marshall J</AU>
<TI>Randomized intraindividual comparison of posterior capsule opacification between a microincision intraocular lens and a conventional intraocular lens</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2009</YR>
<VL>35</VL>
<NO>2</NO>
<PG>265-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dick-1997" MODIFIED="2009-12-09 16:34:40 +0000" MODIFIED_BY="[Empty name]" NAME="Dick 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-12-09 16:34:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dick B, Kohnen T, Jacobi F, Jacobi KW</AU>
<TI>Long-term results after implantation of different intraocular lenses through a clear-corneal tunnel incision</TI>
<TO>Langzeitergebnisse nach Implantation verschiedener Intraokularlinsen über einen Hornhauttunnel</TO>
<SO>Klinische Monatsblätter der Augenheilkunde</SO>
<YR>1997</YR>
<VL>211</VL>
<NO>2</NO>
<PG>106-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Findl-2005a" NAME="Findl 2005a" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Findl O, Buehl W, Menapace R, Sacu S, Georgopoulos M, Rainer G</AU>
<TI>Long-term effect of sharp optic edges of a polymethyl methacrylate intraocular lens on posterior capsule opacification: A randomized trial</TI>
<SO>Ophthalmology</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>11</NO>
<PG>2004-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Findl-2005b" NAME="Findl 2005b" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Findl O, Menapace R, Sacu S, Buehl W, Rainer G</AU>
<TI>Effect of optic material on posterior capsule opacification in intraocular lenses with sharp-edge optics: Randomized clinical trial</TI>
<SO>Ophthalmology</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>1</NO>
<PG>67-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flach-2000" NAME="Flach 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flach J, Dalan B</AU>
<TI>Incidence of postoperative posterior capsular opacification following treatment with Diclofenac 0.1% and Ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation</TI>
<SO>Transactions of the American Ophthalmological Society</SO>
<YR>2000</YR>
<VL>98</VL>
<PG>101-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hancox-2007" MODIFIED="2009-12-09 15:40:42 +0000" MODIFIED_BY="[Empty name]" NAME="Hancox 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 15:40:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hancox J, Spalton D, Heatley C, Jayaram H, Yip J, Boyce J, et al</AU>
<TI>Fellow-eye comparison of posterior capsule opacification rates after implantation of 1CU accommodating and AcrySof MA30 monofocal intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>3</NO>
<PG>413-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hancox-2008" MODIFIED="2009-12-09 16:36:29 +0000" MODIFIED_BY="[Empty name]" NAME="Hancox 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-12-09 16:36:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hancox J, Spalton D, Cleary G, Boyce J, Nanavaty MA, Thyagarajan S, et al</AU>
<TI>Fellow-eye comparison of posterior capsule opacification with AcrySof SN60AT and AF-1 YA-60BB blue-blocking intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>9</NO>
<PG>1489-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayashi-1998" NAME="Hayashi 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi H, Hayashi K, Nakao F, Hayashi F</AU>
<TI>Quantitative comparison of posterior capsule opacification after polymethylmethacrylate, silicone, and soft acrylic intraocular lens implantation</TI>
<SO>Archives of Ophthalmology</SO>
<YR>1998</YR>
<VL>116</VL>
<NO>12</NO>
<PG>1579-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Hayashi H, Nakao F, Hayashi F</AU>
<TI>Changes in posterior capsule opacification after poly(methylmethacrylate), silicone, and acrylic intraocular lens implantation</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>6</NO>
<PG>817-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayashi-2004" NAME="Hayashi 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Hayashi H</AU>
<TI>Posterior capsule opacification after implantation of a hydrogel intraocular lens</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2004</YR>
<VL>88</VL>
<NO>2</NO>
<PG>182-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayashi-2005" NAME="Hayashi 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Hayashi H</AU>
<TI>Posterior capsule opacification in the presence of an intraocular lens with a sharp versus rounded optic edge</TI>
<SO>Ophthalmology</SO>
<YR>2005</YR>
<VL>112</VL>
<NO>9</NO>
<PG>1550-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayashi-2007" MODIFIED="2009-12-09 15:54:18 +0000" MODIFIED_BY="[Empty name]" NAME="Hayashi 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 15:54:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Hayashi H</AU>
<TI>Influence on posterior capsule opacification and visual function of intraocular lens optic material</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2007</YR>
<VL>144</VL>
<NO>2</NO>
<PG>195-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heatley-2005" NAME="Heatley 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heatley CJ, Spalton DJ, Kumar A, Jose R, Boyce J, Bender LE</AU>
<TI>Comparison of posterior capsule opacification rates between hydrophilic and hydrophobic single-piece acrylic intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>4</NO>
<PG>718-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollick-1998" NAME="Hollick 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollick EJ, Spalton DJ, Ursell PG, Pande MV, Barman SA, Boyce JF, et al</AU>
<TI>The effect of polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3 years after cataract surgery</TI>
<SO>Ophthalmology</SO>
<YR>1999</YR>
<VL>106</VL>
<NO>1</NO>
<PG>49-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollick EJ, Spalton DJ, Ursell PG, Pande MV</AU>
<TI>Lens epithelial cell regression on the posterior capsule with different intraocular lens materials</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>1998</YR>
<VL>82</VL>
<NO>10</NO>
<PG>1182-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ursell PG, Spalton DJ, Pande MV, Hollick EJ, Barman S, Boyce J, et al</AU>
<TI>Relationship between intraocular lens biomaterials and posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>3</NO>
<PG>352-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollick-1999" NAME="Hollick 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollick EJ, Spalton DJ, Meacock WR</AU>
<TI>The effect of capsulorhexis size on posterior capsular opacification: one-year results of a randomized prospective trial</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>1999</YR>
<VL>128</VL>
<NO>3</NO>
<PG>271-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollick-2000" NAME="Hollick 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollick EJ, Spalton DJ, Ursell PG, Meacock WR, Barman SA, Boyce JF</AU>
<TI>Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trial</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2000</YR>
<VL>129</VL>
<NO>5</NO>
<PG>577-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-H_x00fc_tz-1989" MODIFIED="2009-12-09 16:49:46 +0000" MODIFIED_BY="[Empty name]" NAME="Hütz 1989" YEAR="1989">
<REFERENCE MODIFIED="2009-12-09 16:39:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hütz W, Hessemer V, Özer E</AU>
<TI>After-cataracts following implantation of intraocular lenses with and without a laser ridge</TI>
<TO>Nachstar bei Intraocularlinsen mit und ohne Laserridge</TO>
<SO>Fortschritte der Ophthalmologie: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft</SO>
<YR>1989</YR>
<VL>86</VL>
<NO>3</NO>
<PG>206-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-12-09 16:40:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hütz W, Küstermann R, Hessemer V</AU>
<TI>Prospective study on the rate of after-cataracts following implantation of different intraocular lenses</TI>
<TO>Prospektive Studie über die Häufigkeit des Nachstars bei verschiedenen Linsentypen mit und ohne Laserridge</TO>
<SO>Fortschritte der Ophthalmologie: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft</SO>
<YR>1990</YR>
<VL>87</VL>
<NO>6</NO>
<PG>583-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-12-09 16:49:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hütz W</AU>
<TI>Secondary cataract in intraocular lenses with and without laser ridge, a prospective study with 5 years follow-up</TI>
<TO>Prospektive Studie über den Nachstar nach 5 Jahren bei Intraokularlinsen mit und ohne Laserridge</TO>
<SO>Klinische Monatsblätter der Augenheilkunde</SO>
<YR>1993</YR>
<VL>203</VL>
<NO>2</NO>
<PG>104-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khanzada-2008" MODIFIED="2009-07-18 17:00:56 +0100" MODIFIED_BY="[Empty name]" NAME="Khanzada 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-18 17:00:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khanzada MA, Gul S, Dabir SA, Jatoi SM, Narsani AK</AU>
<TI>Comparative incidence of posterior capsular opacification in AcrySof and PMMA intraocular lenses</TI>
<SO>International Journal of Ophthalmology</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>12</NO>
<PG>2369-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohnen-2008" MODIFIED="2009-12-09 16:02:49 +0000" MODIFIED_BY="[Empty name]" NAME="Kohnen 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-12-09 16:02:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohnen T, Fabian E, Gerl R, Hunold W, Hütz W, Strobel J, et al</AU>
<TI>Optic edge design as long-term factor for posterior capsular opacification rates</TI>
<SO>Ophthalmology</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>8</NO>
<PG>1308-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kugelberg-2006" NAME="Kugelberg 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kugelberg M, Wejde G, Jayaram H, Zetterstrom C</AU>
<TI>Posterior capsule opacification after implantation of a hydrophilic or a hydrophobic acrylic intraocular lens. One-year follow-up</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>10</NO>
<PG>1627-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" NAME="Kücüksümer 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kücüksümer Y, Bayraktar S, Sahin S, Yilmaz ÖF</AU>
<TI>Posterior capsule opacification 3 years after implantation of an AcrySof and a MemoryLens in fellow eyes</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>8</NO>
<PG>1176-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurell-2002" NAME="Laurell 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurell CG, Zetterstrom C</AU>
<TI>Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>86</VL>
<NO>12</NO>
<PG>1380-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leydolt-2007" MODIFIED="2009-12-09 16:03:24 +0000" MODIFIED_BY="[Empty name]" NAME="Leydolt 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 16:03:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leydolt C, Davidovic S, Sacu S, Menapace R, Neumayer T, Prinz A, et al</AU>
<TI>Long-term effect of 1-piece and 3-piece hydrophobic acrylic intraocular lens on posterior capsule opacification: a randomized trial</TI>
<SO>Ophthalmology</SO>
<YR>2007</YR>
<VL>114</VL>
<NO>9</NO>
<PG>1663-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin-1992" NAME="Martin 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin RG, Sanders DR, Souchek J, Raanan MG, DeLuca M</AU>
<TI>Effect of posterior chamber intraocular lens design and surgical placement on postoperative outcome</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1992</YR>
<VL>18</VL>
<NO>4</NO>
<PG>333-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mastropasqua-1997" NAME="Mastropasqua 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mastropasqua L, Lobefalo L, Ciancaglini M, Ballone E, Gallenga PE</AU>
<TI>Heparin eyedrops to prevent posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>3</NO>
<PG>440-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meacock-2000" NAME="Meacock 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meacock WR, Spalton DJ, Hollick EJ, Boyce JF, Barman S, Sanguinetti G</AU>
<TI>Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>5</NO>
<PG>716-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meacock-2001" NAME="Meacock 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meacock WR, Spalton DJ</AU>
<TI>Effect of intraocular lens haptic compressibility on the posterior lens capsule after cataract surgery</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>9</NO>
<PG>1366-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Menapace-2008" MODIFIED="2009-07-18 18:20:16 +0100" MODIFIED_BY="[Empty name]" NAME="Menapace 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-18 18:20:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Menapace R, Sacu S, Georgopoulos M, Findl O, Rainer G, Nishi O</AU>
<TI>Efficacy and safety of capsular bending ring implantation to prevent posterior capsule opacification: three-year results of a randomized clinical trial</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>8</NO>
<PG>1318-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mester-2004" NAME="Mester 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mester U, Fabian E, Gerl R, Hunold W, Hütz W, Strobel J, et al</AU>
<TI>Posterior capsule opacification after implantation of CeeOn Edge 911A, PhacoFlex SI-40NB, and AcrySof MA60BM lenses: One-year results of an intraindividual comparison multicenter study</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>5</NO>
<PG>978-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nejima-2004" NAME="Nejima 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nejima R, Miyata K, Honbou M, Tokunaga T, Tanabe T, Sato M, et al</AU>
<TI>A prospective, randomised comparison of single and three piece acrylic foldable intraocular lenses</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2004</YR>
<VL>88</VL>
<NO>6</NO>
<PG>746-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nejima-2006" NAME="Nejima 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nejima R, Miyai T, Kataoka Y, Miyata K, Honbou M, Tokunaga T, et al</AU>
<TI>Prospective intrapatient comparison of 6.0-millimeter optic single-piece and 3-piece hydrophobic acrylic foldable intraocular lenses</TI>
<SO>Ophthalmology</SO>
<YR>2006</YR>
<VL>113</VL>
<NO>4</NO>
<PG>585-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olson-1998" NAME="Olson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olson RJ, Crandall AS</AU>
<TI>Silicone versus polymethylmethacrylate intraocular lenses with regard to capsular opacification</TI>
<SO>Ophthalmic Surgery &amp; Lasers</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>1</NO>
<PG>55-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pohjalainen-2002" NAME="Pohjalainen 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pohjalainen T, Vesti E, Uusitalo RJ, Laatikainen L</AU>
<TI>Posterior capsular opacification in pseudophakic eyes with a silicone or acrylic intraocular lens</TI>
<SO>European Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>12</VL>
<NO>3</NO>
<PG>212-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prosdocimo-2003" NAME="Prosdocimo 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prosdocimo G, Tassinari G, Sala M, Biase A, Toschi PG, Gismondi M, et al</AU>
<TI>Posterior capsule opacification after phacoemulsification: silicone CeeOn Edge versus acrylate AcrySof intraocular lens</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>8</NO>
<PG>1551-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabsilber-2006" NAME="Rabsilber 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rabsilber TM, Reuland AJ, Entz BB, Holzer MP, Limberger IJ, Auffarth GU</AU>
<TI>Quantitative evaluation of acrylic and silicone intraocular lenses with a sharp optic edge design</TI>
<TO>Quantitative Nachstarevaluierung von Acrylat- und Silikonintraokularlinsen mit scharfem Kantendesign</TO>
<SO>Ophthalmologe</SO>
<YR>2006</YR>
<VL>103</VL>
<NO>1</NO>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabsilber-2007" MODIFIED="2009-12-09 16:07:27 +0000" MODIFIED_BY="[Empty name]" NAME="Rabsilber 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 16:07:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rabsilber TM, Limberger IJ, Reuland AJ, Holzer MP, Auffarth GU</AU>
<TI>Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2007</YR>
<VL>91</VL>
<NO>7</NO>
<PG>912-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2004a" MODIFIED="2009-12-09 16:42:45 +0000" MODIFIED_BY="[Empty name]" NAME="Sacu 2004a" YEAR="2004">
<REFERENCE MODIFIED="2009-12-09 16:42:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Findl O, Menapace R, Buehl W, Wirtitsch M</AU>
<TI>Comparison of posterior capsule opacification between the 1-piece and 3-piece Acrysof intraocular lenses: Two-year results of a randomized trial</TI>
<SO>Ophthalmology</SO>
<YR>2004</YR>
<VL>111</VL>
<NO>10</NO>
<PG>1840-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2004b" NAME="Sacu 2004b" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Menapace R, Wirtitsch M, Buehl W, Rainer G, Findl O</AU>
<TI>Effect of anterior capsule polishing on fibrotic capsule opacification: Three-year results</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>11</NO>
<PG>2322-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2004c" NAME="Sacu 2004c" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Menapace R, Findl O, Georgopoulos M, Buehl W, Kriechbaum K, et al</AU>
<TI>Influence of optic edge design and anterior capsule polishing on posterior capsule fibrosis</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>3</NO>
<PG>658-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2004d" NAME="Sacu 2004d" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Menapace R, Buehl W, Rainer G, Findl O</AU>
<TI>Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>9</NO>
<PG>1875-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2005a" NAME="Sacu 2005a" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Menapace R, Findl O, Kiss B, Buehl W, Georgopoulos M</AU>
<TI>Long-term efficacy of adding a sharp posterior optic edge to a three-piece silicone intraocular lens on capsule opacification: five-year results of a randomized study</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2005</YR>
<VL>139</VL>
<NO>4</NO>
<PG>696-703</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sellmann-1988" NAME="Sellmann 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sellman TR, Lindstrom RL</AU>
<TI>Effect of a plano-convex posterior chamber lens on capsular opacification from Elschnig pearl formation</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1988</YR>
<VL>14</VL>
<NO>1</NO>
<PG>68-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-2007" MODIFIED="2009-12-09 16:08:57 +0000" MODIFIED_BY="[Empty name]" NAME="Shah 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 16:08:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shah A, Spalton DJ, Gilbert C, Vasavada A, Boyce JF, Minassian D, et al</AU>
<TI>Effect of intraocular lens edge profile on posterior capsule opacification after extracapsular cataract surgery in a developing country</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1259-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-2008" MODIFIED="2009-07-18 20:47:05 +0100" MODIFIED_BY="[Empty name]" NAME="Shah 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-18 20:47:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shah AR, Praveen MR, Vasavada AR</AU>
<TI>Posterior capsule opacification after extra capsular cataract extraction in Indian rural population: foldable acrylic vs poly (methyl-methacrylate) intraocular lenses a randomized clinical trial</TI>
<SO>Eye</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>7</NO>
<PG>889-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sundelin-2005" NAME="Sundelin 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sundelin K, Shams H, Stenevi U</AU>
<TI>Three-year follow-up of posterior capsule opacification with two different silicone intraocular lenses</TI>
<SO>Acta Ophthalmologica Scandinavica</SO>
<YR>2005</YR>
<VL>83</VL>
<NO>1</NO>
<PG>11-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsuchiya-2003" NAME="Tsuchiya 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsuchiya T, Ayaki M, Onishi T, Kageyama T, Yaguchi S</AU>
<TI>Three-year prospective randomized study of incidence of posterior capsule opacification in eyes treated with topical diclofenac and betamethasone</TI>
<SO>Ophthalmic Research</SO>
<YR>2003</YR>
<VL>35</VL>
<NO>2</NO>
<PG>67-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vasavada-2004" NAME="Vasavada 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vasavada AR, Raj SM</AU>
<TI>Anterior capsule relationship of the AcrySof intraocular lens optic and posterior capsule opacification: a prospective randomized clinical trial</TI>
<SO>Ophthalmology</SO>
<YR>2004</YR>
<VL>111</VL>
<NO>5</NO>
<PG>886-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2000" NAME="Wang 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang MC, Woung LC</AU>
<TI>Digital retroilluminated photography to analyze posterior capsule opacification in eyes with intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2000</YR>
<VL>26</VL>
<NO>1</NO>
<PG>56-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wejde-2003" NAME="Wejde 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wejde G, Kugelberg M, Zetterstrom C</AU>
<TI>Posterior capsule opacification: comparison of 3 intraocular lenses of different materials and design</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>8</NO>
<PG>1556-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wejde-2004" NAME="Wejde 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wejde G, Kugelberg M, Zetterström C</AU>
<TI>Position of anterior capsulorhexis and posterior capsule opacification</TI>
<SO>Acta Ophthalmologica Scandinavica</SO>
<YR>2004</YR>
<VL>82</VL>
<NO>5</NO>
<PG>531-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westling-1991" NAME="Westling 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westling AK, Calissendorff BM</AU>
<TI>Factors influencing the formation of posterior capsule opacities after extracapsular cataract extraction with posterior chamber lens implants</TI>
<SO>Acta Ophthalmologica</SO>
<YR>1991</YR>
<VL>69</VL>
<NO>3</NO>
<PG>315-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Winther-1998" NAME="Winther 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Winther-Nielsen A, Johansen J, Pedersen GK, Corydon L</AU>
<TI>Posterior capsule opacification and neodymium:YAG capsulotomy with heparin-surface-modified intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>7</NO>
<PG>940-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoshida-2002" NAME="Yoshida 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yoshida S, Senoo T, Fujikake F, Obara Y</AU>
<TI>Clinical evaluation of posterior capsule opacification in eyes with different small-incision intraocular lenses</TI>
<SO>Ophthalmic Surgery &amp; Lasers</SO>
<YR>2002</YR>
<VL>33</VL>
<NO>6</NO>
<PG>450-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zaczek-2004" NAME="Zaczek 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zaczek A, Laurell CG, Zetterstrom C</AU>
<TI>Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>2</NO>
<PG>316-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zemaitiene-2004" NAME="Zemaitiene 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zemaitiene R, Jasinskas V, Barzdziukas V, Auffarth GU</AU>
<TI>Prevention of posterior capsule opacification using different intraocular lenses (results of one-year clinical study)</TI>
<SO>Medicina (Kaunas, Lithuania)</SO>
<YR>2004</YR>
<VL>40</VL>
<NO>8</NO>
<PG>721-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zemaitiene-2007" MODIFIED="2010-01-19 09:38:44 +0000" MODIFIED_BY="Anupa Shah" NAME="Zemaitiene 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-19 09:38:44 +0000" MODIFIED_BY="Anupa Shah" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zemaitiene R, Jasinskas V, Auffarth GU</AU>
<TI>Influence of three-piece and single-piece designs of two sharp-edge optic hydrophobic acrylic intraocular lenses on the prevention of posterior capsule opacification: a prospective, randomised, long-term clinical trial</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2007</YR>
<VL>91</VL>
<NO>5</NO>
<PG>644-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-01-19 09:40:28 +0000" MODIFIED_BY="Anupa Shah">
<STUDY DATA_SOURCE="PUB" ID="STD-Aasuri-2002" MODIFIED="2010-01-19 09:40:28 +0000" MODIFIED_BY="Anupa Shah" NAME="Aasuri 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-01-19 09:40:28 +0000" MODIFIED_BY="Anupa Shah" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aasuri M, Shah U, Veenashree MP, Deshpande P</AU>
<TI>Performance of a truncated-edged silicone foldable intraocular lens in Indian eyes</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>7</NO>
<PG>1135-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abela_x002d_Formanek-2002" NAME="Abela-Formanek 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abela-Formanek C, Amon M, Schild G, Schauersberger J, Heinze G, Kruger A</AU>
<TI>Uveal and capsular biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>1</NO>
<PG>50-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abhilakh-2003" NAME="Abhilakh 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abhilakh Missier KA, Nuijts RM, Tjia KF</AU>
<TI>Posterior capsule opacification: silicone plate-haptic versus AcrySof intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>8</NO>
<PG>1569-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Afsar-1999" NAME="Afsar 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Afsar AJ, Patel S, Woods RL, Wykes W</AU>
<TI>A comparison of visual performance between a rigid PMMA and a foldable acrylic intraocular lens</TI>
<SO>Eye</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>3A</NO>
<PG>329-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aktan-1992" NAME="Aktan 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aktan SG, Laws DE, Taylor RH, Pearce JL</AU>
<TI>Posterior capsule polishing and postoperative opacification in intercapsular cataract surgery</TI>
<SO>European Journal of Implant &amp; Refractive Surgery</SO>
<YR>1992</YR>
<VL>4</VL>
<NO>3</NO>
<PG>161-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alio-2002" NAME="Alio 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alio JL, Chipont E, BenEzra D, Fakhry MA, Foster CS, Baarsma GS, et al</AU>
<TI>Comparative performance of intraocular lenses in eyes with cataract and uveitis</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>12</NO>
<PG>2096-108</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Auffarth-2003" NAME="Auffarth 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Auffarth GU, Golescu A, Becker KA, Völcker HE</AU>
<TI>Quantification of posterior capsule opacification with round and sharp edge intraocular lenses</TI>
<SO>Ophthalmology</SO>
<YR>2003</YR>
<VL>110</VL>
<NO>4</NO>
<PG>772-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cumming-2001" NAME="Cumming 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cumming JS, Slade SG, Chayet A</AU>
<TI>Clinical evaluation of the model AT-45 silicone accommodating intraocular lens: Results of feasibility and the initial phase of a food and drug administration clinical trial</TI>
<SO>Ophthalmology</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>11</NO>
<PG>2005-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x0027_Eliseo-2003" NAME="D'Eliseo 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Eliseo D, Pastena B, Longanesi L, Grisanti F, Negrini V</AU>
<TI>Prevention of posterior capsule opacification using capsular tension ring for zonular defects in cataract surgery</TI>
<SO>European Journal of Ophthalmology</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>2</NO>
<PG>151-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dada-1999" NAME="Dada 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dada T, Sharma N, Dada VK, Vajpayee RB</AU>
<TI>Comparative evaluation of plate haptic lenses with smaller and larger positioning holes</TI>
<SO>Australian and New Zealand Journal of Ophthalmology</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>6</NO>
<PG>417-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davison-2002" NAME="Davison 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davison JA</AU>
<TI>Clinical performance of Alcon SA30AL and SA60AT single-piece acrylic intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>7</NO>
<PG>1112-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Georgopoulos-2001" NAME="Georgopoulos 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Georgopoulos M, Menapace R, Findl O, Rainer G, Petternel V, Kiss B</AU>
<TI>Posterior continuous capsulorhexis with hydrogel and silicone intraocular lens implantation: Development of capsulorhexis size and capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>6</NO>
<PG>825-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Georgopoulos-2003" NAME="Georgopoulos 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Georgopoulos M, Menapace R, Findl O, Petternel V, Kiss B, Rainer G</AU>
<TI>After-cataract in adults with primary posterior capsulorhexis: comparison of hydrogel and silicone intraocular lenses with round edges after 2 years</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>5</NO>
<PG>955-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayashi-2008" MODIFIED="2009-07-18 16:51:30 +0100" MODIFIED_BY="[Empty name]" NAME="Hayashi 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-18 16:44:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Yoshida M, Hayashi H</AU>
<TI>Comparison of posterior capsule opacification between fellow eyes with two types of acrylic intraocular lens</TI>
<SO>Eye</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khalifa-1992" NAME="Khalifa 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khalifa M</AU>
<TI>Polishing the posterior capsule after extracapsular extraction of senile cataract</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1992</YR>
<VL>18</VL>
<NO>2</NO>
<PG>170-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kruger-2000" NAME="Kruger 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kruger A, Schauersberger J, Abela C, Schild G, Amon M</AU>
<TI>Two year results: Sharp versus rounded optic edges on silicone lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2000</YR>
<VL>26</VL>
<PG>566-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2008" MODIFIED="2009-07-18 18:18:20 +0100" MODIFIED_BY="[Empty name]" NAME="Li 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-18 18:18:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li JG, Wang ML, Chen GP, Gao HM, Zhao CY, Zhang QY</AU>
<TI>Analysis of related factors of posterior capsular opacification</TI>
<SO>International Journal of Ophthalmology</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>3</NO>
<PG>593-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meacock-2001b" NAME="Meacock 2001b" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meacock WR, Spalton DJ, Hollick EJ, Barman S, Boyce JF</AU>
<TI>The effect of polymethylmethacrylate and AcrySof intraocular lenses on the posterior capsule in patients with a large capsulorrhexis</TI>
<SO>Japanese Journal of Ophthalmology</SO>
<YR>2001</YR>
<VL>45</VL>
<NO>4</NO>
<PG>348-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miyata-2007" MODIFIED="2009-07-18 19:35:00 +0100" MODIFIED_BY="[Empty name]" NAME="Miyata 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-18 19:35:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyata K, Kato S, Nejima R, Miyai T, Honbo M, Ohtani S</AU>
<TI>Influences of optic edge design on posterior capsule opacification and anterior capsule contraction</TI>
<SO>Acta Ophthalmologica Scandinavica</SO>
<YR>2007</YR>
<VL>85</VL>
<NO>1</NO>
<PG>99-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mootha-2004" NAME="Mootha 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mootha VV, Tesser R, Qualls C</AU>
<TI>Incidence of and risk factors for residual posterior capsule opacification after cataract surgery</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>11</NO>
<PG>2354-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nekolov_x00e1_-2008" MODIFIED="2009-07-26 20:21:19 +0100" MODIFIED_BY="[Empty name]" NAME="Nekolová 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-07-26 20:21:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nekolová J, Pozlerová J, Jirásková N, Rozsíval P, Kadlecová J</AU>
<TI>Comparison of posterior capsule opacification after two different surgical methods of cataract extraction</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2008</YR>
<VL>145</VL>
<NO>3</NO>
<PG>493-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nirmalan-2002" NAME="Nirmalan 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nirmalan PK, Thulasiraj RD, Maneksha V, Rahmathullah R, Ramakrishnan R, Padmavathi A, et al</AU>
<TI>A population based eye survey of older adults in Tirunelveli district of south India: blindness, cataract surgery, and visual outcomes</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2002</YR>
<VL>86</VL>
<NO>5</NO>
<PG>505-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nishi-1998" NAME="Nishi 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nishi O, Nishi K, Menapace R, Akura J</AU>
<TI>Capsular bending ring to prevent posterior capsule opacification: 2 year follow-up</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2001</YR>
<VL>27</VL>
<NO>9</NO>
<PG>1359-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nishi O, Nishi K, Menapace R</AU>
<TI>Capsule-bending ring for the prevention of capsular opacification: A preliminary report</TI>
<SO>Ophthalmic Surgery &amp; Lasers</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>9</NO>
<PG>749-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nishi-2007" MODIFIED="2009-07-18 19:41:44 +0100" MODIFIED_BY="[Empty name]" NAME="Nishi 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-18 19:41:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nishi Y, Rabsilber TM, Limberger IJ, Reuland AJ, Auffarth GU</AU>
<TI>Influence of 360-degree enhanced optic edge design of a hydrophilic acrylic intraocular lens on posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>2</NO>
<PG>227-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oharazawa-2007" MODIFIED="2009-12-09 16:20:10 +0000" MODIFIED_BY="[Empty name]" NAME="Oharazawa 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-12-09 16:20:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oharazawa H, Suzuki H, Shibata K, Yamada Y, Matsui H, Shiwa T, et al</AU>
<TI>Quantitative analysis of posterior capsule opacification of hydrophobic acrylic intraocular lenses</TI>
<SO>Journal of Nippon Medical School</SO>
<YR>2007</YR>
<VL>74</VL>
<NO>1</NO>
<PG>45-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ozdemir-2007" MODIFIED="2009-07-18 19:48:37 +0100" MODIFIED_BY="[Empty name]" NAME="Ozdemir 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-18 19:48:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ozdemir HG</AU>
<TI>A long-term follow-up study of different irrigation/aspiration techniques on formation of posterior capsule opacification</TI>
<SO>Canadian Journal of Ophthalmology</SO>
<YR>2007</YR>
<VL>42</VL>
<NO>6</NO>
<PG>849-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ram-2001" NAME="Ram 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ram J, Pandey S, Apple D, Werner L, Brar G, Singh R, et al</AU>
<TI>Effect of in-the-bag intraocular lens fixation on the prevention of posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2001</YR>
<VL>27</VL>
<PG>1039-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacu-2005b" NAME="Sacu 2005b" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacu S, Findl O, Menapace R, Buehl W</AU>
<TI>Influence of optic edge design, optic material, and haptic design on capsular bend configuration</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>10</NO>
<PG>1888-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strobel-2002" MODIFIED="2009-12-09 16:46:45 +0000" MODIFIED_BY="[Empty name]" NAME="Strobel 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-12-09 16:46:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strobel J, Hunold W, Kohnen T, Mester U, Hessemer V, Hutz W, Jacobi K, Hoyer H</AU>
<TI>Highly refractive silicone lens with sharp optic edge (CeeOn Edge, Model 911): one year results of a multicenter clinical trial on performance and efficacy</TI>
<TO>Hochrefraktive Silikonlinse mit scharfer Hinterkante (CeeOn Edge, Modell 911): 1-Jahres-Ergebnisse einer multizentrischen klinischen Studie zur Handhabung und Effizienz</TO>
<SO>Klinische Monatsblätter der Augenheilkunde</SO>
<YR>2002</YR>
<VL>219</VL>
<NO>5</NO>
<PG>358-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tassignon-2002" NAME="Tassignon 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tassignon MJ, De-Groot V, Vrensen GF</AU>
<TI>Bag-in-the-lens implantation of intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>7</NO>
<PG>1182-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thompson-2004" NAME="Thompson 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thompson AM, Sachdev N, Wong T, Riley AF, Grupcheva CN, McGhee CN</AU>
<TI>The Auckland Cataract Study: 2 year postoperative assessment of aspects of clinical, visual, corneal topographic and satisfaction outcomes</TI>
<SO>British Journal of Ophthalmology</SO>
<YR>2004</YR>
<VL>88</VL>
<NO>8</NO>
<PG>1042-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tobari-1999" NAME="Tobari 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tobari I, Iwaki Y, Miyake K</AU>
<TI>Effect of tranilast eyedrops in preventing posterior capsule opacification: preliminary report</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>1999</YR>
<VL>25</VL>
<NO>10</NO>
<PG>1394-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vock-2007" MODIFIED="2009-07-18 20:42:47 +0100" MODIFIED_BY="[Empty name]" NAME="Vock 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-18 20:42:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vock L, Menapace R, Stifter E, Bühl W, Georgopoulos M</AU>
<TI>Effect of primary posterior continuous curvilinear capsulorhexis on clinical performance of ACR6D SE single-piece hydrophilic acrylic intraocular lenses</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>4</NO>
<PG>628-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wren-2005" NAME="Wren 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wren SM, Spalton DJ, Jose R, Boyce J, Heatley CJ</AU>
<TI>Factors that influence the development of posterior capsule opacification with a polyacrylic intraocular lens</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2005</YR>
<VL>139</VL>
<NO>4</NO>
<PG>691-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-07-26 20:11:31 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-12-09 15:26:58 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-12-09 15:26:58 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Apple-1992" NAME="Apple 1992" TYPE="JOURNAL_ARTICLE">
<AU>Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UFC, et al</AU>
<TI>Posterior capsule opacification</TI>
<SO>Survey of Ophthalmology</SO>
<YR>1992</YR>
<VL>37</VL>
<NO>2</NO>
<PG>73-116</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buehl-2005b" NAME="Buehl 2005b" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Sacu S, Findl O</AU>
<TI>Association between intensity of posterior capsule opacification and visual acuity</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2005</YR>
<VL>31</VL>
<NO>3</NO>
<PG>543-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buehl-2005c" NAME="Buehl 2005c" TYPE="JOURNAL_ARTICLE">
<AU>Buehl W, Sacu S, Findl O</AU>
<TI>Association between intensity of posterior capsule opacification and contrast sensitivity</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2005</YR>
<VL>140</VL>
<NO>5</NO>
<PG>927-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Findl-2003" NAME="Findl 2003" TYPE="JOURNAL_ARTICLE">
<AU>Findl O, Buehl W, Menapace R, Georgopoulos M, Rainer G, Siegl H, et al</AU>
<TI>Comparison of 4 methods for quantifying posterior capsule opacification</TI>
<SO>Journal of Cataract &amp; Refractive Surgery</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>1</NO>
<PG>106-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glanville-2006" NAME="Glanville 2006" TYPE="JOURNAL_ARTICLE">
<AU>Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J</AU>
<TI>How to identify randomized controlled trials in MEDLINE: ten years on</TI>
<SO>Journal of the Medical Library Association</SO>
<YR>2006</YR>
<VL>94</VL>
<NO>2</NO>
<PG>130-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hayashi-2003" NAME="Hayashi 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hayashi K, Hayashi H, Nakao F, Hayashi F</AU>
<TI>Correlation between posterior capsule opacification and visual function before and after Neodymium: YAG laser posterior capsulotomy</TI>
<SO>American Journal of Ophthalmology</SO>
<YR>2003</YR>
<VL>136</VL>
<NO>4</NO>
<PG>720-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-12-09 15:24:59 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Altman DG (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies</TI>
<SO>In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Javitt-1992" NAME="Javitt 1992" TYPE="JOURNAL_ARTICLE">
<AU>Javitt JC, Tielsch JM, Canner JK, Kolb MM, Sommer A, Steinberg EP, et al</AU>
<TI>National outcomes of cataract extraction: Increased risk of retinal complications associated with Nd:YAG laser capsulotomy</TI>
<SO>Ophthalmology</SO>
<YR>1992</YR>
<VL>99</VL>
<NO>10</NO>
<PG>1487-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meacock-2003" NAME="Meacock 2003" TYPE="JOURNAL_ARTICLE">
<AU>Meacock WR, Spalton DJ, Boyce J, Marshall J</AU>
<TI>The effect of posterior capsule opacification on visual function</TI>
<SO>Investigative Ophthalmology and Visual Science</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>11</NO>
<PG>4665-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Riaz-2006" MODIFIED="2009-12-09 15:26:58 +0000" MODIFIED_BY="[Empty name]" NAME="Riaz 2006" TYPE="COCHRANE_REVIEW">
<AU>Riaz Y, Mehta JS, Wormald R, Evans JR, Foster A, Ravilla T, et al</AU>
<TI>Surgical interventions for age-related cataract</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-11-01 15:56:36 +0000" MODIFIED_BY="Anupa Shah">
<IDENTIFIER MODIFIED="2008-11-01 15:56:36 +0000" MODIFIED_BY="Anupa Shah" TYPE="DOI" VALUE="10.1002/14651858.CD001323.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schaumberg-1998" NAME="Schaumberg 1998" TYPE="JOURNAL_ARTICLE">
<AU>Schaumberg DA, Dana MR, Christen WG, Glynn RJ</AU>
<TI>A systematic overview of the incidence of posterior capsule opacification</TI>
<SO>Ophthalmology</SO>
<YR>1998</YR>
<VL>105</VL>
<NO>7</NO>
<PG>1213-21</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-01-20 14:47:39 +0000" MODIFIED_BY="Anupa Shah">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-01-20 14:47:39 +0000" MODIFIED_BY="Anupa Shah" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-01-20 14:47:09 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Allers-2000">
<CHAR_METHODS MODIFIED="2010-01-20 13:37:39 +0000" MODIFIED_BY="Anupa Shah">
<P>Allergan SI40NB (round edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; prospective, randomised; 1 year follow-up, 5 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:37:43 +0000" MODIFIED_BY="Anupa Shah">
<P>70 eyes of 35 people with bilateral, age-related cataract (intra-individual comparison); mean age 76, setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:37:48 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:47:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:38:11 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Aykan-2003">
<CHAR_METHODS MODIFIED="2010-01-20 13:37:55 +0000" MODIFIED_BY="Anupa Shah">
<P>Effect of small (4.5 -5 mm) vs. large (6 - 7 mm) rhexis on PCO with Alcon MA30BM (acrylic, sharp edge) IOLs; randomised, prospective; 3 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:38:05 +0000" MODIFIED_BY="Anupa Shah">
<P>496 eyes of 367 people with age-related cataract (256 eyes of 198 people in the small rhexis group, 240 eyes of 169 people in the large rhexis group); mean age 66; setting: Turkey.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:38:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco, small or large rhexis.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:38:11 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:38:53 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Barequet-2002">
<CHAR_METHODS MODIFIED="2010-01-20 13:38:20 +0000" MODIFIED_BY="Anupa Shah">
<P>Diclofenac vs. dexamethasone phosphate eyedrops after cataract surgery with implantation of a round edge PMMA (Hanita Balance) or silicone-plate IOL (Staar); randomised, prospective, patient and examiner-masked; 2 years follow-up; 27 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:38:26 +0000" MODIFIED_BY="Anupa Shah">
<P>55 eyes of 55 people with age-related cataract, 2 groups (allocation unclear); mean age 70, setting: Israel.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:38:49 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco of ECCE, postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:38:53 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:40:14 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Bender-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:40:03 +0000" MODIFIED_BY="Anupa Shah">
<P>1-piece (Alcon SA30AL) vs. 3-piece (Alcon MA30BA) hydrophobic acrylic IOLs; prospective, randomised; 1 year follow-up; 35 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:40:09 +0000" MODIFIED_BY="Anupa Shah">
<P>167 people with age-related cataract, 2 groups (115 in the MA30 group, 52 in the SA30 group); mean age 74; setting: UK and Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:40:12 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:40:14 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:40:36 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Bilge-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:40:23 +0000" MODIFIED_BY="Anupa Shah">
<P>1-piece (Alcon SA30AL) vs. 3-piece (Alcon MA30BA) sharp-edge acrylic IOLs; randomised, prospective; 2 years follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:40:30 +0000" MODIFIED_BY="Anupa Shah">
<P>493 eyes of 519 people with age-related cataracts, 2 groups (256 eyes of 198 people in the 3-piece group; 240 eyes of 169 people in the 1-piece group); mean age 70; setting: Turkey.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:40:33 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:40:36 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:40:52 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Bolz-2006">
<CHAR_METHODS MODIFIED="2010-01-20 13:40:43 +0000" MODIFIED_BY="Anupa Shah">
<P>Anterior capsule polishing vs. no polishing in standard cataract surgery with implantation of AMO 911A sharp edge silicone IOLs; prospective, randomised, patient- and examiner-masked; 5 years follow-up, 35 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:40:47 +0000" MODIFIED_BY="Anupa Shah">
<P>130 eyes of 65 people with bilateral, age-related cataracts (intra-individual comparison); mean age 72, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:40:50 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; anterior capsule polished or non polished.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:40:52 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective PCO score (AQUA), YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:41:08 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Buehl-2002">
<CHAR_METHODS MODIFIED="2010-01-20 13:41:00 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO Sensar OptiEdge AR40e (sharp edge hydrophobic acrylic) vs. AMO Sensar AR40 (round edge hydrophobic acrylic) IOL; randomised, prospective, patient- and examiner-masked; 1 year follow-up; 8 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:41:04 +0000" MODIFIED_BY="Anupa Shah">
<P>106 eyes of 53 people with bilateral age-related cataract (intra-individual comparison); mean age 72, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:41:06 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:41:08 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective PCO score (AQUA), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:41:21 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Buehl-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:41:13 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO ClariFlex OptiEdge (sharp edge silicone) vs. AMO PhacoFlex SI40 (round edge silicone) IOL; prospective, randomised, patient- and examiner-masked; 1 year follow-up; 12 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:41:17 +0000" MODIFIED_BY="Anupa Shah">
<P>104 eyes of 52 people with bilateral age-related cataract (intra-individual comparison); mean age 77, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:41:19 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:41:21 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective PCO score (AQUA), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:41:32 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Buehl-2005">
<CHAR_METHODS MODIFIED="2010-01-20 13:41:25 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO Sensar OptiEdge AR40e (sharp edge hydrophobic acrylic) vs. AMO Sensar AR40 (round edge hydrophobic acrylic) IOL; randomised, prospective, patient- and examiner-masked; 3 years follow-up; 22 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:41:27 +0000" MODIFIED_BY="Anupa Shah">
<P>106 eyes of 53 people with bilateral age-related cataract (intra-individual comparison); mean age 72, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:41:30 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:41:32 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective PCO score (AQUA), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:41:42 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Buehl-2007">
<CHAR_METHODS MODIFIED="2010-01-20 13:41:36 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO ClariFlex OptiEdge (sharp edge silicone) vs. AMO PhacoFlex SI40 (round edge silicone) IOL; prospective, randomised, patient- and examiner-masked; 3 years follow-up; 18 drop-outs</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:41:38 +0000" MODIFIED_BY="Anupa Shah">
<P>104 eyes of 52 people with bilateral age-related cataract (intra-individual comparison); mean age 77, setting: Austria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:41:40 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:41:42 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective PCO score (AQUA), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-29 20:31:47 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-12-08 11:44:49 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Clark-1998">
<CHAR_METHODS MODIFIED="2009-12-08 11:44:49 +0000" MODIFIED_BY="Anupa Shah">
<P>Placebo vs. 2 different concentrations of immunotoxin MDX-RA during cataract surgery with implantation of a round-edge PMMA IOL; randomised, prospective; 2 years follow-up; 25 drop-outs</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>63 eyes of 63 people with age-related cataract, 3 groups (21 in the placebo group, 23 people with 50 units, and 19 people with 175 units of immunotoxin); age 40-90; setting: USA</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>phaco; 50 or 175 units of immunotoxin, or placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>own subjective PCO score, YAG rate</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:42:45 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Cleary-2009">
<CHAR_METHODS MODIFIED="2010-01-20 13:42:45 +0000" MODIFIED_BY="Anupa Shah">
<P>HumanOptics MC611MI (sharp edge, 1-piece, hydrophilic acrylic microincision IOL) vs. Alcon Acrysof MA60AC (sharp edge, 3-piece, hydrophobic acrylic IOL); prospective, randomised, 2 years follow-up; 8 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:42:00 +0000" MODIFIED_BY="Anupa Shah">
<P>64 eyes of 32 patients with age-related cataract (intra-individual comparison); mean age 74; setting: London.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:42:02 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:42:03 +0000" MODIFIED_BY="Anupa Shah">
<P>BCVA, POCO objective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-11 18:03:49 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:42:56 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Dick-1997">
<CHAR_METHODS MODIFIED="2010-01-20 13:42:49 +0000" MODIFIED_BY="Anupa Shah">
<P>Chiron Adatomed C10 (round edge, plate-haptic silicone IOL) vs. Chiron Adatomed 90D (round edge, disc silicone IOL) vs. Pharmacia 809C (round edge PMMA IOL); prospective, randomised, 2 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:42:54 +0000" MODIFIED_BY="Anupa Shah">
<P>67 eyes of 67 people with age-related cataract, 3 groups (26 eyes in the C10 group, 25 eyes in the 90D group, 16 eyes in the PMMA group); mean age 70; setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:42:56 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:42:56 +0000" MODIFIED_BY="Anupa Shah">
<P>YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:44:33 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Findl-2005a">
<CHAR_METHODS MODIFIED="2010-01-20 13:43:12 +0000" MODIFIED_BY="Anupa Shah">
<P>Sharp vs. round optic edges in PMMA IOLs (both Microplex MP260 by Dr Schmidt); prospective, randomised, patient- and examiner-masked; 5 years follow-up; 13 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:44:30 +0000" MODIFIED_BY="Anupa Shah">
<P>64 eyes of 32 people with age-related cataract (intra-individual comparison); mean age 74; setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:44:32 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:44:33 +0000" MODIFIED_BY="Anupa Shah">
<P>BCVA, AQUA objective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:44:48 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Findl-2005b">
<CHAR_METHODS MODIFIED="2010-01-20 13:44:38 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO 911A (sharp edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; randomised, prospective, double masked; 3 years follow-up; 25 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:44:45 +0000" MODIFIED_BY="Anupa Shah">
<P>106 eyes of 53 people with age-related cataract (intra-individual comparison); mean age 78; setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:44:47 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:44:48 +0000" MODIFIED_BY="Anupa Shah">
<P>BCVA, AQUA objective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:44:59 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Flach-2000">
<CHAR_METHODS MODIFIED="2010-01-20 13:44:51 +0000" MODIFIED_BY="Anupa Shah">
<P>Diclofenac 0.1% vs. Ketorolac 0.5% eyedrops after cataract surgery with implantation of a silicone IOL (unknown type); randomised, prospective, patient- and examiner-masked; 3 years follow-up; 31 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:44:55 +0000" MODIFIED_BY="Anupa Shah">
<P>120 eyes of 120 people with age-related cataract, 2 groups (62 in the diclofenac group, 58 in the ketorolac group); mean age 71, setting: USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:44:57 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco, postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:44:59 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:45:13 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hancox-2007">
<CHAR_METHODS MODIFIED="2010-01-20 13:45:06 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon Acrysof MA30 (sharp edge hydrophobic acrylic) vs. HumanOptics 1CU (sharp edge hydrophilic acrylic) IOLs; prospective, randomised; 2 years follow-up; 4 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:45:09 +0000" MODIFIED_BY="Anupa Shah">
<P>60 eyes of 30 patients with age-related cataract (intra-individual comparison); mean age 71; setting: London.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:45:12 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:45:13 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-11 21:00:56 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:45:25 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hancox-2008">
<CHAR_METHODS MODIFIED="2010-01-20 13:45:19 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon SN60AT (sharp edge, 1-piece hydrophobic acrylic IOL) vs. Hoya AF-1 YA-60BB (sharp edge, 3-piece hydrophobic acrylic IOL); prospective, randomised, 2 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:45:22 +0000" MODIFIED_BY="Anupa Shah">
<P>72 eyes of 36 people with age-related cataract (intra-individual comparison); mean age 76; setting: London.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:45:24 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:45:25 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-12 19:57:03 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:45:42 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hayashi-1998">
<CHAR_METHODS MODIFIED="2010-01-20 13:45:29 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon MZ60BD (round edge PMMA) vs. Allergan SI30NB (round edge silicone) vs. MA60BM (sharp edge, hydrophobic acrylic) IOLs; 2 years follow-up; 28 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:45:34 +0000" MODIFIED_BY="Anupa Shah">
<P>240 eyes of 240 people with age-related cataract, 3 groups (80 each); mean age 69, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:45:35 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:45:42 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:45:56 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hayashi-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:45:45 +0000" MODIFIED_BY="Anupa Shah">
<P>Storz Hydroview (round edge hydrogel) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; prospective, randomised, patient- and examiner-masked; 2 years follow-up; 14 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:45:48 +0000" MODIFIED_BY="Anupa Shah">
<P>218 eyes of 109 people with bilateral age-related cataract (intra-individual comparison); mean age 71, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:45:50 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:45:56 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:46:11 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hayashi-2005">
<CHAR_METHODS MODIFIED="2010-01-20 13:46:00 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO Sensar AR40e (sharp edge hydrophobic acrylic) vs. AMO Sensar AR40 (round edge hydrophobic acrylic) IOL; prospective, randomised, double-blind; 2 years follow-up; 6 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:46:06 +0000" MODIFIED_BY="Anupa Shah">
<P>150 eyes of 75 people with bilateral age-related cataract (intra-individual comparison); mean age 70, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:46:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:46:11 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:53:16 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hayashi-2007">
<CHAR_METHODS MODIFIED="2010-01-20 13:52:19 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO Sensar AR40e (sharp edge hydrophobic acrylic) vs. AMO ClariFlex (sharp edge silicone) IOL; prospective, randomised, double-blind; 3 years follow-up; 11 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:52:23 +0000" MODIFIED_BY="Anupa Shah">
<P>200 eyes of 100 people with bilateral age-related cataract (intra-individual comparison); mean age 71; setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:52:26 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:53:16 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 15:52:54 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:53:35 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Heatley-2005">
<CHAR_METHODS MODIFIED="2010-01-20 13:53:24 +0000" MODIFIED_BY="Anupa Shah">
<P>Centerflex 570 H (sharp edge hydrophilic acrylic) vs. Alcon SA60AT (1-piece sharp edge hydrophobic acrylic) IOL; prospective, randomised; 1 year follow-up, 7 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:53:31 +0000" MODIFIED_BY="Anupa Shah">
<P>106 eyes of 53 people with bilateral age-related cataract (intra-individual comparison); mean age ?, setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:53:33 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:53:35 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:53:52 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hollick-1998">
<CHAR_METHODS MODIFIED="2010-01-20 13:53:45 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon MC60BM (round edge PMMA,) vs. Iolab L141U (round edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; randomised, prospective; 2 years follow-up; 19 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:53:49 +0000" MODIFIED_BY="Anupa Shah">
<P>90 eyes of 81 people with age-related cataract, 3 groups (30 each); mean age 73, setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:53:50 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:53:52 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:54:04 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hollick-1999">
<CHAR_METHODS MODIFIED="2010-01-20 13:53:57 +0000" MODIFIED_BY="Anupa Shah">
<P>Small (4.5 - 5 mm) vs. large (6 - 7 mm) rhexis, standard cataract surgery with implantation of a Pharmacia 812A (round edge PMMA) IOL; prospective, randomised; 1 year follow-up; 14 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:54:01 +0000" MODIFIED_BY="Anupa Shah">
<P>75 eyes of 75 people with age-related cataract, 2 groups (36 in the small capsulorhexis group, 39 in the large capsulorhexis group); mean age 73, setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:54:03 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:54:04 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA, contrast sensitivity, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:54:21 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Hollick-2000">
<CHAR_METHODS MODIFIED="2010-01-20 13:54:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Storz P497UV (round edge PMMA) vs. Storz Hydroview (round edge hydrogel) vs. Allergan SI30 (round edge silicone) IOL; randomised, prospective, 2 years follow-up; 12 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:54:15 +0000" MODIFIED_BY="Anupa Shah">
<P>93 eyes of 93 people with age-related cataract, 3 groups (30 each); mean age 74; setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:54:18 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:54:21 +0000" MODIFIED_BY="Anupa Shah">
<P>BCVA, contrast sensitivity, POCO objective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:54:34 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-H_x00fc_tz-1989">
<CHAR_METHODS MODIFIED="2010-01-20 13:54:26 +0000" MODIFIED_BY="Anupa Shah">
<P>Round-edge PMMA IOL with laser ridge vs. round-edge PMMA IOL without ridge; prospective, randomised; 5 years follow-up; 56 drop-outs</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:54:31 +0000" MODIFIED_BY="Anupa Shah">
<P>100 eyes of 100 people with age-related cataract, 2 groups (50 each); mean age 71, setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:54:32 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:54:34 +0000" MODIFIED_BY="Anupa Shah">
<P>Own PCO score (semi-quantitative), BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:54:47 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Khanzada-2008">
<CHAR_METHODS MODIFIED="2010-01-20 13:54:38 +0000" MODIFIED_BY="Anupa Shah">
<P>Acrysof SA60AT (sharp edge hydrophobic acrylic) vs. LX10BD (round edge PMMA) IOL; prospective, randomised; 18 months follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:54:42 +0000" MODIFIED_BY="Anupa Shah">
<P>110 eyes of 100 people with age-related cataract, 2 groups (55 each); mean age 60; setting: Pakistan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:54:45 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:54:47 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 17:00:56 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:54:59 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Kohnen-2008">
<CHAR_METHODS MODIFIED="2010-01-20 13:54:51 +0000" MODIFIED_BY="Anupa Shah">
<P>CeeOn Edge 911A (sharp edge silicone IOL) vs. PhacoFlex SI40NB (round edge silicone IOL) or vs. Alcon Acrysof MA60BM (sharp edge hydrophobic acrylic IOL); multicenter, prospective, randomised; 3 years follow-up; 64 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:54:56 +0000" MODIFIED_BY="Anupa Shah">
<P>576 eyes of 288 people with age-related cataract in 2 groups; mean age 72, setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:54:58 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:54:59 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 17:19:35 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:55:16 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Kugelberg-2006">
<CHAR_METHODS MODIFIED="2010-01-20 13:55:10 +0000" MODIFIED_BY="Anupa Shah">
<P>Bausch &amp; Lomb BL27 (sharp edge hydrophilic acrylic) vs. Alcon SA60AT (sharp edge hydrophobic acrylic) IOL; prospective, randomised; 1 year follow-up; 4 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:55:14 +0000" MODIFIED_BY="Anupa Shah">
<P>120 eyes of 120 people with age-related cataract, 2 groups (60 each); mean age 72, setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:55:15 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:55:16 +0000" MODIFIED_BY="Anupa Shah">
<P>POCOman subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:55:26 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000">
<CHAR_METHODS MODIFIED="2010-01-20 13:55:19 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon MA60BM (sharp edge hydrophobic acrylic) vs. MemoryLens (round edge PMMA) IOL; prospective, randomised, double-blind; 3 years follow-up; 29 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:55:22 +0000" MODIFIED_BY="Anupa Shah">
<P>100 eyes of 50 people with bilateral age-related cataract (intra-individual comparison); mean age 67, setting: Turkey.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:55:25 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:55:26 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, contrast sensitivity, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:55:42 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Laurell-2002">
<CHAR_METHODS MODIFIED="2010-01-20 13:55:34 +0000" MODIFIED_BY="Anupa Shah">
<P>Dexamehasone vs. Diclofenac vs. placebo after cataract surgery with HSM-PMMA IOLs; randomised, prospective, patient- and examiner-masked; 4 years follow-up; 78 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:55:39 +0000" MODIFIED_BY="Anupa Shah">
<P>180 people with age-related cataract, 3 groups (60 each); mean age 75; setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:55:41 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:55:42 +0000" MODIFIED_BY="Anupa Shah">
<P>YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:55:52 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Leydolt-2007">
<CHAR_METHODS MODIFIED="2010-01-20 13:55:48 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon Acrysof 1-piece IOL (SA30AL or SA60AT) vs. Alcon Acrysof 3-piece IOL (MA30BA or MA60BM); randomised, prospective; 5 years follow-up; 24 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:55:50 +0000" MODIFIED_BY="Anupa Shah">
<P>104 eyes of 52 people with bilateral age-related cataract (intra-individual comparison); mean age 74; setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:55:52 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:55:52 +0000" MODIFIED_BY="Anupa Shah">
<P>AQUA objective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 17:59:43 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:56:13 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Martin-1992">
<CHAR_METHODS MODIFIED="2010-01-20 13:56:00 +0000" MODIFIED_BY="Anupa Shah">
<P>Effect of lens design and surgical placement on PCO (1-piece/3-piece, biconvex/plano-convex/laser ridge, bag/sulcus placement); prospective, randomised, 1 year follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:56:03 +0000" MODIFIED_BY="Anupa Shah">
<P>600 eyes of 600 people with age-related cataract in 12 groups; mean age 74; setting: USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:56:04 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:56:06 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-01-20 13:56:13 +0000" MODIFIED_BY="Anupa Shah">
<P>Only cases with IOL placement in the bag were included in the review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:56:31 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Mastropasqua-1997">
<CHAR_METHODS MODIFIED="2010-01-20 13:56:20 +0000" MODIFIED_BY="Anupa Shah">
<P>Heparin vs. placebo eyedrops after cataract surgery with implantation of a round-edge PMMA IOL (Iolab 6160B); prospective, randomised, patient- and examiner-masked; 4 years follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:56:26 +0000" MODIFIED_BY="Anupa Shah">
<P>200 eyes of 200 people with age-related cataract, 2 groups (100 each); mean age 68, setting: Italy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:56:28 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE, postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:56:31 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:56:43 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Meacock-2000">
<CHAR_METHODS MODIFIED="2010-01-20 13:56:34 +0000" MODIFIED_BY="Anupa Shah">
<P>Low vs. high dose of immunotoxin MDX-RA vs. placebo intracamerally after standard cataract surgery phaco; randomised, controlled; 1 year follow-up, 3 drop-outs</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:56:41 +0000" MODIFIED_BY="Anupa Shah">
<P>26 eyes of 26 people with age-related cataract, 3 groups (8 in the low dose group, 19 in the high dose group, 9 in the placebo group); mean age 75, setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:56:42 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; low/high dose of cell antibody or placebo.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:56:43 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:56:56 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Meacock-2001">
<CHAR_METHODS MODIFIED="2010-01-20 13:56:48 +0000" MODIFIED_BY="Anupa Shah">
<P>Effect of haptic compressibility on PCO (Storz P497UV PMMA IOL vs. Storz Hydroview hydrogel IOL, both round edge); prospective, randomised, 2 years follow-up, 8 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:56:52 +0000" MODIFIED_BY="Anupa Shah">
<P>60 eyes of 60 people with age-related cataract, 2 groups (30 each); mean age 74, setting: UK.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:56:54 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:56:56 +0000" MODIFIED_BY="Anupa Shah">
<P>Amount of capsular folds, objective PCO score (POCO).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:57:37 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Menapace-2008">
<CHAR_METHODS MODIFIED="2010-01-20 13:57:24 +0000" MODIFIED_BY="Anupa Shah">
<P>Effect of sharp-edge PMMA capsular bending ring implantation on PCO; Hydroview H60M hydrogel IOL; prospective, randomised, 3 years follow-up, 10 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:57:33 +0000" MODIFIED_BY="Anupa Shah">
<P>120 eyes of 60 people with age-related cataract, capsular bending ring in 1 eye (intra-individual comparison); mean age 77, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:57:36 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco ± capsular bending ring implantation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:57:37 +0000" MODIFIED_BY="Anupa Shah">
<P>AQUA objective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 18:20:16 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:57:45 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Mester-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:57:39 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmacia 911A (sharp edge silicone) vs. Pharmacia SI40NB (round edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; prospective, randomised, multi-centre; 1 year follow-up, 109 drop-outs (?)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:57:42 +0000" MODIFIED_BY="Anupa Shah">
<P>576 eyes of 288 people with bilateral age-related cataract (intra-individual comparison: 911A vs. SI40NB or MA60BM); mean age 72, setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:57:44 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:57:45 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:58:06 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Nejima-2004">
<CHAR_METHODS MODIFIED="2010-01-20 13:57:57 +0000" MODIFIED_BY="Anupa Shah">
<P>1-piece (Alcon SA30AL) vs. 3-piece (Alcon MA30BM) sharp edge hydrophobic acrylic IOL; prospective, randomised, patient- and examiner-masked; 18 months follow-up; 4 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:58:01 +0000" MODIFIED_BY="Anupa Shah">
<P>40 eyes of 20 people with bilateral age-related cataract (intra-individual comparison); mean age 71; setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:58:04 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:58:06 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:47:38 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Nejima-2006">
<CHAR_METHODS MODIFIED="2010-01-20 13:58:13 +0000" MODIFIED_BY="Anupa Shah">
<P>1-piece (Alcon SA60AT) vs. 3-piece (Alcon MA60AC) sharp edge hydrophobic acrylic IOL; prospective, randomised, patient- and examiner-masked; 1 year follow-up; 8 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:58:16 +0000" MODIFIED_BY="Anupa Shah">
<P>80 eyes of 40 people with bilateral age-related cataract (intra-individual comparison); mean age 70, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:58:17 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:47:38 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:58:46 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Olson-1998">
<CHAR_METHODS MODIFIED="2010-01-20 13:58:36 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO SI30 (round edge silicone) vs. round edge PMMA IOLs (type not mentioned); prospective, randomised; 3 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:58:41 +0000" MODIFIED_BY="Anupa Shah">
<P>119 eyes of 119 people with age-related cataract, 2 groups (60 in the silicone group, 59 in the PMMA group); mean age 74; setting: USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:58:44 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:58:46 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective and objective score (lens opacity meter), YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:59:01 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Pohjalainen-2002">
<CHAR_METHODS MODIFIED="2010-01-20 13:58:53 +0000" MODIFIED_BY="Anupa Shah">
<P>SI30NB (round edge silicone) vs. MA60BM (sharp edge hydrophobic acrylic) IOL; prospective, randomised; 2 years follow-up; 7 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:58:57 +0000" MODIFIED_BY="Anupa Shah">
<P>80 eyes of 80 people with age-related cataract, 2 groups (40 each); mean age 67, setting: Finland.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:59:00 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:59:01 +0000" MODIFIED_BY="Anupa Shah">
<P>BCVA, own subjective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 13:59:21 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Prosdocimo-2003">
<CHAR_METHODS MODIFIED="2010-01-20 13:59:13 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmacia 911A (sharp edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; prospective, randomised; 18 months follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 13:59:18 +0000" MODIFIED_BY="Anupa Shah">
<P>78 eyes of 78 people with age-related cataract, 2 groups (40 in the 911A group, 38 in the MA60BM group); mean age 71, setting: Italy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 13:59:20 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 13:59:21 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:05:28 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Rabsilber-2006">
<CHAR_METHODS MODIFIED="2010-01-20 14:05:20 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO Sensar AR40e (sharp edge hydrophobic acrylic) vs. AMO ClariFlex (sharp edge silicone) IOL; prospective, randomised; 2 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:05:26 +0000" MODIFIED_BY="Anupa Shah">
<P>47 eyes of 47 people with age-related cataract, 2 groups (22 in the Clariflex group, 25 in the AR40e group); mean age 74; setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:05:27 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:05:28 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO 2000 subjective score, BCVA.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:05:40 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Rabsilber-2007">
<CHAR_METHODS MODIFIED="2010-01-20 14:05:32 +0000" MODIFIED_BY="Anupa Shah">
<P>Effect of sealed capsule irrigation with distilled water on PCO; prospective, randomised; 2 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:05:35 +0000" MODIFIED_BY="Anupa Shah">
<P>34 eyes of 17 people with bilateral, age-related cataract (intra-individual comparison); mean age 70; setting: Germany.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:05:39 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco ± sealed capsule irrigation with distilled water.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:05:40 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 19:51:03 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:05:55 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2004a">
<CHAR_METHODS MODIFIED="2010-01-20 14:05:48 +0000" MODIFIED_BY="Anupa Shah">
<P>1-piece (Alcon SA30AL or SA60AT sharp edge hydrophobic acrylic) vs. 3-piece (Alcon MA30BA or MA60BM sharp edge hydrophobic acrylic) IOL; prospective, randomised, patient- and examiner-masked; 2 years follow-up; 18 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:05:52 +0000" MODIFIED_BY="Anupa Shah">
<P>104 eyes of 52 people with bilateral age related cataract (intra-individual comparison), 2 subgroups (large or small IOL diameter); mean age 74, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:05:54 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:05:55 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective + objective (AQUA) PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:06:09 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2004b">
<CHAR_METHODS MODIFIED="2010-01-20 14:05:59 +0000" MODIFIED_BY="Anupa Shah">
<P>Anterior capsule polishing vs. no polishing in standard cataract surgery with implantation of AMO SI40 or Domilens Silens6 round edge silicone IOLs; prospective, randomised, patient- and examiner-masked; 3 years follow-up, 18 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:06:06 +0000" MODIFIED_BY="Anupa Shah">
<P>104 eyes of 52 people with bilateral age-related cataract (intra-individual comparison), 2 subgroups (26 in the SI40 group, 26 in the Silens6 group); mean age 76, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:06:07 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; anterior capsule polished or non-polished.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:06:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective fibrotic PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:06:46 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2004c">
<CHAR_METHODS MODIFIED="2010-01-20 14:06:20 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO AR40e (sharp edge hydrophobic acrylic) vs. AMO AR40 (round edge hydrophobic acrylic) vs. Pharmacia 911A (sharp edge silicone) IOL; prospective, randomised, patient- and examiner-masked; 1 year follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:06:25 +0000" MODIFIED_BY="Anupa Shah">
<P>144 eyes of 72 people with bilateral age-related cataract (intra-individual comparison), 2 subgroups (46 in the AR40/AR40e group, 26 in the 911A polish/non-polish group); mean age 72, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:06:44 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; anterior capsule polished or non-polished in the 911A group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:06:46 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective fibrotic PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:08:06 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2004d">
<CHAR_METHODS MODIFIED="2010-01-20 14:06:50 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO AR40e (sharp edge hydrophobic acrylic) vs. AMO AR40 (round edge hydrophobic acrylic) vs. AMO ClariFlex (sharp edge silicone) vs. AMO SI40 (round edge silicone) IOL; prospective, randomised, patient- and examiner-masked; 1 year follow-up; 26 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:08:02 +0000" MODIFIED_BY="Anupa Shah">
<P>210 eyes of 105 people with age-related cataract (intra-individual comparison sharp vs. round edge), 2 subgroups (53 in the AR40/AR40e group, 52 in the SI40/ClariFlex group); mean age 77, setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:08:04 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:08:06 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective fibrotic PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:08:17 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2005a">
<CHAR_METHODS MODIFIED="2010-01-20 14:08:10 +0000" MODIFIED_BY="Anupa Shah">
<P>Sharp vs. round optic edges in a silicone IOL (both Microsil by Dr Schmidt); prospective, randomised, patient- and examiner-masked; 5 years follow-up; 27 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:08:13 +0000" MODIFIED_BY="Anupa Shah">
<P>102 eyes of 51 people with bilateral age related-cataract; intra-individual comparison; mean age 73; setting: Austria.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:08:15 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:08:17 +0000" MODIFIED_BY="Anupa Shah">
<P>Objective PCO score (AQUA), YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:09:50 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sellmann-1988">
<CHAR_METHODS MODIFIED="2010-01-20 14:08:20 +0000" MODIFIED_BY="Anupa Shah">
<P>Convex-plano (Vision Care/3M 34R round edge PMMA IOL) vs. plano-convex (Vision Care/3M 34S round edge PMMA IOL) optic, standard cataract surgery; randomised, prospective, multi-centre.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:09:47 +0000" MODIFIED_BY="Anupa Shah">
<P>505 eyes of 505 people with age-related cataract, 2 groups (254 in the 34S group, 251 in the 34R group); mean age 71, setting: USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:09:48 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE or phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:09:50 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score (PCO incidence).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:10:03 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Shah-2007">
<CHAR_METHODS MODIFIED="2010-01-20 14:09:57 +0000" MODIFIED_BY="Anupa Shah">
<P>Sharp-edge vs. round-edge PMMA IOL (both Rayner 604A); randomised, prospective; 5 years follow-up, 11 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:10:01 +0000" MODIFIED_BY="Anupa Shah">
<P>236 eyes of 118 people with age-related bilateral cataract (intra-individual comparison); mean age 58, setting: India.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:10:02 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:10:03 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 20:16:00 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:10:15 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Shah-2008">
<CHAR_METHODS MODIFIED="2010-01-20 14:10:10 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon Acrysof SA60AT (sharp edge hydrophobic acrylic IOL) vs. EPOCH (round edge PMMA IOL); randomised, prospective, 1 year follow-up, 4 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:10:13 +0000" MODIFIED_BY="Anupa Shah">
<P>182 eyes of 91 people with age-related bilateral cataract (intra-individual comparison); mean age 58, setting: India.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:10:14 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:10:15 +0000" MODIFIED_BY="Anupa Shah">
<P>POCO objective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 20:47:05 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:10:26 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sundelin-2005">
<CHAR_METHODS MODIFIED="2010-01-20 14:10:19 +0000" MODIFIED_BY="Anupa Shah">
<P>AMO 911A (sharp edge silicone) vs. AMO SI40NB (round edge silicone) IOL; prospective, randomised; 3 years follow-up; 33 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:10:24 +0000" MODIFIED_BY="Anupa Shah">
<P>116 eyes of 116 people with age-related cataract, 2 groups (57 in the 911A group, 59 in the SI40 group); mean age 72; setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:10:26 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:10:26 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:47:39 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Tsuchiya-2003">
<CHAR_METHODS MODIFIED="2010-01-20 14:10:38 +0000" MODIFIED_BY="Anupa Shah">
<P>Betamethasone vs. Diclofenac eye drops after standard cataract surgery with implantation of an SI55NB (round edge silicone) IOL; prospective, randomised; 3 years follow-up, 10 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:10:41 +0000" MODIFIED_BY="Anupa Shah">
<P>60 eyes of 60 people with age-related cataract, 2 groups (34 in the Betamethasone group, 26 in the Diclofenac group); mean age 75, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:10:43 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco and postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:47:39 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:11:09 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Vasavada-2004">
<CHAR_METHODS MODIFIED="2010-01-20 14:10:49 +0000" MODIFIED_BY="Anupa Shah">
<P>Total anterior capsule cover (360° overlap) vs. partial anterior capsule cover (&lt; 360° overlap) vs. no anterior capsule cover (no overlap) in Alcon MA30BA (sharp edge, hydrophobic acrylic) IOLs; prospective, randomised; 3 years follow-up; 16 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:10:52 +0000" MODIFIED_BY="Anupa Shah">
<P>202 eyes of 202 people with age-related cataract, 3 groups (68 in the full overlap group, 74 in the partial overlap group, 60 in the no-overlap group); mean age 64, setting: India.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:10:58 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; 3 different types of rhexis/IOL overlap.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:11:09 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:11:28 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Wang-2000">
<CHAR_METHODS MODIFIED="2010-01-20 14:11:13 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmacia 812A (round edge PMMA) vs. AMO SI30NB (round edge silicone) IOL; randomised, prospective; 1 year follow-up; no drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:11:24 +0000" MODIFIED_BY="Anupa Shah">
<P>40 eyes of 40 people with age-related cataract, 2 groups (20 each); mean age 67, setting: Taiwan, Republic of China.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:11:25 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:11:28 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser), YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:11:41 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Wejde-2003">
<CHAR_METHODS MODIFIED="2010-01-20 14:11:32 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmaica 809C (HSM-PMMA, round edge) vs. Allergan SI40NB (round edge silicone) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) IOL; randomised, prospective; 2 years follow-up; 17 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:11:37 +0000" MODIFIED_BY="Anupa Shah">
<P>180 people with age-related cataract, 3 groups (61 in the HSM-PMMA group, 60 in the SI40 group, 59 in the MA60 group); mean age 74; setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:11:40 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:11:41 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score; YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:12:22 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Wejde-2004">
<CHAR_METHODS MODIFIED="2010-01-20 14:12:14 +0000" MODIFIED_BY="Anupa Shah">
<P>"Rhexis on" vs. "Rhexis off" the optic (standard cataract surgery with implantation of a round edge silicone IOL (Allergan SI40NB) or a sharp edge hydrophobic acrylic IOL (Alcon MA60BM)); prospective, randomised; 3 years follow-up; 27 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:12:20 +0000" MODIFIED_BY="Anupa Shah">
<P>119 eyes of 119 people with age-related cataract, 2 groups (60 in the SI40 group, 59 in the MA60BM group), 2 sub-groups (rhexis on or rhexis off); mean age 74, setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:12:22 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; rhexis on or rhexis off.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:12:22 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:12:35 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Westling-1991">
<CHAR_METHODS MODIFIED="2010-01-20 14:12:27 +0000" MODIFIED_BY="Anupa Shah">
<P>JF1U (non-ridged) vs. JF1LRU (laser ridge) round-edge PMMA IOL; prospective, randomised; 1 year follow-up; 48 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:12:32 +0000" MODIFIED_BY="Anupa Shah">
<P>319 eyes of 319 people with age-related cataracts, 2 groups (143 in the JF1U group, 176 in the JFLRU group); mean age 71; setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:12:33 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:12:35 +0000" MODIFIED_BY="Anupa Shah">
<P>Own subjective PCO score, BCVA, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:13:13 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Winther-1998">
<CHAR_METHODS MODIFIED="2010-01-20 14:12:41 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmacia 700b (planoconvex, ridge, round-edge PMMA) vs. Pharmacia 725a (biconvex, round-edge PMMA); heparin surface modified (HSM) vs. unmodified; prospective, randomised, patient- and examiner-masked; 3 years follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:12:45 +0000" MODIFIED_BY="Anupa Shah">
<P>250 eyes of 246 people with age-related cataract, 4 groups (62 with unmodified 700b, 58 with HSM-700b, 60 with unmodified 725a, 70 with HSM-725a); mean age 75; setting: Denmark.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:12:47 +0000" MODIFIED_BY="Anupa Shah">
<P>ECCE.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:13:13 +0000" MODIFIED_BY="Anupa Shah">
<P>Subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:13:29 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Yoshida-2002">
<CHAR_METHODS MODIFIED="2010-01-20 14:13:20 +0000" MODIFIED_BY="Anupa Shah">
<P>Pharmacia 811C (round edge PMMA) vs. Alcon MA60BM (sharp edge hydrophobic acrylic) vs. Allergan SI30NB (round edge silicone) IOL; prospective, randomised; 3 years follow-up; no drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:13:26 +0000" MODIFIED_BY="Anupa Shah">
<P>90 eyes of 90 people with age-related cataract, 3 groups (30 each); mean age 71, setting: Japan.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:13:27 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:13:29 +0000" MODIFIED_BY="Anupa Shah">
<P>Scheimpflug objective PCO score (Nidek anterior segment analyser).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:13:43 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Zaczek-2004">
<CHAR_METHODS MODIFIED="2010-01-20 14:13:33 +0000" MODIFIED_BY="Anupa Shah">
<P>Steroidal (dexamethasone) vs. nonsteroidal (diclofenac or placebo) topical treatment after cataract surgery; randomised, prospective, double-blind; 2 years follow-up; 55 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:13:37 +0000" MODIFIED_BY="Anupa Shah">
<P>180 eyes of 180 people with age-related cataract, 3 groups (60 each); mean age 75, setting: Sweden.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:13:42 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco; postoperative topical treatment.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:13:43 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:13:57 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Zemaitiene-2004">
<CHAR_METHODS MODIFIED="2010-01-20 14:13:49 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon MA30BA (3-piece sharp edge hydrophobic acrylic) vs. Alcon SA30AL (1-piece sharp edge hydrophobic acrylic) vs. Pharmacia 911A (sharp edge silicone) vs. Alcon Crystal (round edge PMMA) IOL; randomised, prospective; 1 year follow-up.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:13:54 +0000" MODIFIED_BY="Anupa Shah">
<P>165 eyes of 165 people with age-related cataract, 4 groups (46 in the MA30BA group, 38 in the SA30AL group, 39 in the 911A group, 42 in the PMMA group); mean age 67, setting: Lithuania.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:13:56 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:13:57 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-20 14:14:13 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Zemaitiene-2007">
<CHAR_METHODS MODIFIED="2010-01-20 14:14:07 +0000" MODIFIED_BY="Anupa Shah">
<P>Alcon Acrysof MA30BA (3-piece sharp edge hydrophobic acrylic) vs. Alcon Acrysof SA30AL (1-piece sharp edge hydrophobic acrylic) IOL; randomised, prospective; 2 years follow-up; 10 drop-outs.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-20 14:14:10 +0000" MODIFIED_BY="Anupa Shah">
<P>74 eyes of 74 people in 2 groups (37 each); mean age 67, setting: Lithuania.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-20 14:14:12 +0000" MODIFIED_BY="Anupa Shah">
<P>Phaco.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-20 14:14:13 +0000" MODIFIED_BY="Anupa Shah">
<P>EPCO subjective PCO score, YAG rate.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-07-18 20:59:31 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AQUA (Automated Quantification of After-cataract): objective PCO scoring system, Austria<BR/>BCVA: best corrected visual acuity<BR/>EPCO (evaluation of PCO): subjective PCO scoring system, Germany<BR/>HSM-PMMA: heparin surface modified PMMA<BR/>Hydrogel: hydrophilic acrylic<BR/>IOL: intraocular lens<BR/>PCO: posterior capsule opacification<BR/>PMMA: poly methyl methacrylate<BR/>POCO (posterior capsule opacification): semi-objective PCO scoring system, UK<BR/>YAG: YAG laser capsulotomy</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2010-01-20 14:14:24 +0000" MODIFIED_BY="Anupa Shah" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aasuri-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Abela_x002d_Formanek-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>main outcome measure flare (cell count), PCO score not assessable</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Abhilakh-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>retrospective study, not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-12-08 11:45:23 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Afsar-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-12-08 11:45:23 +0000" MODIFIED_BY="Anupa Shah">
<P>less than 12 months follow-up, no PCO assessment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-12-08 11:45:24 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Aktan-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-12-08 11:45:24 +0000" MODIFIED_BY="Anupa Shah">
<P>less than 12 months follow-up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Alio-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>not age-related cataract</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Auffarth-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cumming-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-D_x0027_Eliseo-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dada-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Davison-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>retrospective study, not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Georgopoulos-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Georgopoulos-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 16:46:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayashi-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 16:46:14 +0100" MODIFIED_BY="[Empty name]">
<P>does not fit into any category of this review (comparison of two sharp edge, hydrophobic acrylic IOLs)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Khalifa-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kruger-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 18:18:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Li-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 18:18:36 +0100" MODIFIED_BY="[Empty name]">
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meacock-2001b">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 19:35:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyata-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 19:35:19 +0100" MODIFIED_BY="[Empty name]">
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mootha-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-26 20:21:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nekolov_x00e1_-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-26 20:21:32 +0100" MODIFIED_BY="[Empty name]">
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nirmalan-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nishi-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 19:41:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nishi-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 19:41:56 +0100" MODIFIED_BY="[Empty name]">
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 19:46:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oharazawa-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 19:46:20 +0100" MODIFIED_BY="[Empty name]">
<P>does not fit into any category of this review (comparison of two sharp edge, hydrophobic acrylic IOLs), not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 19:49:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ozdemir-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 19:49:27 +0100" MODIFIED_BY="[Empty name]">
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ram-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-01-20 14:14:24 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Sacu-2005b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-01-20 14:14:24 +0000" MODIFIED_BY="Anupa Shah">
<P>summary of other published studies</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Strobel-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tassignon-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Thompson-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>inadequate randomisation (patients were selected retrospectively from another study)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-12-08 11:45:24 +0000" MODIFIED_BY="Anupa Shah" STUDY_ID="STD-Tobari-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-12-08 11:45:24 +0000" MODIFIED_BY="Anupa Shah">
<P>less than 12 months follow-up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-07-18 20:43:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vock-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-07-18 20:43:18 +0100" MODIFIED_BY="[Empty name]">
<P>does not meet the inclusion criteria of this review (posterior capsulorhexis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wren-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>retrospective study, not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>PCO: posterior capsule opacification</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-07-26 20:11:31 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2010-01-20 14:14:15 +0000" MODIFIED_BY="Anupa Shah">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-01-20 14:14:15 +0000" MODIFIED_BY="Anupa Shah" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:05:20 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Allers-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:05:25 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Aykan-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:38:56 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Barequet-2002">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:05:28 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Bender-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:40:39 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Bilge-2004">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:15 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Bolz-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:15 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Buehl-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:16 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Buehl-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:17 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Buehl-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:17 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Buehl-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:06:00 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Clark-1998">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:18 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Cleary-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:43:01 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Dick-1997">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:18 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Findl-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:19 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Findl-2005b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:45:01 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Flach-2000">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:19 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hancox-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:20 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hancox-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:20 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hayashi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:21 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hayashi-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:21 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hayashi-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:21 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Hayashi-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:53:36 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Heatley-2005">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:53:54 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Hollick-1998">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:54:06 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Hollick-1999">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:54:23 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Hollick-2000">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:54:36 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-H_x00fc_tz-1989">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:54:49 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Khanzada-2008">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:22 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Kohnen-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:22 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Kugelberg-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:23 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:23 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Laurell-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:24 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Leydolt-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:24 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Martin-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:25 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Mastropasqua-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:56:44 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Meacock-2000">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:57:20 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Meacock-2001">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:25 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Menapace-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:57:47 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Mester-2004">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:26 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Nejima-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:26 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Nejima-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:58:48 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Olson-1998">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 13:59:03 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Pohjalainen-2002">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:05:16 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Prosdocimo-2003">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:05:30 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Rabsilber-2006">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:27 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Rabsilber-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:27 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Sacu-2004a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:28 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Sacu-2004b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:28 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Sacu-2004c">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:28 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Sacu-2004d">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:29 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Sacu-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:09:52 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Sellmann-1988">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:29 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Shah-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:30 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Shah-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:10:35 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Sundelin-2005">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:10:46 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Tsuchiya-2003">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:30 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Vasavada-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:11:29 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2000">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:11:43 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Wejde-2003">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:12:24 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Wejde-2004">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:12:37 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Westling-1991">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:13:16 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Winther-1998">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:13:31 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Yoshida-2002">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-10 13:07:30 +0000" MODIFIED_BY="Anupa Shah" RESULT="YES" STUDY_ID="STD-Zaczek-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:14:02 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Zemaitiene-2004">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-20 14:14:15 +0000" MODIFIED_BY="Anupa Shah" RESULT="UNKNOWN" STUDY_ID="STD-Zemaitiene-2007">
<DESCRIPTION>
<P>3-piece</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-12-10 14:35:58 +0000" MODIFIED_BY="Anupa Shah">
<COMPARISON ID="CMP-001" MODIFIED="2009-07-26 15:22:43 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>PMMA versus Silicone</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="313" TOTAL_2="339" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>PMMA</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PMMA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Silicone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="18.0" MEAN_2="18.0" ORDER="27953" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Dick-1997" TOTAL_1="16" TOTAL_2="51" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="26.3" MEAN_2="12.0" ORDER="27954" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hayashi-1998" TOTAL_1="69" TOTAL_2="70" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="56.1" MEAN_2="39.9" ORDER="27955" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hollick-1998" TOTAL_1="23" TOTAL_2="22" WEIGHT="0.0"/>
<CONT_DATA CI_END="42.0952224928715" CI_START="14.304777507128502" EFFECT_SIZE="28.200000000000003" ESTIMABLE="YES" MEAN_1="45.6" MEAN_2="17.4" ORDER="27956" SD_1="32.0" SD_2="18.5" SE="7.089529502825175" STUDY_ID="STD-Hollick-2000" TOTAL_1="28" TOTAL_2="25" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="10.4" MEAN_2="8.6" ORDER="27957" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Olson-1998" TOTAL_1="42" TOTAL_2="42" WEIGHT="0.0"/>
<CONT_DATA CI_END="2.0202909733256895" CI_START="-18.980290973325697" EFFECT_SIZE="-8.480000000000004" ESTIMABLE="YES" MEAN_1="79.22" MEAN_2="87.7" ORDER="27958" SD_1="21.1" SD_2="11.35" SE="5.357389756215241" STUDY_ID="STD-Wang-2000" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="15.5" MEAN_2="5.8" ORDER="27959" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2003" TOTAL_1="43" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="11.892028218762064" CI_START="2.547971781237937" EFFECT_SIZE="7.220000000000001" ESTIMABLE="YES" MEAN_1="14.24" MEAN_2="7.02" ORDER="27960" SD_1="12.83" SD_2="2.42" SE="2.3837316683441254" STUDY_ID="STD-Yoshida-2002" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
<CONT_DATA CI_END="2.8544370931960943" CI_START="2.545562906803906" EFFECT_SIZE="2.7" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="0.4" ORDER="27961" SD_1="0.5" SD_2="0.1" SE="0.07879588319697424" STUDY_ID="STD-Zemaitiene-2004" TOTAL_1="42" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="46" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-26 15:22:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="224" TOTAL_2="254" WEIGHT="0.0" Z="0.0">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>PMMA</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PMMA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Silicone</GRAPH_LABEL_2>
<DICH_DATA CI_END="26.272008866429776" CI_START="0.039616771116206" EFFECT_SIZE="1.02020202020202" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.4194932820075896" LOG_CI_START="-1.4021209236374044" LOG_EFFECT_SIZE="0.00868617918509262" ORDER="27962" O_E="0.0" SE="1.6574301516114478" STUDY_ID="STD-Dick-1997" TOTAL_1="16" TOTAL_2="51" VAR="2.747074707470747" WEIGHT="0.0"/>
<DICH_DATA CI_END="22.392513765444072" CI_START="2.3271327242819977" EFFECT_SIZE="7.21875" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="4" LOG_CI_END="1.3501028498622538" LOG_CI_START="0.36682115328222276" LOG_EFFECT_SIZE="0.8584620015722384" ORDER="27963" O_E="0.0" SE="0.5775845358940075" STUDY_ID="STD-Hayashi-1998" TOTAL_1="69" TOTAL_2="70" VAR="0.33360389610389607" WEIGHT="0.0"/>
<DICH_DATA CI_END="183.299009835243" CI_START="0.47871065288491116" EFFECT_SIZE="9.36734693877551" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.263160118948842" LOG_CI_START="-0.31992690793134665" LOG_EFFECT_SIZE="0.9716166055087476" ORDER="27964" O_E="0.0" SE="1.5173181060764234" STUDY_ID="STD-Hollick-2000" TOTAL_1="28" TOTAL_2="25" VAR="2.3022542350273443" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.6273589255220589" CI_START="0.24003616772783362" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.21148335022157375" LOG_CI_START="-0.6197233155334233" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="27965" O_E="0.0" SE="0.4882549100038392" STUDY_ID="STD-Olson-1998" TOTAL_1="42" TOTAL_2="42" VAR="0.23839285714285713" WEIGHT="0.0"/>
<DICH_DATA CI_END="17.18118077307193" CI_START="0.058203217416075405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2350530073187374" LOG_CI_START="-1.2350530073187374" LOG_EFFECT_SIZE="0.0" ORDER="27966" O_E="0.0" SE="1.4509525002200232" STUDY_ID="STD-Wang-2000" TOTAL_1="20" TOTAL_2="20" VAR="2.1052631578947367" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.4759329215482357" CI_START="0.3441413935335323" EFFECT_SIZE="0.9230769230769231" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.39373887451767875" LOG_CI_START="-0.46326308703610264" LOG_EFFECT_SIZE="-0.03476210625921192" ORDER="27967" O_E="0.0" SE="0.5034071944448186" STUDY_ID="STD-Wejde-2003" TOTAL_1="49" TOTAL_2="46" VAR="0.2534188034188034" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>PMMA versus Hydrogel</NAME>
<CONT_OUTCOME CHI2="4.242369299504427E-31" CI_END="-6.3093511804965505" CI_START="-27.690648819503444" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-16.999999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.9999999999999994" P_Q="1.0" P_Z="0.0018289671458315622" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="56" TOTAL_2="49" UNITS="" WEIGHT="100.0" Z="3.116685273245045">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>PMMA</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrogel</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PMMA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Hydrogel</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.9402524233994285" CI_START="-32.05974757660057" EFFECT_SIZE="-17.0" ESTIMABLE="YES" MEAN_1="45.6" MEAN_2="62.6" ORDER="27968" SD_1="32.0" SD_2="23.7" SE="7.683685871470057" STUDY_ID="STD-Hollick-2000" TOTAL_1="28" TOTAL_2="25" WEIGHT="50.39329338172052"/>
<CONT_DATA CI_END="-1.821324868555898" CI_START="-32.1786751314441" EFFECT_SIZE="-17.0" ESTIMABLE="YES" MEAN_1="45.6" MEAN_2="62.6" ORDER="27969" SD_1="32.0" SD_2="23.7" SE="7.74436431035037" STUDY_ID="STD-Meacock-2001" TOTAL_1="28" TOTAL_2="24" WEIGHT="49.60670661827948"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2009-07-26 15:23:25 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>PMMA versus Acrylic (edge)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2009-07-26 15:23:25 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="39.86" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="349" TOTAL_2="384" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>PMMA</GROUP_LABEL_1>
<GROUP_LABEL_2>Acrylic</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PMMA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Acrylic</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.024132265792192" CI_START="6.57586773420781" EFFECT_SIZE="10.3" ESTIMABLE="YES" MEAN_1="26.3" MEAN_2="16.0" ORDER="27970" SD_1="12.2" SD_2="10.3" SE="1.900102397374478" STUDY_ID="STD-Hayashi-1998" TOTAL_1="69" TOTAL_2="73" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="56.1" MEAN_2="10.2" ORDER="27971" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hollick-1998" TOTAL_1="23" TOTAL_2="19" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="34.5" MEAN_2="14.5" MODIFIED="2009-07-18 17:13:02 +0100" MODIFIED_BY="[Empty name]" ORDER="172" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Khanzada-2008" TOTAL_1="55" TOTAL_2="55" WEIGHT="0.0"/>
<CONT_DATA CI_END="33.337072451110046" CI_START="20.12292754888996" EFFECT_SIZE="26.730000000000004" ESTIMABLE="YES" MEAN_1="38.38" MEAN_2="11.65" MODIFIED="2009-07-18 20:54:45 +0100" MODIFIED_BY="[Empty name]" ORDER="194" SD_1="29.62" SD_2="10.55" SE="3.371017275432502" STUDY_ID="STD-Shah-2008" TOTAL_1="87" TOTAL_2="87" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="15.5" MEAN_2="1.5" ORDER="27972" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2003" TOTAL_1="43" TOTAL_2="36" WEIGHT="0.0"/>
<CONT_DATA CI_END="12.031517219379388" CI_START="2.788482780620612" EFFECT_SIZE="7.41" ESTIMABLE="YES" MEAN_1="14.24" MEAN_2="6.83" ORDER="27973" SD_1="12.83" SD_2="1.48" SE="2.357960276736372" STUDY_ID="STD-Yoshida-2002" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
<CONT_DATA CI_END="2.85714672258354" CI_START="2.5428532774164605" EFFECT_SIZE="2.7" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="0.4" ORDER="27974" SD_1="0.5" SD_2="0.2" SE="0.08017837257372731" STUDY_ID="STD-Zemaitiene-2004" TOTAL_1="42" TOTAL_2="84" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.5950586525188086" CI_END="18.962737519002257" CI_START="2.7235052407742453" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="7.186453576864535" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="5" I2="61.46522549579437" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="1.277901033612638" LOG_CI_START="0.43512821531216017" LOG_EFFECT_SIZE="0.8565146244623991" METHOD="MH" MODIFIED="2009-07-18 20:56:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.10719751553829604" P_Q="0.0" P_Z="6.78093284644999E-5" Q="0.0" RANDOM="NO" SCALE="51.64181132091278" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="205" TOTAL_2="198" WEIGHT="99.99999999999999" Z="3.9838442335230217">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>PMMA</GROUP_LABEL_1>
<GROUP_LABEL_2>Acrylic</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PMMA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Acrylic</GRAPH_LABEL_2>
<DICH_DATA CI_END="69.32316189853593" CI_START="3.4796411467145503" EFFECT_SIZE="15.53125" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="2" LOG_CI_END="1.8408783630979904" LOG_CI_START="0.5415344577288618" LOG_EFFECT_SIZE="1.1912064104134261" ORDER="27975" O_E="0.0" SE="0.7632410418698895" STUDY_ID="STD-Hayashi-1998" TOTAL_1="69" TOTAL_2="73" VAR="0.5825368879946344" WEIGHT="33.453496755587594"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-07-18 20:56:59 +0100" MODIFIED_BY="[Empty name]" ORDER="195" O_E="0.0" SE="0.0" STUDY_ID="STD-Shah-2008" TOTAL_1="87" TOTAL_2="87" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.755178437390576" CI_START="0.7612637313619129" EFFECT_SIZE="2.9914529914529915" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="3" LOG_CI_END="1.0702292258715007" LOG_CI_START="-0.11846486066327276" LOG_EFFECT_SIZE="0.47588218260411397" ORDER="27976" O_E="0.0" SE="0.6982447905611524" STUDY_ID="STD-Wejde-2003" TOTAL_1="49" TOTAL_2="38" VAR="0.48754578754578753" WEIGHT="66.54650324441239"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2009-07-26 15:38:23 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Acrylic versus Silicone</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2009-07-26 15:32:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1.2" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="144" TOTAL_2="141" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Silicone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Acrylic</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.05598221980291364" CI_START="-0.07598221980291366" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="0.89" MEAN_2="0.9" ORDER="27977" SD_1="0.14" SD_2="0.12" SE="0.033665016461206926" STUDY_ID="STD-Allers-2000" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.03143791127005841" CI_START="-0.07143791127005844" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.98" MEAN_2="1.0" MODIFIED="2009-07-18 16:28:29 +0100" MODIFIED_BY="[Empty name]" ORDER="168" SD_1="0.18" SD_2="0.17" SE="0.026244314526080125" STUDY_ID="STD-Hayashi-2007" TOTAL_1="89" TOTAL_2="89" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.06327021238908301" CI_START="-0.3567297876109169" EFFECT_SIZE="-0.20999999999999996" ESTIMABLE="YES" MEAN_1="0.64" MEAN_2="0.85" ORDER="27978" SD_1="0.3" SD_2="0.21" SE="0.0748635121707862" STUDY_ID="STD-Rabsilber-2006" TOTAL_1="25" TOTAL_2="22" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2009-07-26 15:38:23 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="9.2" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="587" TOTAL_2="553" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Acrylic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Silicone</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.6" ORDER="27979" SD_1="0.0" SD_2="0.3" SE="0.0" STUDY_ID="STD-Allers-2000" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
<CONT_DATA CI_END="8.506367740344555" CI_START="-2.5063677403445555" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="22.0" MEAN_2="19.0" ORDER="27980" SD_1="11.0" SD_2="10.0" SE="2.809422919899591" STUDY_ID="STD-Findl-2005b" TOTAL_1="28" TOTAL_2="28" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.5781922618512475" CI_START="0.40180773814875115" EFFECT_SIZE="0.4899999999999993" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="4.61" MODIFIED="2009-07-18 16:20:23 +0100" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="0.31" SD_2="0.29" SE="0.044996878793129594" STUDY_ID="STD-Hayashi-2007" TOTAL_1="89" TOTAL_2="89" WEIGHT="0.0"/>
<CONT_DATA CI_END="3.698176245638418" CI_START="-1.5181762456384182" EFFECT_SIZE="1.09" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.01" MODIFIED="2009-07-18 17:43:39 +0100" MODIFIED_BY="[Empty name]" ORDER="174" SD_1="10.0" SD_2="2.5" SE="1.3307266185559428" STUDY_ID="STD-Kohnen-2008" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.13002317106854375" CI_START="-0.33002317106854373" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.3" ORDER="27981" SD_1="0.5" SD_2="1.1" SE="0.11736091728365274" STUDY_ID="STD-Mester-2004" TOTAL_1="106" TOTAL_2="106" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="15.6" MEAN_2="11.4" ORDER="27982" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Pohjalainen-2002" TOTAL_1="16" TOTAL_2="22" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="9.1" MEAN_2="2.2" ORDER="27983" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Prosdocimo-2003" TOTAL_1="38" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="4.864743083614876" CI_START="-0.8647430836148764" EFFECT_SIZE="1.9999999999999998" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="1.8" ORDER="27984" SD_1="5.0" SD_2="5.0" SE="1.461630471892139" STUDY_ID="STD-Rabsilber-2006" TOTAL_1="25" TOTAL_2="22" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.5" MEAN_2="5.8" ORDER="27985" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2003" TOTAL_1="36" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.4" MEAN_2="5.6" ORDER="27986" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2004" TOTAL_1="45" TOTAL_2="47" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.825077186529207" CI_START="-1.205077186529206" EFFECT_SIZE="-0.1899999999999995" ESTIMABLE="YES" MEAN_1="6.83" MEAN_2="7.02" ORDER="27987" SD_1="1.48" SD_2="2.42" SE="0.5179060403844182" STUDY_ID="STD-Yoshida-2002" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.05304955745617548" CI_START="-0.05304955745617548" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.4" ORDER="27988" SD_1="0.2" SD_2="0.1" SE="0.027066598098038342" STUDY_ID="STD-Zemaitiene-2004" TOTAL_1="84" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="7.526044955929564" CI_END="1.6358711312037673" CI_START="0.4327438551065991" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="OR" EFFECT_SIZE="0.8413757660966421" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.2137490883258371" LOG_CI_START="-0.3637690903208373" LOG_EFFECT_SIZE="-0.07501000099750009" METHOD="MH" MODIFIED="2009-07-18 17:55:11 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.48107927081250035" P_Q="0.0" P_Z="0.6106587152395904" Q="0.0" RANDOM="YES" SCALE="186.8236882574533" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="520" TOTAL_2="531" WEIGHT="100.00000000000001" Z="0.5091334121461784">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Acrylic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Silicone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="27989" O_E="0.0" SE="0.0" STUDY_ID="STD-Allers-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="16.821717284708434" CI_START="0.05944696270154517" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2258703297022433" LOG_CI_START="-1.2258703297022433" LOG_EFFECT_SIZE="0.0" ORDER="27990" O_E="0.0" SE="1.4401645996461914" STUDY_ID="STD-Findl-2005b" TOTAL_1="28" TOTAL_2="28" VAR="2.0740740740740744" WEIGHT="5.548585204451296"/>
<DICH_DATA CI_END="2.6220935938454826" CI_START="0.08238781646384365" EFFECT_SIZE="0.4647887323943662" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.418648189476562" LOG_CI_START="-1.0841370071589376" LOG_EFFECT_SIZE="-0.33274440884118783" ORDER="27991" O_E="0.0" SE="0.8827434634103889" STUDY_ID="STD-Hayashi-1998" TOTAL_1="73" TOTAL_2="70" VAR="0.7792360221937686" WEIGHT="14.768537891696377"/>
<DICH_DATA CI_END="9.784978957840082" CI_START="0.612016135487245" EFFECT_SIZE="2.4471544715447155" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9905598960641512" LOG_CI_START="-0.21323712775526027" LOG_EFFECT_SIZE="0.38866138415444546" MODIFIED="2009-07-18 16:23:55 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.707116330682894" STUDY_ID="STD-Hayashi-2007" TOTAL_1="89" TOTAL_2="89" VAR="0.5000135051184399" WEIGHT="23.015731780319516"/>
<DICH_DATA CI_END="2.953612854824665" CI_START="0.0069095593323850145" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.47035356950266693" LOG_CI_START="-2.160549649531181" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="27992" O_E="0.0" SE="1.5454055740414514" STUDY_ID="STD-Hollick-1998" TOTAL_1="19" TOTAL_2="22" VAR="2.388278388278388" WEIGHT="4.818607737199015"/>
<DICH_DATA CI_END="7.247850352242814" CI_START="0.13797194359711837" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8602092177998117" LOG_CI_START="-0.8602092177998117" LOG_EFFECT_SIZE="0.0" ORDER="180" O_E="0.0" SE="1.0105823052798226" STUDY_ID="STD-Kohnen-2008" TOTAL_1="96" TOTAL_2="96" VAR="1.0212765957446808" WEIGHT="11.268423038669612"/>
<DICH_DATA CI_END="16.199420258972555" CI_START="0.06173060418295641" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.20949947239236" LOG_CI_START="-1.20949947239236" LOG_EFFECT_SIZE="0.0" ORDER="27993" O_E="0.0" SE="1.4209319544044392" STUDY_ID="STD-Mester-2004" TOTAL_1="106" TOTAL_2="106" VAR="2.019047619047619" WEIGHT="5.699804507717266"/>
<DICH_DATA CI_END="114.04914786656252" CI_START="0.16628462853131953" EFFECT_SIZE="4.354838709677419" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.057092044735576" LOG_CI_START="-0.7791478954141092" LOG_EFFECT_SIZE="0.6389720746607334" ORDER="27994" O_E="0.0" SE="1.6660213804580568" STUDY_ID="STD-Pohjalainen-2002" TOTAL_1="16" TOTAL_2="22" VAR="2.7756272401433693" WEIGHT="4.1461535446485245"/>
<DICH_DATA CI_END="21.637947573130965" CI_START="0.15410858915840878" EFFECT_SIZE="1.826086956521739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3352160642008708" LOG_CI_START="-0.8121731554402556" LOG_EFFECT_SIZE="0.26152145438030755" ORDER="27995" O_E="0.0" SE="1.2613870573652692" STUDY_ID="STD-Rabsilber-2006" TOTAL_1="25" TOTAL_2="22" VAR="1.5910973084886129" WEIGHT="7.2328553753101845"/>
<DICH_DATA CI_END="1.2161964849788425" CI_START="0.07829024973071573" EFFECT_SIZE="0.30857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.08500374389123999" LOG_CI_START="-1.106292321617892" LOG_EFFECT_SIZE="-0.510644288863326" ORDER="27996" O_E="0.0" SE="0.699773205890694" STUDY_ID="STD-Wejde-2003" TOTAL_1="38" TOTAL_2="46" VAR="0.4896825396825397" WEIGHT="23.501300919988207"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.649336238413466" CI_END="2.0672280928801388" CI_START="0.4509090182326258" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9654697249647379" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.3153883982596127" LOG_CI_START="-0.34591107866659476" LOG_EFFECT_SIZE="-0.015261340203491057" METHOD="MH" MODIFIED="2009-07-18 17:46:03 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.4601547448084403" P_Q="0.0" P_Z="0.9279190310610115" Q="0.0" RANDOM="YES" SCALE="32.72932528706303" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="412" TOTAL_2="417" WEIGHT="100.0" Z="0.09046333226721555">
<NAME>YAG rate (only sharp edge IOLs)</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Silicone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Acrylic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Silicone</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="27997" O_E="0.0" SE="0.0" STUDY_ID="STD-Allers-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="16.821717284708434" CI_START="0.05944696270154517" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2258703297022433" LOG_CI_START="-1.2258703297022433" LOG_EFFECT_SIZE="0.0" ORDER="27998" O_E="0.0" SE="1.4401645996461914" STUDY_ID="STD-Findl-2005b" TOTAL_1="28" TOTAL_2="28" VAR="2.0740740740740744" WEIGHT="7.27523957942934"/>
<DICH_DATA CI_END="9.784978957840082" CI_START="0.612016135487245" EFFECT_SIZE="2.4471544715447155" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9905598960641512" LOG_CI_START="-0.21323712775526027" LOG_EFFECT_SIZE="0.38866138415444546" MODIFIED="2009-07-18 16:24:30 +0100" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.707116330682894" STUDY_ID="STD-Hayashi-2007" TOTAL_1="89" TOTAL_2="89" VAR="0.5000135051184399" WEIGHT="30.177956474991"/>
<DICH_DATA CI_END="7.247850352242814" CI_START="0.13797194359711837" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8602092177998117" LOG_CI_START="-0.8602092177998117" LOG_EFFECT_SIZE="0.0" ORDER="176" O_E="0.0" SE="1.0105823052798226" STUDY_ID="STD-Kohnen-2008" TOTAL_1="96" TOTAL_2="96" VAR="1.0212765957446808" WEIGHT="14.775023590322553"/>
<DICH_DATA CI_END="16.199420258972555" CI_START="0.06173060418295641" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.20949947239236" LOG_CI_START="-1.20949947239236" LOG_EFFECT_SIZE="0.0" ORDER="27999" O_E="0.0" SE="1.4209319544044392" STUDY_ID="STD-Mester-2004" TOTAL_1="106" TOTAL_2="106" VAR="2.019047619047619" WEIGHT="7.473516549099323"/>
<DICH_DATA CI_END="21.637947573130965" CI_START="0.15410858915840878" EFFECT_SIZE="1.826086956521739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3352160642008708" LOG_CI_START="-0.8121731554402556" LOG_EFFECT_SIZE="0.26152145438030755" ORDER="28000" O_E="0.0" SE="1.2613870573652692" STUDY_ID="STD-Rabsilber-2006" TOTAL_1="25" TOTAL_2="22" VAR="1.5910973084886129" WEIGHT="9.48363479333983"/>
<DICH_DATA CI_END="1.2161964849788425" CI_START="0.07829024973071573" EFFECT_SIZE="0.30857142857142855" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.08500374389123999" LOG_CI_START="-1.106292321617892" LOG_EFFECT_SIZE="-0.510644288863326" ORDER="28001" O_E="0.0" SE="0.699773205890694" STUDY_ID="STD-Wejde-2003" TOTAL_1="38" TOTAL_2="46" VAR="0.4896825396825397" WEIGHT="30.814629012817957"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2009-07-26 16:09:58 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Acrylic versus Hydrogel</NAME>
<CONT_OUTCOME CHI2="3.620917043776898" CI_END="0.1178203106216674" CI_START="0.061738400742578574" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.08977935568212299" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2009-07-26 15:56:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4597323853973493" P_Q="1.0" P_Z="3.490488471158782E-10" Q="0.0" RANDOM="YES" SCALE="0.35796420094236164" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="212" TOTAL_2="212" UNITS="" WEIGHT="100.0" Z="6.275260741709656">
<NAME>BCDVA</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrogel</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Hydrogel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Acrylic</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.12686147941050158" CI_START="0.013138520589498534" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="1.02" MEAN_2="0.95" MODIFIED="2009-07-12 20:19:13 +0100" MODIFIED_BY="[Empty name]" ORDER="168" SD_1="0.09" SD_2="0.11" SE="0.029011491975882014" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" WEIGHT="24.319200274452363"/>
<CONT_DATA CI_END="0.1446307423237776" CI_START="0.03536925767622257" EFFECT_SIZE="0.09000000000000008" ESTIMABLE="YES" MEAN_1="1.05" MEAN_2="0.96" MODIFIED="2009-07-11 21:13:22 +0100" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="0.09" SD_2="0.11" SE="0.02787333989537452" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" WEIGHT="26.345800297323386"/>
<CONT_DATA CI_END="0.18437959215066346" CI_START="0.05562040784933654" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="0.84" ORDER="28002" SD_1="0.2" SD_2="0.25" SE="0.03284733426658931" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="18.97095338482686"/>
<CONT_DATA CI_END="0.12520972798562244" CI_START="0.014790272014377465" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.76" ORDER="28003" SD_1="0.13" SD_2="0.14" SE="0.028168746171414256" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" WEIGHT="25.796119743174806"/>
<CONT_DATA CI_END="0.3111998248814376" CI_START="0.04880017511856252" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" MEAN_1="0.93" MEAN_2="0.75" ORDER="28004" SD_1="0.1" SD_2="0.29" SE="0.06693991620066746" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="4.567926300222587"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2009-07-26 16:05:12 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="165.15" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="271" TOTAL_2="269" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrogel</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Acrylic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Hydrogel</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.8263099381515353" CI_START="-32.433690061848466" EFFECT_SIZE="-17.63" ESTIMABLE="YES" MEAN_1="7.82" MEAN_2="25.45" MODIFIED="2009-07-12 20:20:33 +0100" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="13.35" SD_2="34.51" SE="7.553041881696848" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0"/>
<CONT_DATA CI_END="-86.1188614693349" CI_START="-102.2811385306651" EFFECT_SIZE="-94.2" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="96.4" MODIFIED="2009-07-11 21:17:14 +0100" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="1.0" SD_2="21.0" SE="4.123105625617661" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.0"/>
<CONT_DATA CI_END="-8.302120544761237" CI_START="-13.697879455238763" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="20.0" ORDER="28005" SD_1="6.0" SD_2="12.0" SE="1.3764944032233706" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.7" MEAN_2="58.9" ORDER="28006" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="4.65" MEAN_2="18.2" ORDER="28008" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Kugelberg-2006" TOTAL_1="59" TOTAL_2="57" WEIGHT="0.0"/>
<CONT_DATA CI_END="-26.433842343270317" CI_START="-53.566157656729686" EFFECT_SIZE="-40.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="44.0" ORDER="28007" SD_1="10.3" SD_2="30.0" SE="6.921636195224914" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="55" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-26 16:09:58 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="276" TOTAL_2="274" WEIGHT="0.0" Z="0.0">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Acrylic</GROUP_LABEL_1>
<GROUP_LABEL_2>Hydrogel</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Acrylic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Hydrogel</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.2479853284817" CI_START="0.012394047796175789" EFFECT_SIZE="0.3197278911564626" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9163478797530177" LOG_CI_START="-1.9067868333779345" LOG_EFFECT_SIZE="-0.4952194768124586" MODIFIED="2009-07-12 20:22:10 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="1.6583233052353332" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" VAR="2.7500361846866404" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.25440513470241566" CI_START="7.702907322146394E-4" EFFECT_SIZE="0.01399878271454656" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.5944741274952384" LOG_CI_START="-3.113345327339699" LOG_EFFECT_SIZE="-1.853909727417469" MODIFIED="2009-07-11 21:20:03 +0100" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="1.4795974114021666" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" VAR="2.189208499827992" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.2274310017425465" CI_START="0.012108967285239601" EFFECT_SIZE="0.052478134110787174" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="28" LOG_CI_END="-0.6431503357431562" LOG_CI_START="-1.9168928941357724" LOG_EFFECT_SIZE="-1.2800216149394643" ORDER="28009" O_E="0.0" SE="0.7482026839271746" STUDY_ID="STD-Hayashi-2004" TOTAL_1="100" TOTAL_2="100" VAR="0.5598072562358276" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.5121048008627422" CI_START="0.004353344388187545" EFFECT_SIZE="0.08113391984359726" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.17958189226247304" LOG_CI_START="-2.361176974934646" LOG_EFFECT_SIZE="-1.0907975413360862" ORDER="28010" O_E="0.0" SE="1.4924543355508189" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" VAR="2.227419943704436" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.372376720384365" CI_START="0.3517294667903691" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0558512376587752" LOG_CI_START="-0.45379124633081286" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="28012" O_E="0.0" SE="0.8867714679463004" STUDY_ID="STD-Kugelberg-2006" TOTAL_1="59" TOTAL_2="57" VAR="0.7863636363636364" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.7968411209616402" CI_START="0.004552023345778852" EFFECT_SIZE="0.09043927648578812" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.25450967792137913" LOG_CI_START="-2.3417955192586506" LOG_EFFECT_SIZE="-1.0436429206686357" ORDER="28011" O_E="0.0" SE="1.5250825247415485" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" VAR="2.325876707272056" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2009-07-26 16:14:10 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Silicone versus Hydrogel</NAME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2009-07-26 16:33:39 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Hydrogel versus other materials</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2009-07-26 16:24:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="237" TOTAL_2="240" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA</NAME>
<GROUP_LABEL_1>Hydrogel</GROUP_LABEL_1>
<GROUP_LABEL_2>other materials</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours others</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Hydrogel</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.12686147941050158" CI_START="0.013138520589498534" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="1.02" MEAN_2="0.95" MODIFIED="2009-07-26 16:11:24 +0100" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="0.09" SD_2="0.11" SE="0.029011491975882014" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.1446307423237776" CI_START="0.03536925767622257" EFFECT_SIZE="0.09000000000000008" ESTIMABLE="YES" MEAN_1="1.05" MEAN_2="0.96" MODIFIED="2009-07-26 16:11:27 +0100" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="0.09" SD_2="0.11" SE="0.02787333989537452" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.05562040784933654" CI_START="-0.18437959215066346" EFFECT_SIZE="-0.12" ESTIMABLE="YES" MEAN_1="0.84" MEAN_2="0.96" ORDER="28013" SD_1="0.25" SD_2="0.2" SE="0.03284733426658931" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.01278469614669249" CI_START="-0.12721530385330743" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.83" ORDER="28014" SD_1="0.14" SD_2="0.14" SE="0.02919201796799047" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.021598686851725543" CI_START="-0.14159868685172566" EFFECT_SIZE="-0.06000000000000005" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.91" ORDER="28015" SD_1="0.19" SD_2="0.09" SE="0.04163274809913122" STUDY_ID="STD-Hollick-2000" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.04880017511856252" CI_START="-0.3111998248814376" EFFECT_SIZE="-0.18000000000000005" ESTIMABLE="YES" MEAN_1="0.75" MEAN_2="0.93" ORDER="28016" SD_1="0.29" SD_2="0.1" SE="0.06693991620066746" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" MODIFIED="2009-07-26 16:29:24 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="53.24" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="261" TOTAL_2="268" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Hydrogel</GROUP_LABEL_1>
<GROUP_LABEL_2>other materials</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Hydrogel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours others</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.8263099381515353" CI_START="-32.433690061848466" EFFECT_SIZE="-17.63" ESTIMABLE="YES" MEAN_1="7.82" MEAN_2="25.45" MODIFIED="2009-07-26 16:11:32 +0100" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="13.35" SD_2="34.51" SE="7.553041881696848" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0"/>
<CONT_DATA CI_END="-86.1188614693349" CI_START="-102.2811385306651" EFFECT_SIZE="-94.2" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="96.4" MODIFIED="2009-07-26 16:11:35 +0100" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="1.0" SD_2="21.0" SE="4.123105625617661" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.0"/>
<CONT_DATA CI_END="13.697879455238763" CI_START="8.302120544761237" EFFECT_SIZE="11.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="9.0" ORDER="28017" SD_1="12.0" SD_2="6.0" SE="1.3764944032233706" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="58.9" MEAN_2="1.7" ORDER="28018" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" WEIGHT="0.0"/>
<CONT_DATA CI_END="32.05974757660057" CI_START="1.9402524233994285" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="62.6" MEAN_2="45.6" ORDER="28019" SD_1="23.7" SD_2="32.0" SE="7.683685871470057" STUDY_ID="STD-Hollick-2000" TOTAL_1="25" TOTAL_2="28" WEIGHT="0.0"/>
<CONT_DATA CI_END="53.566157656729686" CI_START="26.433842343270317" EFFECT_SIZE="40.0" ESTIMABLE="YES" MEAN_1="44.0" MEAN_2="4.0" ORDER="28020" SD_1="30.0" SD_2="10.3" SE="6.921636195224914" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.0"/>
<CONT_DATA CI_END="32.1786751314441" CI_START="1.821324868555898" EFFECT_SIZE="17.0" ESTIMABLE="YES" MEAN_1="62.6" MEAN_2="45.6" ORDER="28021" SD_1="23.7" SD_2="32.0" SE="7.74436431035037" STUDY_ID="STD-Meacock-2001" TOTAL_1="24" TOTAL_2="28" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="44" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-26 16:33:39 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="242" TOTAL_2="245" WEIGHT="0.0" Z="0.0">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Hydrogel</GROUP_LABEL_1>
<GROUP_LABEL_2>other materials</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Hydrogel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours others</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.2479853284817" CI_START="0.012394047796175789" EFFECT_SIZE="0.3197278911564626" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9163478797530177" LOG_CI_START="-1.9067868333779345" LOG_EFFECT_SIZE="-0.4952194768124586" MODIFIED="2009-07-26 16:11:40 +0100" MODIFIED_BY="[Empty name]" ORDER="204" O_E="0.0" SE="1.6583233052353332" STUDY_ID="STD-Cleary-2009" TOTAL_1="24" TOTAL_2="24" VAR="2.7500361846866404" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.25440513470241566" CI_START="7.702907322146394E-4" EFFECT_SIZE="0.01399878271454656" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="15" LOG_CI_END="-0.5944741274952384" LOG_CI_START="-3.113345327339699" LOG_EFFECT_SIZE="-1.853909727417469" MODIFIED="2009-07-26 16:11:42 +0100" MODIFIED_BY="[Empty name]" ORDER="205" O_E="0.0" SE="1.4795974114021666" STUDY_ID="STD-Hancox-2007" TOTAL_1="26" TOTAL_2="26" VAR="2.189208499827992" WEIGHT="0.0"/>
<DICH_DATA CI_END="82.58342569138536" CI_START="4.3969379387072625" EFFECT_SIZE="19.055555555555557" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="2" LOG_CI_END="1.9168928941357728" LOG_CI_START="0.6431503357431563" LOG_EFFECT_SIZE="1.2800216149394645" ORDER="28022" O_E="0.0" SE="0.7482026839271747" STUDY_ID="STD-Hayashi-2004" TOTAL_1="100" TOTAL_2="100" VAR="0.5598072562358277" WEIGHT="0.0"/>
<DICH_DATA CI_END="229.70845190043354" CI_START="0.6613298227936597" EFFECT_SIZE="12.325301204819278" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.3611769749346463" LOG_CI_START="-0.17958189226247329" LOG_EFFECT_SIZE="1.0907975413360862" ORDER="28023" O_E="0.0" SE="1.492454335550819" STUDY_ID="STD-Heatley-2005" TOTAL_1="46" TOTAL_2="46" VAR="2.2274199437044366" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.201658634241388" CI_START="0.5916807676590472" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.9638661176469677" LOG_CI_START="-0.22791254705777886" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="28024" O_E="0.0" SE="0.7000566870471027" STUDY_ID="STD-Hollick-2000" TOTAL_1="25" TOTAL_2="28" VAR="0.49007936507936506" WEIGHT="0.0"/>
<DICH_DATA CI_END="219.68252885330924" CI_START="0.5565322322236349" EFFECT_SIZE="11.057142857142857" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.3417955192586506" LOG_CI_START="-0.25450967792137913" LOG_EFFECT_SIZE="1.0436429206686357" ORDER="28025" O_E="0.0" SE="1.5250825247415485" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" VAR="2.325876707272056" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2009-07-26 16:40:41 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>HSM-PMMA versus PMMA</NAME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2009-07-26 16:54:04 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Sharp versus round optic edges (PMMA)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.01" MODIFIED="2009-07-26 16:47:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.48" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="139" TOTAL_2="139" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA (2 years)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours round</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sharp</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.08476979441475158" CI_START="-0.18476979441475166" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.81" MODIFIED="2009-07-26 16:44:02 +0100" MODIFIED_BY="[Empty name]" ORDER="207" SD_1="0.27" SD_2="0.28" SE="0.06876136269737534" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.58" MEAN_2="0.59" MODIFIED="2009-07-18 20:35:50 +0100" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.787963965259163" CI_END="-10.473205195241183" CI_START="-28.871894469020916" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-19.67254983213105" ESTIMABLE="YES" I2="73.60059363892121" I2_Q="0.0" ID="CMP-009.02" MODIFIED="2009-07-26 16:47:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.051622447736036525" P_Q="1.0" P_Z="2.773239451765524E-5" Q="0.0" RANDOM="NO" SCALE="35.97" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="139" TOTAL_2="139" UNITS="" WEIGHT="100.0" Z="4.191329999794632">
<NAME>PCO score 0-100</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours round</GRAPH_LABEL_2>
<CONT_DATA CI_END="-15.646462800997854" CI_START="-40.953537199002156" EFFECT_SIZE="-28.300000000000004" ESTIMABLE="YES" MEAN_1="22.9" MEAN_2="51.2" MODIFIED="2009-07-26 16:44:12 +0100" MODIFIED_BY="[Empty name]" ORDER="208" SD_1="32.0" SD_2="17.6" SE="6.456004956627589" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" WEIGHT="52.855463563557635"/>
<CONT_DATA CI_END="3.398037973067657" CI_START="-23.39803797306766" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="45.0" MODIFIED="2009-07-18 20:41:15 +0100" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="50.0" SD_2="50.0" SE="6.835859270246632" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" WEIGHT="47.14453643644236"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.680507951343965" CI_END="1.1297909646356648" CI_START="0.2602000941215166" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="0.5421915854528166" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="22" I2="62.69363799131371" I2_Q="0.0" ID="CMP-009.03" LOG_CI_END="0.05299809719747287" LOG_CI_START="-0.5846925506781685" LOG_EFFECT_SIZE="-0.26584722674034783" METHOD="MH" MODIFIED="2009-07-26 16:54:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.10158338374855846" P_Q="0.0" P_Z="0.10222083800819641" Q="0.0" RANDOM="NO" SCALE="8.27" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="139" TOTAL_2="139" WEIGHT="99.99999999999999" Z="1.6341810611045613">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours round</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8467721366452235" CI_START="0.06694757650886135" EFFECT_SIZE="0.23809523809523808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.07223344104034041" LOG_CI_START="-1.1742651397554607" LOG_EFFECT_SIZE="-0.6232492903979004" MODIFIED="2009-07-26 16:44:29 +0100" MODIFIED_BY="[Empty name]" ORDER="209" O_E="0.0" SE="0.6473388749701496" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" VAR="0.419047619047619" WEIGHT="53.41098169717137"/>
<DICH_DATA CI_END="2.2879639103678358" CI_START="0.3468383937428081" EFFECT_SIZE="0.8908163265306123" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3594491697487327" LOG_CI_START="-0.459872833722583" LOG_EFFECT_SIZE="-0.05021183198692512" MODIFIED="2009-07-18 20:30:43 +0100" MODIFIED_BY="[Empty name]" ORDER="191" O_E="0.0" SE="0.48127380054837765" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" VAR="0.2316244710942796" WEIGHT="46.58901830282861"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2009-07-26 16:40:37 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Sharp versus round optic edges (Acrylic)</NAME>
<CONT_OUTCOME CHI2="0.6408028759736382" CI_END="0.12080781686049369" CI_START="0.008910577387558967" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="0.06485919712402632" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="0.42342046171060366" P_Q="1.0" P_Z="0.023079573671029256" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="100" TOTAL_2="100" UNITS="" WEIGHT="100.00000000000001" Z="2.272114862315673">
<NAME>BCDVA (2 years)</NAME>
<GROUP_LABEL_1>sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Round</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sharp</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.20263056197006007" CI_START="-0.002630561970060119" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.95" MEAN_2="0.85" ORDER="28026" SD_1="0.15" SD_2="0.25" SE="0.05236349380886428" STUDY_ID="STD-Buehl-2005" TOTAL_1="31" TOTAL_2="31" WEIGHT="29.718394248052736"/>
<CONT_DATA CI_END="0.11673728567566634" CI_START="-0.016737285675666472" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.97" MEAN_2="0.92" ORDER="28027" SD_1="0.2" SD_2="0.2" SE="0.034050261230349946" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" WEIGHT="70.28160575194728"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="167" TOTAL_2="167" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<CONT_DATA CI_END="-6.590653692640713" CI_START="-15.209346307359283" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="21.9" ORDER="28028" SD_1="7.5" SD_2="12.7" SE="2.198686476563273" STUDY_ID="STD-Buehl-2002" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0"/>
<CONT_DATA CI_END="-3.920240318518813" CI_START="-6.27975968148119" EFFECT_SIZE="-5.100000000000001" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="15.3" ORDER="28029" SD_1="3.0" SD_2="4.0" SE="0.601929265428846" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="-11.002723410103055" CI_START="-22.597276589896946" EFFECT_SIZE="-16.8" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="23.3" ORDER="28030" SD_1="10.5" SD_2="18.8" SE="2.9578485296796897" STUDY_ID="STD-Sacu-2004d" TOTAL_1="53" TOTAL_2="53" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.16590272659322694" CI_END="0.3209865020048689" CI_START="0.016319977514334266" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="0.07237743084086551" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-010.03" LOG_CI_END="-0.49351322998782543" LOG_CI_START="-1.7872804439527017" LOG_EFFECT_SIZE="-1.1403968369702635" METHOD="MH" MODIFIED="2008-11-01 16:08:24 +0000" MODIFIED_BY="Anupa Shah" NO="3" P_CHI2="0.6837793991627231" P_Q="0.0" P_Z="5.498075481664757E-4" Q="0.0" RANDOM="NO" SCALE="110.26013089671272" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="100" TOTAL_2="100" WEIGHT="100.0" Z="3.455237857968772">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.4394304864750029" CI_START="0.006338872501780661" EFFECT_SIZE="0.05277777777777778" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.3571098162171136" LOG_CI_START="-2.197987983411803" LOG_EFFECT_SIZE="-1.2775488998144584" ORDER="28031" O_E="0.0" SE="1.0813409479040526" STUDY_ID="STD-Buehl-2005" TOTAL_1="31" TOTAL_2="31" VAR="1.169298245614035" WEIGHT="56.696795398520955"/>
<DICH_DATA CI_END="0.7965698308028525" CI_START="0.01206634677928031" EFFECT_SIZE="0.09803921568627451" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.09877614603610495" LOG_CI_START="-1.9184241974877299" LOG_EFFECT_SIZE="-1.0086001717619175" ORDER="28032" O_E="0.0" SE="1.0688702728258088" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" VAR="1.142483660130719" WEIGHT="43.303204601479045"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" MODIFIED="2009-07-26 17:02:15 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Sharp versus round optic edges (Silicone)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="97" TOTAL_2="99" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA</NAME>
<GROUP_LABEL_1>sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Round</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sharp</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0713437659324185" CI_START="-0.0713437659324185" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.0" ORDER="28033" SD_1="0.13" SD_2="0.19" SE="0.03640054944640259" STUDY_ID="STD-Buehl-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.3671091814985793" CI_START="0.11289081850142069" EFFECT_SIZE="0.24" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.59" ORDER="28034" SD_1="0.21" SD_2="0.45" SE="0.0648528148992534" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-011.02" MODIFIED="2009-07-26 17:01:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="28.49" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="287" TOTAL_2="289" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.8601438392290506" CI_START="-10.939856160770951" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="7.1" MEAN_2="14.0" ORDER="28035" SD_1="6.5" SD_2="11.3" SE="2.0611889772653065" STUDY_ID="STD-Buehl-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="1.9213489182626748" CI_START="-5.421348918262675" EFFECT_SIZE="-1.75" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="1.75" MODIFIED="2009-07-18 17:50:31 +0100" MODIFIED_BY="[Empty name]" ORDER="177" SD_1="2.0" SD_2="14.0" SE="1.873171623163388" STUDY_ID="STD-Kohnen-2008" TOTAL_1="57" TOTAL_2="57" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.1374509225884316" CI_START="-1.6625490774115685" EFFECT_SIZE="-0.9000000000000001" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="1.1" ORDER="28036" SD_1="1.2" SD_2="3.1" SE="0.38906280086086187" STUDY_ID="STD-Mester-2004" TOTAL_1="73" TOTAL_2="73" WEIGHT="0.0"/>
<CONT_DATA CI_END="-8.819109015179995" CI_START="-20.180890984820003" EFFECT_SIZE="-14.5" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="20.5" ORDER="28037" SD_1="8.8" SD_2="15.0" SE="2.8984670277771163" STUDY_ID="STD-Sacu-2004d" TOTAL_1="36" TOTAL_2="36" WEIGHT="0.0"/>
<CONT_DATA CI_END="-5.906224328597537" CI_START="-18.09377567140246" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="24.0" ORDER="28038" SD_1="6.0" SD_2="14.0" SE="3.1091263510296048" STUDY_ID="STD-Sacu-2005a" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0"/>
<CONT_DATA CI_END="-3.881981059247688" CI_START="-13.49801894075231" EFFECT_SIZE="-8.69" ESTIMABLE="YES" MEAN_1="0.75" MEAN_2="9.44" ORDER="28039" SD_1="5.54" SD_2="17.98" SE="2.4531159647204492" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.3298708896388303" CI_END="0.5181123610097567" CI_START="0.10123953505673784" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="OR" EFFECT_SIZE="0.22902719169517075" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-011.03" LOG_CI_END="-0.28557604628788463" LOG_CI_START="-0.9946498580096034" LOG_EFFECT_SIZE="-0.6401129521487439" METHOD="MH" MODIFIED="2009-07-26 17:02:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6753360684762824" P_Q="0.0" P_Z="4.0210863390716654E-4" Q="0.0" RANDOM="YES" SCALE="807.8299071979499" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="276" TOTAL_2="278" WEIGHT="100.00000000000001" Z="3.538696004588943">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5929357299306035" CI_START="0.019392323780398686" EFFECT_SIZE="0.17575757575757575" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2021982537047301" LOG_CI_START="-1.7123701463346306" LOG_EFFECT_SIZE="-0.7550859463149502" ORDER="179" O_E="0.0" SE="1.124626955449548" STUDY_ID="STD-Buehl-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.26478578892372" WEIGHT="13.716430852776188"/>
<DICH_DATA CI_END="0.8460831602355288" CI_START="0.10158602682190465" EFFECT_SIZE="0.2931726907630522" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.07258694871458087" LOG_CI_START="-0.9931660252359799" LOG_EFFECT_SIZE="-0.5328764869752805" MODIFIED="2009-07-18 17:52:50 +0100" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.540752706488592" STUDY_ID="STD-Kohnen-2008" TOTAL_1="88" TOTAL_2="88" VAR="0.29241348957473734" WEIGHT="59.32813442559105"/>
<DICH_DATA CI_END="5.560021583002775" CI_START="0.043723531866742424" EFFECT_SIZE="0.4930555555555556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7450764774383192" LOG_CI_START="-1.359284764190668" LOG_EFFECT_SIZE="-0.30710414337617437" ORDER="28041" O_E="0.0" SE="1.2361122100890123" STUDY_ID="STD-Mester-2004" TOTAL_1="73" TOTAL_2="73" VAR="1.5279733959311423" WEIGHT="11.35382779801225"/>
<DICH_DATA CI_END="1.830496416032352" CI_START="0.004721952908554314" EFFECT_SIZE="0.09297052154195011" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.26256888290403085" LOG_CI_START="-2.325878348400237" LOG_EFFECT_SIZE="-1.0316547327481032" ORDER="28042" O_E="0.0" SE="1.5204667166885675" STUDY_ID="STD-Sacu-2005a" TOTAL_1="24" TOTAL_2="24" VAR="2.3118190365577127" WEIGHT="7.5041975790535"/>
<DICH_DATA CI_END="0.8143008709399274" CI_START="0.0026239464380849262" EFFECT_SIZE="0.04622425629290618" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.08921510070488818" LOG_CI_START="-2.5810450343427083" LOG_EFFECT_SIZE="-1.335130067523798" ORDER="28043" O_E="0.0" SE="1.4637132377759594" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" VAR="2.1424564424405825" WEIGHT="8.09740934456702"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" MODIFIED="2009-07-26 17:16:29 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Sharp versus round optic edges (all materials)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.01" MODIFIED="2009-07-26 17:07:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="452" TOTAL_2="454" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA (ALL)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Round</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Sharp</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0713437659324185" CI_START="-0.0713437659324185" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.0" ORDER="28044" SD_1="0.13" SD_2="0.19" SE="0.03640054944640259" STUDY_ID="STD-Buehl-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.20263056197006007" CI_START="-0.002630561970060119" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.95" MEAN_2="0.85" ORDER="28045" SD_1="0.15" SD_2="0.25" SE="0.05236349380886428" STUDY_ID="STD-Buehl-2005" TOTAL_1="31" TOTAL_2="31" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.08476979441475158" CI_START="-0.18476979441475166" EFFECT_SIZE="-0.050000000000000044" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.81" ORDER="28046" SD_1="0.27" SD_2="0.28" SE="0.06876136269737534" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.18437959215066346" CI_START="0.05562040784933654" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.96" MEAN_2="0.84" ORDER="28047" SD_1="0.2" SD_2="0.25" SE="0.03284733426658931" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.11673728567566634" CI_START="-0.016737285675666472" EFFECT_SIZE="0.04999999999999993" ESTIMABLE="YES" MEAN_1="0.97" MEAN_2="0.92" ORDER="28048" SD_1="0.2" SD_2="0.2" SE="0.034050261230349946" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.3111998248814376" CI_START="0.04880017511856252" EFFECT_SIZE="0.18000000000000005" ESTIMABLE="YES" MEAN_1="0.93" MEAN_2="0.75" ORDER="28049" SD_1="0.1" SD_2="0.29" SE="0.06693991620066746" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.58" MEAN_2="0.59" MODIFIED="2009-07-26 13:50:28 +0100" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.3671091814985793" CI_START="0.11289081850142069" EFFECT_SIZE="0.24" ESTIMABLE="YES" MEAN_1="0.83" MEAN_2="0.59" ORDER="28050" SD_1="0.21" SD_2="0.45" SE="0.0648528148992534" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-012.02" MODIFIED="2009-07-26 17:14:30 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="11.66" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="960" TOTAL_2="929" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<CONT_DATA CI_END="-6.590653692640713" CI_START="-15.209346307359283" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="11.0" MEAN_2="21.9" ORDER="28051" SD_1="7.5" SD_2="12.7" SE="2.198686476563273" STUDY_ID="STD-Buehl-2002" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0"/>
<CONT_DATA CI_END="-2.8601438392290506" CI_START="-10.939856160770951" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="7.1" MEAN_2="14.0" ORDER="28052" SD_1="6.5" SD_2="11.3" SE="2.0611889772653065" STUDY_ID="STD-Buehl-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
<CONT_DATA CI_END="-15.646462800997854" CI_START="-40.953537199002156" EFFECT_SIZE="-28.300000000000004" ESTIMABLE="YES" MEAN_1="22.9" MEAN_2="51.2" ORDER="28053" SD_1="32.0" SD_2="17.6" SE="6.456004956627589" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="-6.57586773420781" CI_START="-14.024132265792192" EFFECT_SIZE="-10.3" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="26.3" ORDER="28054" SD_1="10.3" SD_2="12.2" SE="1.900102397374478" STUDY_ID="STD-Hayashi-1998" TOTAL_1="73" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="-8.302120544761237" CI_START="-13.697879455238763" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="20.0" ORDER="28055" SD_1="6.0" SD_2="12.0" SE="1.3764944032233706" STUDY_ID="STD-Hayashi-2004" TOTAL_1="95" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="-3.920240318518813" CI_START="-6.27975968148119" EFFECT_SIZE="-5.100000000000001" ESTIMABLE="YES" MEAN_1="10.2" MEAN_2="15.3" ORDER="28056" SD_1="3.0" SD_2="4.0" SE="0.601929265428846" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="10.2" MEAN_2="56.1" ORDER="28057" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hollick-1998" TOTAL_1="19" TOTAL_2="23" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="14.5" MEAN_2="34.5" MODIFIED="2009-07-18 17:17:50 +0100" MODIFIED_BY="[Empty name]" ORDER="173" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Khanzada-2008" TOTAL_1="55" TOTAL_2="55" WEIGHT="0.0"/>
<CONT_DATA CI_END="1.9213489182626748" CI_START="-5.421348918262675" EFFECT_SIZE="-1.75" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="1.75" ORDER="181" SD_1="2.0" SD_2="14.0" SE="1.873171623163388" STUDY_ID="STD-Kohnen-2008" TOTAL_1="57" TOTAL_2="57" WEIGHT="0.0"/>
<CONT_DATA CI_END="-26.433842343270317" CI_START="-53.566157656729686" EFFECT_SIZE="-40.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="44.0" ORDER="28058" SD_1="10.3" SD_2="30.0" SE="6.921636195224914" STUDY_ID="STD-K_x00fc_c_x00fc_ks_x00fc_mer-2000" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.0"/>
<CONT_DATA CI_END="-0.1374509225884316" CI_START="-1.6625490774115685" EFFECT_SIZE="-0.9000000000000001" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="1.1" ORDER="28059" SD_1="1.2" SD_2="3.1" SE="0.38906280086086187" STUDY_ID="STD-Mester-2004" TOTAL_1="73" TOTAL_2="73" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="15.6" MEAN_2="11.4" ORDER="28060" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Pohjalainen-2002" TOTAL_1="16" TOTAL_2="22" WEIGHT="0.0"/>
<CONT_DATA CI_END="-11.002723410103055" CI_START="-22.597276589896946" EFFECT_SIZE="-16.8" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="23.3" ORDER="28061" SD_1="10.5" SD_2="18.8" SE="2.9578485296796897" STUDY_ID="STD-Sacu-2004d" TOTAL_1="53" TOTAL_2="53" WEIGHT="0.0"/>
<CONT_DATA CI_END="-5.906224328597537" CI_START="-18.09377567140246" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="24.0" ORDER="28062" SD_1="6.0" SD_2="14.0" SE="3.1091263510296048" STUDY_ID="STD-Sacu-2005a" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.0"/>
<CONT_DATA CI_END="3.398037973067657" CI_START="-23.39803797306766" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="45.0" MODIFIED="2009-07-26 13:50:35 +0100" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="50.0" SD_2="50.0" SE="6.835859270246632" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" WEIGHT="0.0"/>
<CONT_DATA CI_END="-3.881981059247688" CI_START="-13.49801894075231" EFFECT_SIZE="-8.69" ESTIMABLE="YES" MEAN_1="0.75" MEAN_2="9.44" ORDER="28063" SD_1="5.54" SD_2="17.98" SE="2.4531159647204492" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="5.8" MEAN_2="15.5" ORDER="28064" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2003" TOTAL_1="40" TOTAL_2="43" WEIGHT="0.0"/>
<CONT_DATA CI_END="-2.5428532774164605" CI_START="-2.85714672258354" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="3.1" ORDER="28065" SD_1="0.2" SD_2="0.5" SE="0.08017837257372731" STUDY_ID="STD-Zemaitiene-2004" TOTAL_1="84" TOTAL_2="42" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="16.0139385151755" CI_END="0.45270384503853034" CI_START="0.14885474400462792" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="OR" EFFECT_SIZE="0.2595902828749974" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="126" I2="25.065279920812223" I2_Q="0.0" ID="CMP-012.03" LOG_CI_END="-0.34418581681041405" LOG_CI_START="-0.8272373198200723" LOG_EFFECT_SIZE="-0.5857115683152432" METHOD="MH" MODIFIED="2009-07-26 17:16:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.1905985919858948" P_Q="0.0" P_Z="2.0041344076001288E-6" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.24188263830053144" TOTALS="YES" TOTAL_1="661" TOTAL_2="795" WEIGHT="100.0" Z="4.753006965401762">
<NAME>YAG rate (ALL)</NAME>
<GROUP_LABEL_1>Sharp</GROUP_LABEL_1>
<GROUP_LABEL_2>Round</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sharp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Round</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.4394304864750029" CI_START="0.006338872501780661" EFFECT_SIZE="0.05277777777777778" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="12" LOG_CI_END="-0.3571098162171136" LOG_CI_START="-2.197987983411803" LOG_EFFECT_SIZE="-1.2775488998144584" ORDER="28067" O_E="0.0" SE="1.0813409479040526" STUDY_ID="STD-Buehl-2005" TOTAL_1="31" TOTAL_2="31" VAR="1.169298245614035" WEIGHT="5.705311941519397"/>
<DICH_DATA CI_END="1.5929357299306035" CI_START="0.019392323780398686" EFFECT_SIZE="0.17575757575757575" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2021982537047301" LOG_CI_START="-1.7123701463346306" LOG_EFFECT_SIZE="-0.7550859463149502" ORDER="160" O_E="0.0" SE="1.124626955449548" STUDY_ID="STD-Buehl-2007" TOTAL_1="34" TOTAL_2="34" VAR="1.26478578892372" WEIGHT="5.343728588960028"/>
<DICH_DATA CI_END="0.8467721366452235" CI_START="0.06694757650886135" EFFECT_SIZE="0.23809523809523808" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.07223344104034041" LOG_CI_START="-1.1742651397554607" LOG_EFFECT_SIZE="-0.6232492903979004" ORDER="28068" O_E="0.0" SE="0.6473388749701496" STUDY_ID="STD-Findl-2005a" TOTAL_1="32" TOTAL_2="32" VAR="0.419047619047619" WEIGHT="12.181659197969845"/>
<DICH_DATA CI_END="0.5589074278382629" CI_START="0.029521138196008295" EFFECT_SIZE="0.12845070422535212" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="25" LOG_CI_END="-0.2526601186042879" LOG_CI_START="-1.5298669021770304" LOG_EFFECT_SIZE="-0.8912635103906591" ORDER="28069" O_E="0.0" SE="0.7502375869461719" STUDY_ID="STD-Hayashi-1998" TOTAL_1="73" TOTAL_2="139" VAR="0.562856436866815" WEIGHT="10.004767255731197"/>
<DICH_DATA CI_END="0.7965698308028525" CI_START="0.01206634677928031" EFFECT_SIZE="0.09803921568627451" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.09877614603610495" LOG_CI_START="-1.9184241974877299" LOG_EFFECT_SIZE="-1.0086001717619175" ORDER="28070" O_E="0.0" SE="1.0688702728258088" STUDY_ID="STD-Hayashi-2005" TOTAL_1="69" TOTAL_2="69" VAR="1.142483660130719" WEIGHT="5.815821403457482"/>
<DICH_DATA CI_END="2.953612854824665" CI_START="0.0069095593323850145" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.47035356950266693" LOG_CI_START="-2.160549649531181" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="28071" O_E="0.0" SE="1.5454055740414514" STUDY_ID="STD-Hollick-1998" TOTAL_1="19" TOTAL_2="22" VAR="2.388278388278388" WEIGHT="3.061115675915097"/>
<DICH_DATA CI_END="0.8460831602355288" CI_START="0.10158602682190465" EFFECT_SIZE="0.2931726907630522" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="15" LOG_CI_END="-0.07258694871458087" LOG_CI_START="-0.9931660252359799" LOG_EFFECT_SIZE="-0.5328764869752805" ORDER="182" O_E="0.0" SE="0.540752706488592" STUDY_ID="STD-Kohnen-2008" TOTAL_1="88" TOTAL_2="88" VAR="0.29241348957473734" WEIGHT="15.068848020027632"/>
<DICH_DATA CI_END="5.560021583002775" CI_START="0.043723531866742424" EFFECT_SIZE="0.4930555555555556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7450764774383192" LOG_CI_START="-1.359284764190668" LOG_EFFECT_SIZE="-0.30710414337617437" ORDER="28072" O_E="0.0" SE="1.2361122100890123" STUDY_ID="STD-Mester-2004" TOTAL_1="73" TOTAL_2="73" VAR="1.5279733959311423" WEIGHT="4.5490859103332975"/>
<DICH_DATA CI_END="114.04914786656252" CI_START="0.16628462853131953" EFFECT_SIZE="4.354838709677419" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.057092044735576" LOG_CI_START="-0.7791478954141092" LOG_EFFECT_SIZE="0.6389720746607334" MODIFIED="2009-07-18 17:56:35 +0100" MODIFIED_BY="[Empty name]" ORDER="28073" O_E="0.0" SE="1.6660213804580568" STUDY_ID="STD-Pohjalainen-2002" TOTAL_1="16" TOTAL_2="22" VAR="2.7756272401433693" WEIGHT="2.668169276315215"/>
<DICH_DATA CI_END="1.830496416032352" CI_START="0.004721952908554314" EFFECT_SIZE="0.09297052154195011" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.26256888290403085" LOG_CI_START="-2.325878348400237" LOG_EFFECT_SIZE="-1.0316547327481032" ORDER="28074" O_E="0.0" SE="1.5204667166885675" STUDY_ID="STD-Sacu-2005a" TOTAL_1="24" TOTAL_2="24" VAR="2.3118190365577127" WEIGHT="3.1527673055579593"/>
<DICH_DATA CI_END="2.2879639103678358" CI_START="0.3468383937428081" EFFECT_SIZE="0.8908163265306123" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.3594491697487327" LOG_CI_START="-0.459872833722583" LOG_EFFECT_SIZE="-0.05021183198692512" MODIFIED="2009-07-26 13:50:41 +0100" MODIFIED_BY="[Empty name]" ORDER="199" O_E="0.0" SE="0.48127380054837765" STUDY_ID="STD-Shah-2007" TOTAL_1="107" TOTAL_2="107" VAR="0.2316244710942796" WEIGHT="17.003392322729724"/>
<DICH_DATA CI_END="0.8143008709399274" CI_START="0.0026239464380849262" EFFECT_SIZE="0.04622425629290618" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" LOG_CI_END="-0.08921510070488818" LOG_CI_START="-2.5810450343427083" LOG_EFFECT_SIZE="-1.335130067523798" ORDER="28075" O_E="0.0" SE="1.4637132377759594" STUDY_ID="STD-Sundelin-2005" TOTAL_1="57" TOTAL_2="59" VAR="2.1424564424405825" WEIGHT="3.376712319851397"/>
<DICH_DATA CI_END="1.1538660879074956" CI_START="0.08953926942941326" EFFECT_SIZE="0.32142857142857145" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="20" LOG_CI_END="0.06215540963649763" LOG_CI_START="-1.0479864534422862" LOG_EFFECT_SIZE="-0.49291552190289434" ORDER="28076" O_E="0.0" SE="0.6521028256633268" STUDY_ID="STD-Wejde-2003" TOTAL_1="38" TOTAL_2="95" VAR="0.4252380952380952" WEIGHT="12.06862078163173"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" MODIFIED="2009-07-26 17:26:37 +0100" MODIFIED_BY="[Empty name]" NO="13">
<NAME>1-piece versus 3-piece design (Acrylic)</NAME>
<CONT_OUTCOME CHI2="2.8582838683626135" CI_END="0.04649734504910547" CI_START="-0.018457773072525586" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.014019785988289941" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.01" MODIFIED="2009-07-26 17:18:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.41399512666206484" P_Q="1.0" P_Z="0.39751392337385416" Q="0.0" RANDOM="NO" SCALE="0.15173616440277943" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="160" TOTAL_2="160" UNITS="" WEIGHT="100.00000000000001" Z="0.8460696062950238">
<NAME>BCDVA (2 years)</NAME>
<GROUP_LABEL_1>1piece</GROUP_LABEL_1>
<GROUP_LABEL_2>3piece</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 3-piece</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 1-piece</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.14257076632601576" CI_START="-0.0025707663260156333" EFFECT_SIZE="0.07000000000000006" ESTIMABLE="YES" MEAN_1="0.78" MEAN_2="0.71" MODIFIED="2009-07-12 20:12:59 +0100" MODIFIED_BY="[Empty name]" ORDER="166" SD_1="0.13" SD_2="0.16" SE="0.03702658155886773" STUDY_ID="STD-Hancox-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="20.028265697557043"/>
<CONT_DATA CI_END="0.11087230594797426" CI_START="-0.11087230594797426" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.8" MODIFIED="2009-07-18 18:11:22 +0100" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="0.2" SD_2="0.2" SE="0.05656854249492381" STUDY_ID="STD-Leydolt-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="8.580658186957399"/>
<CONT_DATA CI_END="0.06197950323045617" CI_START="-0.06197950323045617" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.0" ORDER="28077" SD_1="0.1" SD_2="0.1" SE="0.0316227766016838" STUDY_ID="STD-Nejima-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="27.45810619826368"/>
<CONT_DATA CI_END="0.04899909961350136" CI_START="-0.04899909961350136" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="1.25" ORDER="28079" SD_1="0.1" SD_2="0.1" SE="0.025" STUDY_ID="STD-Nejima-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="43.93296991722189"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.0" MEAN_2="1.0" ORDER="28078" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Sacu-2004a" TOTAL_1="52" TOTAL_2="52" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-013.02" MODIFIED="2009-07-26 17:26:37 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="32.16" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="521" TOTAL_2="602" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>1piece</GROUP_LABEL_1>
<GROUP_LABEL_2>3piece</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 1-piece</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 3-piece</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.41112795501311" CI_START="-6.41112795501311" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="11.4" ORDER="28080" SD_1="12.2" SD_2="14.9" SE="2.505723571326545" STUDY_ID="STD-Bender-2004" TOTAL_1="38" TOTAL_2="94" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="10.07" MEAN_2="10.56" ORDER="28081" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Bilge-2004" TOTAL_1="252" TOTAL_2="267" WEIGHT="0.0"/>
<CONT_DATA CI_END="-13.580705981313567" CI_START="-33.63929401868643" EFFECT_SIZE="-23.61" ESTIMABLE="YES" MEAN_1="8.83" MEAN_2="32.44" MODIFIED="2009-07-18 18:12:53 +0100" MODIFIED_BY="[Empty name]" ORDER="167" SD_1="10.89" SD_2="26.82" SE="5.117080771787759" STUDY_ID="STD-Hancox-2008" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="12.632745862207809" CI_START="-4.632745862207809" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="13.0" MODIFIED="2009-07-18 18:12:36 +0100" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="17.0" SD_2="14.0" SE="4.404543109109048" STUDY_ID="STD-Leydolt-2007" TOTAL_1="25" TOTAL_2="25" WEIGHT="0.0"/>
<CONT_DATA CI_END="3.6172006259877896" CI_START="-1.217200625987791" EFFECT_SIZE="1.1999999999999993" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="11.3" ORDER="28082" SD_1="3.9" SD_2="3.9" SE="1.2332882874656679" STUDY_ID="STD-Nejima-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
<CONT_DATA CI_END="1.1465789309559318" CI_START="-1.1465789309559318" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="10.94" MEAN_2="10.94" ORDER="28085" SD_1="2.34" SD_2="2.34" SE="0.585" STUDY_ID="STD-Nejima-2006" TOTAL_1="32" TOTAL_2="32" WEIGHT="0.0"/>
<CONT_DATA CI_END="4.409424512184815" CI_START="1.5905754878151845" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="12.0" ORDER="28083" SD_1="3.3" SD_2="4.0" SE="0.7191073526361587" STUDY_ID="STD-Sacu-2004a" TOTAL_1="52" TOTAL_2="52" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.36984798212917613" CI_START="0.23015201787082384" EFFECT_SIZE="0.3" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="0.3" ORDER="28084" SD_1="0.2" SD_2="0.1" SE="0.03563738042133842" STUDY_ID="STD-Zemaitiene-2004" TOTAL_1="38" TOTAL_2="46" WEIGHT="0.0"/>
<CONT_DATA CI_END="2.8452847900159686" CI_START="-2.1452847900159684" EFFECT_SIZE="0.3500000000000001" ESTIMABLE="YES" MEAN_1="3.75" MEAN_2="3.4" MODIFIED="2009-07-18 21:10:06 +0100" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="4.75" SD_2="5.58" SE="1.2731278787255564" STUDY_ID="STD-Zemaitiene-2007" TOTAL_1="32" TOTAL_2="34" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.36881169388570845" CI_END="4.185728167877565" CI_START="0.27053139419921607" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0641291636802594" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-013.03" LOG_CI_END="0.621771020700207" LOG_CI_START="-0.5677823293139912" LOG_EFFECT_SIZE="0.02699434569310795" METHOD="MH" MODIFIED="2009-07-18 21:11:13 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5436529824975866" P_Q="0.0" P_Z="0.929118225971588" Q="0.0" RANDOM="NO" SCALE="110.26013089671272" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="399" TOTAL_2="472" WEIGHT="100.0" Z="0.08895430430940154">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>1piece</GROUP_LABEL_1>
<GROUP_LABEL_2>3piece</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 1-piece</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 3-piece</GRAPH_LABEL_2>
<DICH_DATA CI_END="10.243633048326464" CI_START="0.022540730429272276" EFFECT_SIZE="0.4805194805194805" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="1.0104540125979022" LOG_CI_START="-1.647032014808876" LOG_EFFECT_SIZE="-0.31828900110548686" ORDER="28086" O_E="0.0" SE="1.5610204472667346" STUDY_ID="STD-Bender-2004" TOTAL_1="38" TOTAL_2="94" VAR="2.4367848367848364" WEIGHT="36.308423554264586"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="28087" O_E="0.0" SE="0.0" STUDY_ID="STD-Bilge-2004" TOTAL_1="252" TOTAL_2="267" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.001708006335201" CI_START="0.27866360428784476" EFFECT_SIZE="1.3968253968253967" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.8452039953348187" LOG_CI_START="-0.554919749941645" LOG_EFFECT_SIZE="0.14514212269658688" MODIFIED="2009-07-18 18:14:08 +0100" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.8224396186997112" STUDY_ID="STD-Leydolt-2007" TOTAL_1="25" TOTAL_2="25" VAR="0.6764069264069263" WEIGHT="63.69157644573541"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="28088" O_E="0.0" SE="0.0" STUDY_ID="STD-Sacu-2004a" TOTAL_1="52" TOTAL_2="52" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-07-18 21:11:13 +0100" MODIFIED_BY="[Empty name]" ORDER="197" O_E="0.0" SE="0.0" STUDY_ID="STD-Zemaitiene-2007" TOTAL_1="32" TOTAL_2="34" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" MODIFIED="2009-07-26 17:36:48 +0100" MODIFIED_BY="[Empty name]" NO="14">
<NAME>1-piece versus 3-piece design (PMMA)</NAME>
</COMPARISON>
<COMPARISON ID="CMP-015" MODIFIED="2009-07-26 17:38:34 +0100" MODIFIED_BY="[Empty name]" NO="15">
<NAME>Convex-plano versus plano-convex IOLs</NAME>
</COMPARISON>
<COMPARISON ID="CMP-016" MODIFIED="2009-07-26 17:38:34 +0100" MODIFIED_BY="[Empty name]" NO="16">
<NAME>Ridge versus no ridge in PMMA IOLs</NAME>
<DICH_OUTCOME CHI2="2.4114410343699397" CI_END="2.156014323594069" CI_START="0.8752743146330866" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="OR" EFFECT_SIZE="1.373719024918457" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="101" I2="17.062040021121266" I2_Q="0.0" ID="CMP-016.01" LOG_CI_END="0.33365164178241985" LOG_CI_START="-0.057855815936473105" LOG_EFFECT_SIZE="0.13789791292297332" METHOD="MH" NO="1" P_CHI2="0.2994762092890191" P_Q="0.0" P_Z="0.16737472636023973" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0298669341074606" TOTALS="YES" TOTAL_1="289" TOTAL_2="276" WEIGHT="100.0" Z="1.3806886052542526">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>ridge</GROUP_LABEL_1>
<GROUP_LABEL_2>no ridge</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ridge</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no-ridge</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.628229173269057" CI_START="0.21606535946310323" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6654148555134974" LOG_CI_START="-0.6654148555134974" LOG_EFFECT_SIZE="0.0" ORDER="28089" O_E="0.0" SE="0.7817359599705717" STUDY_ID="STD-H_x00fc_tz-1989" TOTAL_1="22" TOTAL_2="22" VAR="0.6111111111111112" WEIGHT="8.251105273171676"/>
<DICH_DATA CI_END="1.862930883466112" CI_START="0.5327631704685784" EFFECT_SIZE="0.9962434259954921" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="22" LOG_CI_END="0.2701967424506723" LOG_CI_START="-0.27346580526251396" LOG_EFFECT_SIZE="-0.0016345314059207998" ORDER="28090" O_E="0.0" SE="0.31935007169973945" STUDY_ID="STD-Westling-1991" TOTAL_1="147" TOTAL_2="124" VAR="0.10198446829462873" WEIGHT="40.111650179963675"/>
<DICH_DATA CI_END="3.1448550236473873" CI_START="1.0940603806057265" EFFECT_SIZE="1.8549019607843138" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="75" LOG_CI_END="0.4976006294693026" LOG_CI_START="0.03904129113841017" LOG_EFFECT_SIZE="0.2683209603038564" ORDER="28091" O_E="0.0" SE="0.2693600252408996" STUDY_ID="STD-Winther-1998" TOTAL_1="120" TOTAL_2="130" VAR="0.07255482319777806" WEIGHT="51.63724454686465"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-017" MODIFIED="2009-07-26 17:39:41 +0100" MODIFIED_BY="[Empty name]" NO="17">
<NAME>Bag versus sulcus IOL placement</NAME>
</COMPARISON>
<COMPARISON ID="CMP-018" MODIFIED="2009-12-10 14:34:57 +0000" MODIFIED_BY="Anupa Shah" NO="18">
<NAME>Rhexis on versus rhexis off</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-018.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="378" TOTAL_2="340" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (ALL)</NAME>
<GROUP_LABEL_1>Rhexis on</GROUP_LABEL_1>
<GROUP_LABEL_2>Rhexis off (decent.)</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Rhexis on</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Rhexis off</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="7.1" MEAN_2="16.6" ORDER="28092" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Aykan-2003" TOTAL_1="256" TOTAL_2="240" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="43.5" MEAN_2="42.2" ORDER="28093" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Vasavada-2004" TOTAL_1="62" TOTAL_2="68" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1.25" MEAN_2="6.73" ORDER="28094" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wejde-2004" TOTAL_1="60" TOTAL_2="32" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-019" MODIFIED="2009-07-26 17:40:27 +0100" MODIFIED_BY="[Empty name]" NO="19">
<NAME>Small versus large rhexis</NAME>
</COMPARISON>
<COMPARISON ID="CMP-020" MODIFIED="2009-07-26 17:40:27 +0100" MODIFIED_BY="[Empty name]" NO="20">
<NAME>Anterior capsule polishing versus non-polished</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-020.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="NO" TOTAL_1="78" TOTAL_2="78" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100 (FIBROSIS)</NAME>
<GROUP_LABEL_1>polished</GROUP_LABEL_1>
<GROUP_LABEL_2>non-polished</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Polished</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Non-Polished</GRAPH_LABEL_2>
<CONT_DATA CI_END="-7.773212983979312" CI_START="-17.226787016020687" EFFECT_SIZE="-12.5" ESTIMABLE="YES" MEAN_1="12.5" MEAN_2="25.0" ORDER="28095" SD_1="8.8" SD_2="15.0" SE="2.4116703435904845" STUDY_ID="STD-Sacu-2004b" TOTAL_1="52" TOTAL_2="52" WEIGHT="0.0"/>
<CONT_DATA CI_END="7.955963392001597" CI_START="-4.555963392001597" EFFECT_SIZE="1.7000000000000002" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="4.3" ORDER="28096" SD_1="14.0" SD_2="8.3" SE="3.1918767086272184" STUDY_ID="STD-Sacu-2004c" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-021" MODIFIED="2009-12-10 14:35:13 +0000" MODIFIED_BY="Anupa Shah" NO="21">
<NAME>Capsular bending ring versus no ring</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-021.01" MODIFIED="2009-07-18 18:46:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.32" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BCDVA (3 years)</NAME>
<GROUP_LABEL_1>CBR</GROUP_LABEL_1>
<GROUP_LABEL_2>No Ring</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours No Ring</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Bending Ring</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.22605823279296416" CI_START="0.03394176720703586" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.63" MODIFIED="2009-07-18 18:44:53 +0100" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="0.24" SD_2="0.25" SE="0.04901020301937139" STUDY_ID="STD-Menapace-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-021.02" MODIFIED="2009-07-18 18:46:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="30.27269141572956" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="49" TOTAL_2="49" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100</NAME>
<GROUP_LABEL_1>CBR</GROUP_LABEL_1>
<GROUP_LABEL_2>No Ring</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Bending Ring</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours No Ring</GRAPH_LABEL_2>
<CONT_DATA CI_END="-11.261856774673214" CI_START="-19.33814322532679" EFFECT_SIZE="-15.3" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="24.3" MODIFIED="2009-07-18 18:39:52 +0100" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="8.0" SD_2="12.0" SE="2.0603150145508513" STUDY_ID="STD-Menapace-2008" TOTAL_1="49" TOTAL_2="49" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-021.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-18 18:46:23 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>CBR</GROUP_LABEL_1>
<GROUP_LABEL_2>No Ring</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Bending Ring</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours No Ring</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.34268571584646446" CI_START="0.005488197183423761" EFFECT_SIZE="0.04336734693877551" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="16" LOG_CI_END="-0.4651039978705359" LOG_CI_START="-2.2605702934138305" LOG_EFFECT_SIZE="-1.3628371456421833" MODIFIED="2009-07-18 18:35:50 +0100" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="1.0546657897036333" STUDY_ID="STD-Menapace-2008" TOTAL_1="50" TOTAL_2="50" VAR="1.1123199279711884" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-022" MODIFIED="2009-12-10 14:35:26 +0000" MODIFIED_BY="Anupa Shah" NO="22">
<NAME>Sealed capsule irrigation versus none</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-022.01" MODIFIED="2009-07-18 20:04:35 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.269539964566704" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="17" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100</NAME>
<GROUP_LABEL_1>Sealed Capsule Irrigation</GROUP_LABEL_1>
<GROUP_LABEL_2>No SCI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SCI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.351301115558114" CI_START="-14.351301115558114" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="19.5" MODIFIED="2009-07-18 20:04:13 +0100" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="18.0" SD_2="17.25" SE="6.046693311223912" STUDY_ID="STD-Rabsilber-2007" TOTAL_1="17" TOTAL_2="17" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-022.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-18 20:02:36 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="30.4258591762675" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="17" WEIGHT="0.0" Z="0.0">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Sealed Capsule Irrigation</GROUP_LABEL_1>
<GROUP_LABEL_2>No SCI</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours SCI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.091949480610218" CI_START="0.232863318371624" EFFECT_SIZE="1.6071428571428572" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.0450078828728113" LOG_CI_START="-0.6328989180065624" LOG_EFFECT_SIZE="0.20605448243312446" MODIFIED="2009-07-18 20:01:42 +0100" MODIFIED_BY="[Empty name]" ORDER="189" O_E="0.0" SE="0.9856107606091623" STUDY_ID="STD-Rabsilber-2007" TOTAL_1="17" TOTAL_2="17" VAR="0.9714285714285714" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-023" MODIFIED="2009-12-10 14:35:33 +0000" MODIFIED_BY="Anupa Shah" NO="23">
<NAME>Dexamethasone versus placebo</NAME>
<DICH_OUTCOME CHI2="0.005584584462042935" CI_END="2.475142686713425" CI_START="0.5442478864672995" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.1606425702811245" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-023.01" LOG_CI_END="0.39360024014477296" LOG_CI_START="-0.26420324882314994" LOG_EFFECT_SIZE="0.06469849566081151" METHOD="MH" NO="1" P_CHI2="0.9404294764032309" P_Q="0.0" P_Z="0.6998330022781807" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="100" TOTAL_2="100" WEIGHT="100.0" Z="0.3855459068727899">
<NAME>YAG rate (2 years)</NAME>
<GROUP_LABEL_1>Dexamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Dexamethas.</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.023917717166846" CI_START="0.4247617047093" EFFECT_SIZE="1.1333333333333333" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.4805699695452482" LOG_CI_START="-0.37185464490006287" LOG_EFFECT_SIZE="0.054357662322592676" ORDER="28097" O_E="0.0" SE="0.5007184380950696" STUDY_ID="STD-Laurell-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.250718954248366" WEIGHT="60.24096385542169"/>
<DICH_DATA CI_END="3.954981369069567" CI_START="0.36532474649927293" EFFECT_SIZE="1.202020202020202" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5971444419855695" LOG_CI_START="-0.4373209083956079" LOG_EFFECT_SIZE="0.07991176679498084" ORDER="28098" O_E="0.0" SE="0.6076500674999733" STUDY_ID="STD-Zaczek-2004" TOTAL_1="40" TOTAL_2="40" VAR="0.36923860453272217" WEIGHT="39.75903614457832"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-024" MODIFIED="2009-12-10 14:35:40 +0000" MODIFIED_BY="Anupa Shah" NO="24">
<NAME>Diclofenac versus placebo</NAME>
<DICH_OUTCOME CHI2="0.0023894379516565187" CI_END="2.627048360302016" CI_START="0.5972809242064309" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="OR" EFFECT_SIZE="1.2526315789473683" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-024.01" LOG_CI_END="0.4194680676162923" LOG_CI_START="-0.2238213554089264" LOG_EFFECT_SIZE="0.09782335610368295" METHOD="MH" NO="1" P_CHI2="0.9610134460576086" P_Q="0.0" P_Z="0.5511129085474235" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="105" TOTAL_2="100" WEIGHT="100.0" Z="0.5960932915961802">
<NAME>YAG rate (2 years)</NAME>
<GROUP_LABEL_1>Diclofenac</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Diclofenac</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.3365019996637386" CI_START="0.4850172156255839" EFFECT_SIZE="1.272108843537415" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.5232913894723189" LOG_CI_START="-0.3142428458956732" LOG_EFFECT_SIZE="0.1045242717883229" ORDER="28099" O_E="0.0" SE="0.49197175571648727" STUDY_ID="STD-Laurell-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.24203620842276302" WEIGHT="58.456140350877185"/>
<DICH_DATA CI_END="3.894294376671854" CI_START="0.3854810929345154" EFFECT_SIZE="1.2252252252252251" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.5904287775209429" LOG_CI_START="-0.4139969183538228" LOG_EFFECT_SIZE="0.08821592958356005" ORDER="28100" O_E="0.0" SE="0.5900046257442191" STUDY_ID="STD-Zaczek-2004" TOTAL_1="45" TOTAL_2="40" VAR="0.3481054583995761" WEIGHT="41.54385964912281"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-025" MODIFIED="2009-07-26 20:29:56 +0100" MODIFIED_BY="[Empty name]" NO="25">
<NAME>Dexamethasone versus Diclofenac</NAME>
<CONT_OUTCOME CHI2="0.27141049460471056" CI_END="4.181499035819509" CI_START="-0.27804795220112255" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.951725541809193" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-025.01" NO="1" P_CHI2="0.6023872187944301" P_Q="1.0" P_Z="0.08624247721291997" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="83" TOTAL_2="80" UNITS="" WEIGHT="99.99999999999999" Z="1.7155606970522386">
<NAME>PCO score 0-100</NAME>
<GROUP_LABEL_1>Dexa-/Betamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Cortisone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Diclofenac</GRAPH_LABEL_2>
<CONT_DATA CI_END="22.573711086311867" CI_START="-10.073711086311873" EFFECT_SIZE="6.249999999999998" ESTIMABLE="YES" MEAN_1="16.88" MEAN_2="10.63" ORDER="28101" SD_1="26.88" SD_2="14.38" SE="8.328577063186478" STUDY_ID="STD-Barequet-2002" TOTAL_1="13" TOTAL_2="15" WEIGHT="1.865879949981553"/>
<CONT_DATA CI_END="4.120871655478622" CI_START="-0.38087165547862023" EFFECT_SIZE="1.870000000000001" ESTIMABLE="YES" MEAN_1="12.73" MEAN_2="10.86" ORDER="28102" SD_1="4.92" SD_2="3.2" SE="1.148425008435466" STUDY_ID="STD-Tsuchiya-2003" TOTAL_1="30" TOTAL_2="20" WEIGHT="98.13412005001844"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="18.0" MEAN_2="19.5" ORDER="28103" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Zaczek-2004" TOTAL_1="40" TOTAL_2="45" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.062445389078762" CI_END="2.0643938061792673" CI_START="0.5593310590604615" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0745601769692132" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-025.02" LOG_CI_END="0.31479254738192824" LOG_CI_START="-0.25233106409021083" LOG_EFFECT_SIZE="0.031230741645858717" METHOD="MH" NO="2" P_CHI2="0.786146785866356" P_Q="0.0" P_Z="0.8290928160304122" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="143" TOTAL_2="140" WEIGHT="99.99999999999999" Z="0.2158652103285433">
<NAME>YAG rate</NAME>
<GROUP_LABEL_1>Dexa-/Betamethasone</GROUP_LABEL_1>
<GROUP_LABEL_2>Diclofenac</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Cortisone</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Diclofenac</GRAPH_LABEL_2>
<DICH_DATA CI_END="99.47570058684678" CI_START="0.13911337058559792" EFFECT_SIZE="3.72" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9977170064756786" LOG_CI_START="-0.8566311267118838" LOG_EFFECT_SIZE="0.5705429398818975" ORDER="28104" O_E="0.0" SE="1.6766582226855073" STUDY_ID="STD-Barequet-2002" TOTAL_1="13" TOTAL_2="15" VAR="2.8111827956989246" WEIGHT="3.947676675469554"/>
<DICH_DATA CI_END="2.2867707240007995" CI_START="0.3470916432215901" EFFECT_SIZE="0.8909090909090909" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="11" LOG_CI_END="0.3592226235954571" LOG_CI_START="-0.45955584252691745" LOG_EFFECT_SIZE="-0.0501666094657302" ORDER="28105" O_E="0.0" SE="0.48095452401905636" STUDY_ID="STD-Laurell-2002" TOTAL_1="60" TOTAL_2="60" VAR="0.23131725417439705" WEIGHT="47.97584509063509"/>
<DICH_DATA CI_END="10.33933335166131" CI_START="0.31336643183860613" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.0144925376913476" LOG_CI_START="-0.5039475274847355" LOG_EFFECT_SIZE="0.25527250510330607" ORDER="28106" O_E="0.0" SE="0.8919392106839769" STUDY_ID="STD-Tsuchiya-2003" TOTAL_1="30" TOTAL_2="20" VAR="0.7955555555555556" WEIGHT="13.949548432619753"/>
<DICH_DATA CI_END="2.999819422553255" CI_START="0.32084595010215716" EFFECT_SIZE="0.9810606060606061" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.4770951126699846" LOG_CI_START="-0.49370343824714313" LOG_EFFECT_SIZE="-0.008304162788579228" ORDER="28107" O_E="0.0" SE="0.5702518743390504" STUDY_ID="STD-Zaczek-2004" TOTAL_1="40" TOTAL_2="45" VAR="0.3251872001872002" WEIGHT="34.126929801275594"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-026" MODIFIED="2009-07-26 20:29:56 +0100" MODIFIED_BY="[Empty name]" NO="26">
<NAME>Diclofenac versus Ketorolac</NAME>
</COMPARISON>
<COMPARISON ID="CMP-027" MODIFIED="2009-12-10 14:35:48 +0000" MODIFIED_BY="Anupa Shah" NO="27">
<NAME>Immunotoxin MDX-A versus placebo</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-027.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="59" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>PCO score 0-100</NAME>
<GROUP_LABEL_1>Immunotoxin</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Immunotoxin</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="25.0" MEAN_2="62.5" ORDER="28108" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Clark-1998" TOTAL_1="42" TOTAL_2="21" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="5.6" MEAN_2="32.1" ORDER="28109" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Meacock-2000" TOTAL_1="17" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-028" MODIFIED="2009-12-10 14:35:58 +0000" MODIFIED_BY="Anupa Shah" NO="28">
<NAME>Heparin eye drops versus no treatment</NAME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-12-09 15:07:16 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2009-12-09 15:01:52 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-12-09 15:01:52 +0000" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-12-09 15:00:14 +0000" MODIFIED_BY="[Empty name]">
<P>#1 MeSH descriptor Cataract Extraction<BR/>#2 phacoemulsificat* or capsulorhexis<BR/>#3 cataract* NEAR/3 (extract* or surg*)<BR/>#4 MeSH descriptor Lenses, Intraocular<BR/>#5 MeSH descriptor Lens Implantation, Intraocular<BR/>#6 MeSH descriptor Lens Capsule, Crystalline<BR/>#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)<BR/>#8 posterior NEAR/3 capsul* NEAR/3 opaci*<BR/>#9 PCO<BR/>#10 aftercataract<BR/>#11 secondary cataract*<BR/>#12 (#8 OR #9 OR #10 OR #11)<BR/>#13 (#7 AND #12)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-12-09 15:03:50 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2009-12-09 15:02:17 +0000" MODIFIED_BY="[Empty name]">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-12-09 15:03:50 +0000" MODIFIED_BY="[Empty name]">
<P>1 randomized controlled trial.pt. <BR/>2 (randomized or randomised).ab,ti. <BR/>3 placebo.ab,ti. <BR/>4 dt.fs. <BR/>5 randomly.ab,ti. <BR/>6 trial.ab,ti. <BR/>7 groups.ab,ti. <BR/>8 or/1-7<BR/>9 exp animals/ <BR/>10 exp humans/ <BR/>11 9 not (9 and 10) <BR/>12 8 not 11 <BR/>13 exp cataract extraction/ <BR/>14 (phacoemulsificat$ or capsulorhexis).tw. <BR/>15 ((extract$ or surg$) adj3 cataract$).tw. <BR/>16 exp lenses, intraocular/ <BR/>17 exp lens implantation, intraocular/ <BR/>18 exp lens capsule crystalline/ <BR/>19 or/13-18<BR/>20 (posterior adj3 capsul$ adj3 opaci$).tw. <BR/>21 PCO.tw. <BR/>22 aftercataract.tw. <BR/>23 secondary cataract$.tw.<BR/>24 or/20-23 <BR/>25 19 and 24 <BR/>26 12 and 25 </P>
<P>The search filter for trials at the beginning of the MEDLINE strategy was from the published paper by Glanville et al (<LINK REF="REF-Glanville-2006" TYPE="REFERENCE">Glanville 2006</LINK>).</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2009-12-09 15:06:14 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2009-12-09 15:02:25 +0000" MODIFIED_BY="[Empty name]">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-12-09 15:06:14 +0000" MODIFIED_BY="[Empty name]">
<P>1 exp randomized controlled trial/ <BR/>2 exp randomization/ <BR/>3 exp double blind procedure/ <BR/>4 exp single blind procedure/ <BR/>5 random$.tw.<BR/>6 or/1-5 <BR/>7 (animal or animal experiment).sh. <BR/>8 human.sh. <BR/>9 7 and 8 <BR/>10 7 not 9 <BR/>11 6 not 10 <BR/>12 exp clinical trial/ <BR/>13 (clin$ adj3 trial$).tw. <BR/>14 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw. <BR/>15 exp placebo/<BR/>16 placebo$.tw. <BR/>17 random$.tw. <BR/>18 exp experimental design/ <BR/>19 exp crossover procedure/ <BR/>20 exp control group/ <BR/>21 exp latin square design/ <BR/>22 or/12-21 <BR/>23 22 not 10<BR/>24 23 not 11 <BR/>25 exp comparative study/ <BR/>26 exp evaluation/ <BR/>27 exp prospective study/ <BR/>28 (control$ or prospectiv$ or volunteer$).tw. <BR/>29 or/25-28 <BR/>30 29 not 10 <BR/>31 30 not (11 or 23) <BR/>32 11 or 24 or 31 <BR/>33 exp cataract extraction/ <BR/>34 (phacoemulsificat$ or capsulorhexis).tw. <BR/>35 ((extract$ or surg$) adj3 cataract$).tw. <BR/>36 lens implantation/ <BR/>37 lens implant/ <BR/>38 exp lens capsule/ <BR/>39 or/33-38 <BR/>40 exp aftercataract/ <BR/>41 (posterior adj3 capsul$ adj3 opaci$).tw.<BR/>42 PCO.tw. <BR/>43 aftercataract.tw. <BR/>44 secondary cataract$.tw. <BR/>45 or/40-44 <BR/>46 39 and 45 <BR/>47 32 and 46 </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2009-12-09 15:07:16 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2009-12-09 15:02:39 +0000" MODIFIED_BY="[Empty name]">LILACS search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-12-09 15:07:16 +0000" MODIFIED_BY="[Empty name]">
<P>cataract and posterior capsul$ opaci$ or PCO </P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>